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During embryonic development, organ morphogenesis is driven by coordination and 
alignment of local cellular behaviors with the three body axes: dorsal-ventral (DV), anterior-
posterior (AP) and left-right (LR) axes. This involves translation and amplification of molecular 
chirality defined by genetically encoded spatial cues into asymmetric cell behavior that is critical 
for defining the organ’s form and function.   
The gastrointestinal tract, displaying profound LR asymmetries, presents itself as a 
powerful model to study the asymmetric mechanisms involved in the establishment of its 
stereotypical looping topology and patterning of its vasculature. Asymmetric looping 
morphogenesis of the gut initiates with a critical leftward tilt directed by the evolutionarily 
conserved LR pathway. Failure to do so leads to gut malrotation and the catastrophic midgut 
volvulus, highlighting an urgent need to define the molecular basis of this process. Previous 
research in mice and birds has shown that the leftward tilt of the gut is established by cellular and 
extracellular asymmetries across the LR axis of the dorsal mesentery (DM), which suspends the 
gut tube. The left DM condenses while the right expands causing the DM to tilt the gut tube 
leftward, and this critical bias determines gut chirality. Concomitantly, vasculogenesis of the gut 
proceeds within the left DM but is excluded on the right, suggesting that the cellular processes 
within the DM are also employed to pattern abdominal blood vessels. While the left DM has been 
 shown to be under the control of the left-determining transcription factor Pitx2, the mechanisms 
that regulate the expansion and vascular exclusion specific to the right DM have remained 
unknown.  
Surprisingly, my research demonstrates that the expansion of the right DM precedes all 
other cell asymmetries that collectively deform this structure, suggesting that the key initiator of 
asymmetric gut tilting derives from the right side. Hyaluronan (HA), a unique and highly 
conserved glycosaminoglycan, predominates in the extracellular matrix (ECM) of the right DM. 
Targeted degradation of HA in the right DM ablates expansion, gut tilting and results in aberrant 
retention of vasculature in the right DM.  This unexpected finding demonstrates that HA is a 
critical regulator of the ECM expansion and vascular exclusion necessary for asymmetric gut 
looping and vascular morphogenesis. Investigating into how HA enacts its functions, I show that 
the tumor necrosis factor alpha-inducible protein 6 (Tsg6/Tnfaip6), an enzyme that covalently 
modifies HA to form a stable heavy chain (HC) HA complex, is restricted to the right DM. 
Knockdown of Tsg6 on the right prevents ECM expansion, gut tilting, and disrupts the normal 
process of vascular exclusion, leading to aberrant gut vascular patterning. Furthermore, 
misexpression of Tsg6 in the left DM prevents the formation of abdominal blood vessels 
demonstrating that Tsg6 is both necessary and sufficient to inhibit gut vascular development. The 
ability of Tsg6 to mediate ECM expansion and vascular exclusion is dependent on its enzymatic 
ability to covalent modify HA. Further analysis of Tsg6 knockout mice revealed randomized gut 
looping chirality and gut malrotations in Tsg6 mutant embryos that predispose them volvulus.  
Collectively, my study identifies a new pathway during LR organogenesis initiated by HA-
rich ECM on the right side of the embryo and presents a novel mouse model to understand the 
origin of gut malrotations and vascular anomalies.
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1.1 Organ morphogenesis – an interplay between shape, form, and function  
Morphogenesis is a dynamic process that is elegantly choreographed to sculpt the embryo as it 
transitions from a formless single cell into a multicellular organism with an exquisitely defined 
form and structure. The initial phase of embryonic development involves rapid proliferation to 
give rise to a population of cells while maintaining the spherical symmetry of the single cell state. 
To transform this spherical ball of cells into a functional organism requires the timely break of 
symmetries based on genetically encoded spatial cues defined by heterogeneous molecular 
distributions that define the coordinate axes (anterior-posterior, AP; dorsal-ventral, DV; and left-
right, LR) of the embryo (Nelson CM, 2012). These global spatial cues are then differentially 
interpreted across fields of cells resulting in the specification of unique cellular identities which 
determine the cell fates (Weischaus E, 2016). Accompanying the specification of cell fates are 
complex changes in gene expression and epigenetic states that ultimately modify the physical 
properties and behavior of cells to generate the stereotypical morphological patterns (Cheedipudi 
S, 2014). A principal challenge in studying organ morphogenesis is how global patterning signals 
and individual cellular responses are coordinated for tissue growth and remodeling.  
At the level of a single cell, morphogenesis is choreographed by integration of global 
signaling cues with cell intrinsic transcriptional networks. This regulates cell–cell adhesion, cell-
matrix adhesion, cytoskeletal remodeling and actomyosin-based contractility in order to modulate 
the cortical tension within cells that defines the cell's shape and how the cell packaged within the 
tissue. The resulting changes range from large-scale changes, such as cell elongation, to local 
modulations in cell shape, such as the formation of specialized cell protrusions (Lecuit T, 2007). 
Within cell populations, the global signaling networks are integrated with cues in the 
microenvironment which regulates cellular behaviors such as oriented cell division, cell migration, 
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cellular rearrangements and programmed cell death (Bischoff M, 2009). This concept forms the 
premise for Chapter 3 of this thesis (Invited review for the Journal of Cell Biology). At the level 
of tissues, interactions between different cell populations lead to the formation and remodeling of 
tissue-specific connective matrices. The matrices reciprocally modulate the cellular behaviors and 
integrate the forces generated at the cellular level to give rise to global alterations in tissue 
morphology such as bending of epithelial sheets, tissue rotations, tissue narrowing and extension 
due to cell intercalation (Bonnans C, 2014). These processes are coordinated with the 
establishment of organ-specific vascular and neuronal networks to ultimately give rise to 
functional organs.  
 
1.2 Overview of asymmetric left-right (LR) morphogenesis  
While the precise mechanisms involved in the specification of coordinate axes during organ 
morphogenesis have been challenging to study in vertebrate systems, it is known that the AP and 
DV axes are defined before or during fertilization (Cowan CR, 2004; Goldstein B, 1996; St 
Johnston D, 1992). Following the definition of the AP and DV axes, vertebrates subsequently 
specify their left- right (LR) axes (Levin M, 2005). On the exterior, the body plan of vertebrates 
appears bilaterally symmetric. Yet, internally, the vertebrate body plan exhibits striking and 
conserved asymmetries in the position or shape of the viscera (Neville C, 1976). Failure to follow 
the conserved asymmetries results in an important class of birth defects such as heterotaxia (where 
the individual organ systems are mispositioned randomly on the left or the right sides), 
dextrocardia (reversal of the positioning and morphology of the heart), isomerisms (mirroring of 
the LR axis resulting in the loss of unpaired organs) and situs inversus total (a complete reversal 
of the left and right sides) (Casey B., 2000) (Figure 1.1).  
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Importantly the LR asymmetries extend beyond the basic body plan and contribute to 
structure, circuitry and function of organs. Well-studied examples include the heart, brain, gut and 
abdominal vasculature (Davis NM, 2008; Guglielmotti V, 2006; Kurpios NA, 2008; Mahadevan 
A, 2014; Roussigne M, 2012; Savin T, 2011; Welsh IC, 2013). Additionally, LR biases have also 
been observed in cancers (mammary, ovarian, lung and testicular) (Wilting J, 2011), disease 
conditions (infection of the kidney and eyes) (Schreuder MF, 2011; Vaibhav P. Pai, 2012) and 
birth defects (cleft palate, unilateral polydactyly) (Paulozzi LJ, 1999; Schnall BS, 1974). Thus, the 
Figure 1.1: Classification of situs solitus and situs anomalies. (Top panel – left to right) Under 
normal situs (situs solitus), organs are positioned in their respective locations. Situs inversus is a 
condition where all the organs have a reversed orientation. Right isomerism and left isomerism fall 
under the group of conditions known as heterotaxia. In cases for right isomerism (double-right), 
there is absence of the spleen (asplenia) and in cases of left isomerism (double left) there is bilateral 
presence of the spleen (polysplenia). The abdominal organs in both cases have ambiguous positions 
and intestinal malrotation is frequently observed. (Figure adapted from Fulcher AS and Turner MA, 
2002) 
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study of the generation of asymmetry holds fundamental importance for both developmental 
biology and biomedical applications.   
The traditional model for the establishment of LR asymmetries during development is a 
linear model where the first phase involves the breaking of the bilateral symmetry relative to the 
AP and DV axes using biophysical mechanisms (Levin M, 2007; Wang G, 2013). One physical 
candidate for providing the chirality is the directional fluid flow triggered by motile cilia in the 
node of early neurulating embryos (Basu B, 2008).  The resulting directional fluid flow is thought 
to contribute to the asymmetric accumulation of morphogens to the left side of the midline 
resulting in induction of differential expression of genes on the left and right sides of the midline 
in the second phase (Tanaka Y, 2005). In the third phase, the differential expression of genes 
triggers differential cell behavior downstream of the gene expression pathways to drive 
asymmetric positioning and shape of organs. While mouse models provide strong evidence for the 
ciliary flow mechanism as the physical regulator of LR asymmetry (Basu B, 2008; McGrath J, 
2003; Tabin CJ, 2003), this does not explain the establishment of LR asymmetries in other 
vertebrates and animals with non-motile cilia or lacking ciliated structures (snails, sea urchins, C. 
Elegans, Drosophila, chick and pig) (Adams DS, 2006; Gros J, 2009; Männer J, 2001; Okumura 
T, 2008). Furthermore, while the model of ciliary flow as the initiator of asymmetry presumes the 
existence of bilateral symmetries before the initiation of ciliary rotation, asymmetric distributions 
of small signaling molecules have been shown to exist prior to cilial formation (Albrieux M, 2000; 
Bunney TD, 2003; Roberts RM, 2011). Thus, the search for the origin of asymmetry extends far 
upstream of neurulation. In addition to the cilial model, other competing models have been 
proposed that attribute the initiation of LR asymmetries to intracellular chiralities observed within 
the blastula such as asymmetric placement of K+ and ATPase ion pumps, anti-clockwise rotation 
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of the centrioles, the chiralities of the cytoskeleton and asymmetric chromatid segregation 
(Danilchik MV, 2011; Levin M, 2007; Qiu D, 2005; Sauer S, 2012) (Figure 1.2A). While 
considerable evidence supports these models, it is not clear how these sub-cellular asymmetries 
are prioritized and amplified to give rise to LR asymmetries. Furthermore, none of the proposed 
models have been able to explain the full range of experimental results suggesting that multiple 
mechanisms could contribute to the physical initiation of asymmetry (Vandenberg LN, 2009).  
Downstream of physical chiralities, physiological mechanisms and gene regulatory 
networks function to amplify the subcellular chiralities into asymmetric cell behavior. These gene 
regulatory networks consist of sequentially interacting left and right sided genes (Figure 1.2B). 
The asymmetric gene expression initiates with Sonic hedgehog (Shh), a signaling molecule 
initially expressed within the ectoderm of the node, which becomes restricted to the left side of the 
node due to the presence of Activin receptor IIA (cAct-RIIA), a known repressor of Shh on the 
right side (Levin M, 1998; Streit, 1994). Thus, the inhibition of Shh on the right side gives rise to 
the left side-restricted gene expression during early development. The expression of Shh 
subsequently induces the expression of Nodal in the adjacent ectodermal cells of the node. Nodal, 
being a member of the TGF-β superfamily and an extracellular morphogen that can induce its own 
expression, is rapidly induced in the left lateral plate mesoderm (LPM) and serves as the master 
regulator that is necessary and sufficient for establishing the left sided identity (Levin M, 1997). 
At the same time, the notochord drives the expression of Lefty1, an antagonizer of Nodal in the 
embryonic midline to restrict Nodal to the left side (Bisgrove BW, 1999). 
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Figure 1.2: A) Competing models for the initiation of chirality: chromatid segregation, ion flux and 
ciliary flow model all of them serve to establish asymmetric expression of Nodal in LPM B) The 
early gene regulatory networks of the left and the right side. While left has specific regulators to drive 
asymmetric morphogenesis, the right sided genes mainly function to repress the left sided genes. 
(Adapted from (McDowell G, 2016 #46;Levin M, 2005 #2) 
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Perturbation and misexpression studies have revealed that while the expression of Nodal 
in the left LPM is transient, timed expression of nodal during early development is sufficient to 
activate a dense cascade of left sided genes (Levin M, 2005). The most distal member of this 
network is the homeobox transcription factor Pitx2, which serves as the memory of Nodal and is 
expressed strictly in the left LPM. However, unlike the other LR genes, asymmetric expression of 
Pitx2 is maintained in the visceral organs that later become lateralized (Raya A, 2006). Also, Pitx2 
is the most downstream effector that directly regulates organ-specific left-sided cellular behaviors 
to direct asymmetric organ morphogenesis (Piedra ME, 1998). This left-sided activation of Nodal, 
Pitx2, and the corresponding inhibitor Lefty is one of the most conserved and canonical pathways 
in vertebrates and mammals for specification of the left side identity. Intriguingly, while much is 
known about the genes that regulate cellular behavior on the left side, the right side remains 
unexplored with little known about the downstream genes involved in the regulation of the right-
sided cellular behavior. 
Recent studies investigating proteins with roles in the establishment of early embryonic 
symmetry have revealed surprising anomalies to the Nodal-Lefty-Pitx2 pathway (McDowell G, 
2016). While misexpression of intercellular myosin motor proteins in the blastula results in 
incorrect expression of Nodal on the right side, the number of embryos with reversed organs is 
drastically reduced compared to embryos with incorrect Nodal expression (McDowell GS, 2016). 
Thus, the misexpression of Nodal despite its established role as a “master regulator” of the left 
side identity, does not lead to a reversal of organs in all the cases. Hence the pathway from Nodal 
to organ situs is not as linear as had been assumed (McDowell G, 2016). These observations also 
suggest the presence of other Nodal-Pitx2 independent mechanisms that reinforce and reinstate the 
proper asymmetric positioning of organs. 
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1.3 LR asymmetric morphogenesis of the intestine 
The human intestine is of remarkable length, approximately a 30 feet long. Yet, it is very efficiently 
packaged within the limited space of the body cavity. This is accomplished by timely introduction 
of loops during gut development.  Although, the intestine may appear as a random bundle of loops, 
the topology of looping is evolutionarily conserved across organisms of the same species. Failure 
to follow this stereotypical pattern of looping leads to intestinal malrotation anomalies which are 
fairly frequent in humans, occurring in 1 in 500 live births (Torres AM, 1993). Different 
classifications of intestinal malrotations have been described in the literature. These have been 
categorized into: 1) True malrotation with a narrow mesenteric stalk; 2) Nonrotation with a broad 
mesentery; 3) Atypical malrotation defined as malpositioning of the duodenum and the cecum with 
respect to one another (Graziano K, 2015). Those individuals with true malrotation are at greatest 
risk where the contorted twisting of different segments of the gut tube around each other leads to 
a life-threatening condition known as midgut volvulus characterized by gastrointestinal (GI) 
occlusion and strangulation of the associated mesenteric vasculature (Filston HC, 1981; Torres 
AM, 1993) (Figure 1.3). Furthermore, malrotation of the intestines has been reported to occur 
frequently in association with other malformations (or syndromes) such as gut atresias, short bowel 
syndrome, biliary/liver/pancreatic malformations, heart defects, and recurrent respiratory 
symptoms including asthma and aspirations, which often tend to overshadow malrotations during 
diagnosis in terms of severity and significance (Langer JC, 2017). This observed association of 
intestinal malrotations with GI and cardiovascular deformities suggest that the regulatory 
mechanisms of gut looping morphogenesis are common to and may affect the functional 
morphogenesis of other organs. Furthermore, congenital malrotations are currently  
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Figure 1.3: Spectrum of intestinal malrotation anomalies. Top panel shows normal rotation where 
cecum and the duodeno-jejunal junction (DJJ) are fixed with respect to one another. In non-rotation 
(Category 2), neither point is fixed. During malrotation without volvulus (Category 3), the cecum is 
fixed in a wrong position. The final one indicates malrotation with volvulus where the intestine wraps 
around the Superior Mesenteric Artery and Superior Mesenteric Vein (Category 1). The green lines 
represent the positioning of cecum with respect to DJJ- an important factor in identifying intestinal 
malrotation. Figure modified from (Langer JC, 2017) 
11 
 
regarded to be relatively asymptomatic due to lack of proper diagnostic tools and methods and 
may be missed leading to catastrophic volvulus, or delayed diagnosis because it becomes too late 
to operate due to the extent of necrosis. Hence it is critical to understand the regulatory mechanisms 
that drive the proper looping morphogenesis of the gut tube. 
Amongst the different organ systems, the GI tract is arguably the first organ to initiate a 
break in symmetry during development to undergo stereotypical looping morphogenesis (Boorman 
CJ, 2002). Furthermore, the intestine, to the first approximation, remains as a relatively simple 
cylindrical tube as it elongates and loops. Thus, the intestine simplifies the challenge in studying 
LR asymmetric organ morphogenesis by reducing the problem to the question of how the 
asymmetric mechanisms provide directionality for the looping of this structure (Davis NM, 2008). 
The development of the vertebrate GI tract initiates when the endodermal layer of the tri-laminar 
embryo, folds to form a midline tube along the AP axis of the embryo (Burn SF, 2009). This results 
in the endoderm recruiting the lateral limbs of the splanchnic mesoderm to form the outer layer of 
the primitive gut tube. The dorsal part of the splanchnic mesoderm called the “dorsal mesentery” 
remains distinct from the gut tube and serves to separate and suspend the gut tube from the body 
wall (Davis NM, 2008). As the primitive gut tube develops, it is progressively patterned along the 
AP axis and is specified into foregut, midgut, and hindgut based on its vascular supply (Aaron MZ, 
2009). Following the specification of the regions, the primitive gut tube undergoes differential 
elongation along the AP axis. The midgut, which gives rise to the intestine, elongates 
disproportionately compared to the other regions of the primitive gut and undergoes physiological 
herniation, extending out of the body cavity (Soffers JHM, 2015). Simultaneously, the symmetry 
of the midgut is broken along the LR axis by the initiation of a characteristic “leftward tilt” that 
causes the elongating gut tube to undergo a critical counterclockwise rotation which sets the stage  
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Figure 1.4: A) Asymmetric gut morphogenesis is initiated with a leftward tilt of the gut tube that 
results in a counterclockwise rotation critical for subsequent conserved looping morphogenesis. This 
tilt is initiated by an asymmetric shape change of the dorsal mesentery DM shown in orange that 
suspends the gut tube from the dorsal body wall. B) asymmetric changes in the cellular organization 
across the LR axis underlies the shape change of the dorsal mesentery. Prior to initiation tilt, the left 
and right sides of DM are symmetric with dense mesenchyme sandwiched by an epithelial bilayer. 
The left and right sides have vascular cords running through at symmetric DM. At the onset of the 
counterclockwise rotation, the left side condenses and the right side expands leading to the 
deformation of the mesentery and providing a physical force to tilt the gut tube leftward. 
Simultaneously, the right side becomes excluded of vasculature and has an anti angiogenic 
microenvironment.  
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for subsequent looping morphogenesis (Davis NM, 2008). Surprisingly, this leftward tilt is 
mediated by a reorganization of the cellular architecture of the DM across the LR axis while the 
gut tube maintains its cylindrical symmetry (Kurpios NA, 2008).  
Prior to the initiation of the leftward tilt, the DM is a symmetric structure comprising of 
dense mesenchyme sandwiched by an epithelial bilayer. However, during the initiation of the tilt, 
the left mesenchymal cells of the DM become densely packed resulting in the condensation of the 
left mesenchymal compartment while the right mesenchymal cells become sparsely distributed 
with a dramatic increase in cell-free spaces resulting in the expansion of the right mesenchymal 
compartment. These changes are accompanied by the cuboidal to columnar transformation of the 
left epithelia while the right epithelia transitions from cuboidal to squamous morphology (Davis 
NM, 2008; Kurpios NA, 2008; Welsh IC, 2013). As a consequence of these cellular asymmetries, 
the dorsal mesentery deforms to tilt the gut tube leftward and initiate the counterclockwise midgut 
rotation.  
Recent work by our lab has shown that, in addition to directing the gut rotation, the DM 
also initiates the formation of gut-specific arteries commensurate with the onset of gut rotation. 
Intriguingly, whereas the left DM is pro- angiogenic in nature and serves as the origin of gut 
arteries, the right DM becomes devoid of all vasculature and remains anti-angiogenic  (Mahadevan 
A, 2014). Thus, the DM displays both cellular and vascular asymmetries that serve to initiate gut 
rotation and the formation of intestinal vasculature (Figure 1.4).  
 Previous studies in birds and mice have established that the left specific transcription 
factor Pitx2 is expressed in the left DM and is sufficient and necessary for the induction of the left 
specific cellular and vascular behaviors in the DM (Davis NM, 2008; Kurpios NA, 2008; Savin T, 
2011; Welsh IC, 2013). Pitx2-null mice failed to initiate the leftward tilt, exhibit randomized 
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chirality of gut rotation, and display loss of gut vasculature (Mahadevan A, 2014; Welsh IC, 2013). 
To understand the downstream targets of Pitx2 in the left DM, we previously performed 
transcriptional profiling of the different cellular compartments of the chicken DM using laser 
capture microdissection (Welsh IC, 2015). This elucidated the Pitx2-mediated mechanisms that 
regulate the mesenchymal condensation and the pro-angiogenic microenvironment specific to the 
left side of the DM. Particularly, Pitx2 was discovered to potentiate the non-canonical Wnt-
dependent activation of a formin called Daam2, which stabilized cadherin-based junctions in the 
left DM leading to tighter packing and condensation of the left mesenchymal compartment (Welsh 
IC, 2013).  To maintain arteriogenesis in the left DM, Pitx2 regulates the expression of the Cxcl12 
ligand and its G-protein-coupled-receptor Cxcr4 which establishes the morphogenic gradient 
needed for vascular remodeling in the left DM (Mahadevan A, 2014). While these studies highlight 
the role of Pitx2 in mediating the left side-specific cellular behavior in the DM, the mechanisms 
that regulate the right side have remained unknown. This question sets the premise for Chapter 2 
of this thesis where I show that the asymmetric accumulation of Hyaluronan (HA) – a non-sulfated 
glycosaminoglycan in the extracellular matrix (ECM) of right DM mediates its mesenchymal 
expansion and avascularity. Importantly, I show that the transformations specific to the right side 
precede changes taking place on the left and thus provide the first symmetry-breaking mechanism 
required to initiate gut rotation. Furthermore, targeted degradation of HA ablates expansion, gut 
tilting and results in aberrant gut arterial development (Manuscript in preparation).  
 
1.4 Extracellular matrix (ECM) as a critical regulator of organogenesis 
The ECM is a three-dimensional connective matrix that is ubiquitously present in tissues and is a 
prerequisite for multicellular life processes. In addition to providing a physical scaffold for 
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organizing the cellular architecture of tissues, it functions to create chemically distinct 
microenvironments within tissues by governing the heterogeneous distribution of biochemical 
signals (i.e. growth factors, chemokines, and cytokines) to regulate and coordinate diverse cellular 
behaviors within the tissue (Heisenberg CP, 2013; Mouw JK, 2014). The cells reciprocally play a 
critical role in dynamic remodeling and reorganization of the ECM by targeted degradation and 
reassembly of its components thereby giving rise to unique tissue-specific composition and 
organization of the ECM (Hynes RO, 2009; Kim HY, 2012).  This dynamic reciprocal 
communication between cells and the ECM plays a fundamental role during organogenesis. 
Despite the tissue-specific differences, ECM can be broadly categorized into two main 
classes: interstitial connective matrices- and basement membrane (Bonnans C, 2014). The 
interstitial connective matrices provide the underlying support and tensile strength to the tissue 
and are mainly composed of water, polysaccharides and structural scaffolding proteins such as 
collagen I and fibronectins (Mouw JK, 2014). Often, the interstitial connective matrices are 
embedded with narrow zones of biochemically and biomechanically distinct pericellular matrices 
that surround the cells of a particular cell type within the tissue to elicit localized, cell-type specific 
responses to external stimuli (Mecham RP, 2001). In contrast, the basement membrane is a 
specialized compact form of ECM that separates epithelia from the surrounding stroma and 
interacts with cell-surface receptors to transduce extracellular signals that regulate adhesion, 
migration, proliferation, apoptosis and differentiation of the epithelia (Lu P, 2012). Despite the 
organization differences, the two classes of matrices are often continuous and well integrated 
within the tissues enabling the tissues to respond optimally to physiological challenges and 
maintain homeostasis.  
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 The functional importance of the ECM in organogenesis is highlighted by the loss of 
function studies where genetic deletion of specific ECM components result in a wide range of 
tissue defects that ultimately contribute to embryonic lethality (Bonnans C, 2014; Mouw JK, 
2014). Given the distinct structure and function of organs, it is not surprising to note that the ECM 
assembly, modification, and degradation are unique and organ specific (Faulk DM, 2014). This 
specificity allows the ECM to play distinct permissive and instructive roles in different organs to 
regulate cellular and vascular behaviors needed for proper development and functioning of the 
organ. 
  Recent chemical characterization and analysis of the human and mouse genomes have 
revealed a core set of 300 odd protein complexes and polysaccharides that constitute the ECM, 
and this set of molecules are commonly referred to as the matrisome (Hynes RO, 2012). While the 
largest set of macromolecules in the matrisome are structural and adhesive fibrous proteins such 
as collagens (Blum RS, 2011), fibronectin and laminin (Schwarzbauer JE, 2011), the second 
largest category of macromolecules are glycosaminoglycans (GAGs) which predominantly 
contribute to the non-Newtonian viscous component of ECM that forms a gel-like lattice in the 
interstitial spaces of the tissues (Gandhi NS, 2008). In addition to functions such as lubrication, 
this gel also acts as a reservoir of biochemical signals and enables selective and rapid diffusion of 
small signaling molecules to facilitate rapid cell-cell communication (Kirkpatrick CA, 2004).  In 
the following sections, we take a closer look at the structural and functional aspects of GAGs. 
 
 
 
18 
 
1.5 Glycosaminoglycans (GAGs) – Not Just Goo! 
The GAGs are polymeric sugar chains of linear repeating disaccharide units, with each unit 
composed of a hexosamine and a hexose or a hexuronic acid. The macromolecules that form up 
this group are Hyaluronan (HA), dermatan sulfate, keratan sulfate, chondroitin, chondroitin 
sulfate, heparin, and heparan sulfate. Except for HA, the other GAGs exist in the form of 
proteoglycans, a class of carbohydrates that are covalently linked to protein cores. In general, the 
proteoglycans can have one or more GAGs covalently attached to it (Esko JD, 2009; Gandhi NS, 
2008; Raman R, 2005). 
Historically, the first isolation of sulfated GAGs was carried out in the late 1800's, while 
HA was first isolated in 1930 (Esko JD, 2009). By 1960's, advances in characterization of the 
chemical structure of GAGs provided insights into their in vivo chemical states. With the exception 
of HA, the other classes of GAG chains underwent further modifications such as sulfation and 
epimerization and displayed varying stoichiometry of substitutions with other GAGs when 
covalently linked to their protein cores (Habuchi H, 2004; Yanagishita M, 1993). Thus, while the 
chemical structure of HA was reproducible across species, the proteoglycans exhibited differences 
in the number and length of GAG chains, and the arrangement of sulfated residues along the chains 
(Hascall V, 2009). By 1970's analytical methods for purification of GAGs from tissues such as 
cartilages were developed that yielded information regarding the in vivo non-covalent interactions 
between proteoglycans, HA and link proteins. During this period, it was also realized that 
proteoglycans and GAGs were present on the cell surface, inside the cell, and in the ECM of all 
animal tissues leading to further investigation and appreciation of the manifold roles of the GAGs 
in regulating a variety of cellular behavior (Figure 1.5). 
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Figure 1.5: Schematic representation of the family of GAGs comprising a diverse set of molecules. 
Amongst ECM GAGs, the largest member is Hyaluronan (HA,shown in blue) in the extracellular space. 
The other ECM proteoglycans such as aggrecan and versican bind to HA via the link domains (purple 
hexagons) and form a gel-like lattice in the interstitial space.  In addition to the HA binding GAGs, the 
ECM GAGs also encompass smaller secreted proteoglycans such as perlecan, biglycan and decorin. The 
cell surface GAGs include membrane-traversing GAGs such as syndecan and GAGs that are bound to outer 
plasma membranes such as glypicans.  
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Figure 1.6: A) Differences in synthesis of sulfated GAGs attached to a proteoglycan and the non-sulfated GAG HA. 
While the sulfated GAGs are synthesized in the golgi, attached to the protein core and secreted to the plasma 
membrane, the non-sulfated HA is synthesized by Has enzymes in plasma membrane which directly utilize the 
cytoplasmic sugar pools to synthesize HA. Hence HA has a higher rate and degree of polymerization B) Current 
model for HA catabolism: the HMW HA is tethered to the cell surface by the HA receptor, CD44 (red dots), which 
creates caveolin coated pits that maintain an acidic environment and activates HA degrading enzyme hyaluronidase 
2 (Hyal2, blue oval-sticks) and CEMIP (brown oval-sticks).  Hyal2 then cleaves the HA polymer to 
20kDA fragments which are internalized through the endosomes and ultimately transported to the lysosomes 
where Hyal1 degrades the 20kDa fragments to small tetrasaccharides which are further cleaved into mono and 
disaccharides by lysosomal exoglucosidases. (modified from (Csoka AB, 2001 #91;Hascall V, 2009 #76)) 
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The GAGs in the ECM can be classified based on the type of ECM they are associated 
with. For example, the interstitial GAGs represent a diverse class of molecules, differing in size 
and composition. They can contain high molecular weight HA (HMW-HA), chondroitin sulfate, 
and dermatan sulfate which have the ability to bind water to form gel-like hydrated matrices that 
regulate tissue volume and macro-mechanical properties of tissues. In cartilages, the interstitial 
aggregates of proteoglycans and HA provide a stable matrix capable of absorbing high 
compressive forces by water desorption and resorption. The interstitial GAGs can also comprise 
of the small leucine-rich family of proteoglycans, which stabilize and organize collagen fibers as 
observed in tendons and cornea (Esko JD, 2009).  
Proteoglycans comprising of GAGs containing low molecular weight HA (LMW-HA), 
heparan sulfate, and chondroitin sulfate are present in the basement membrane and play a 
significant role in its organization and are key for modulating the permeability properties of 
specialized basement membranes (Iozzo RV, 2005). Both the interstitial GAGs and the GAGs in 
the basement membrane can bind to biochemical signals (cytokines, chemokines, growth factors, 
and morphogens), protect them against proteolysis and facilitate the formation of gradients 
essential for cellular functions (Lindhardt RJ, 2004). 
The cellular and intracellular GAGs are membrane bound and are present in a variety of 
vesicles from secretory to endocytic intercellular vesicles. The membrane GAGs have been shown 
to interact with integrins and other cell adhesion receptors to regulate cell attachment, cell-cell 
interactions, and cell motility (Kim SH, 2011). They have also been shown to act as co-receptors 
for various growth factor receptors and function as endocytic receptors for clearance of bound 
ligands (Christianson HC, 2014). GAGs are also found in secretory vesicles and have a role in 
packaging granular contents, maintaining matrix proteases in an active state, and regulating 
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various biological activities after secretion, such as coagulation, host defense, and wound repair 
(Kolset SO, 2008).  
The following section describes how the structural and chemical attributes of the unique 
non-sulfated GAG, HA, contributes to its highly diverse and critical biological functions, 
particularly in the context of development. 
 
1.6 Hyaluronan (HA) - the sweet, giant non-sulfated GAG molecule 
1.6.1 Structure of Hyaluronan 
 Hyaluronan is a non-sulfated GAG and the largest polysaccharide found in ECM of vertebrates. 
It exists as a linear unbranched polymer and consists of repeating disaccharide units that are 
composed of N-acetylglucosamine (GlcNAc) and glucuronic acid (GlcA) linked by alternating β-
(1,4) and β-(1,3) glycosidic bonds (Figure 1.6). In aqueous environments, HA exists in the 
polyanionic form due to the carboxyl groups of the glucuronic acid residues, and at the 
macroscopic level, it has a large hydrodynamic volume (Hascall V, 2009). The anionic nature of 
hyaluronan together with stereochemical restrictions around the glycosidic bonds results in HA 
behaving as stiffened random coils at the macroscopic level (Cowman MK, 2005). HA lacks a 
protein core, and its chemical structure and properties are highly reproducible across species. 
Numerous hyaluronan-binding proteins (commonly referred to as hyaladherins) and several 
enzymes responsible for its synthesis and degradation are present in the vertebrate genome and 
enable HA to play essential roles in development, tissue organization, cell proliferation and signal 
transduction pathways across the plasma membrane (Day AJ, 2002).  
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1.6.2 Hyaluronan synthesis  
The synthesis of HA is catalyzed by enzymes called Hyaluronan synthases (also known as Has 
enzymes) that are localized to the inner plasma membrane. The Has enzymes possess the catalytic 
activities needed to synthesize HA by sequestering the N-acetylglucosamine and glucuronic acid 
units from the corresponding nucleotide sugars in the cytoplasm and to extrude the growing 
polymer into the extracellular environment (Itano N, 2002). While the sulfated GAGs are 
assembled on the non-reducing end of the core proteins of proteoglycans as they transit through 
the Golgi, HA synthesis normally occurs at the inner surface of the plasma membrane and new 
units are added at the reducing end (Vigetti D, 2014; Weigel, 2015). Furthermore, since HA is 
directly extruded into the extracellular space, HA has a high degree of polymerization in the range 
of 104 disaccharides (Figure 1.6A).  
In the mammalian genome, there are three Has enzymes.  These enzymes differ in their 
enzymatic properties, and the differences are thought to underlie physiologically distinct functions. 
Has3 is intrinsically more catalytically active followed by Has2 and Has1. In vitro experiments 
suggest that the product size generated by each Has are significantly different with Has1 and Has2 
producing high molecular weight chains of 2 X 106 Da while Has3 produces shorter chains of 2 X 
105 Da (Itano N, 1999). The catalytic activity of Has enzymes can be regulated at the 
transcriptional and the post-translational level (Tammi RH, 2011). At the transcriptional level, 
Has2 is the most widely expressed form of Has during embryonic development, and its expression 
is critical for tissue expansion, cell motility, and growth. Has3 is expressed late in embryonic 
development and in many adult tissues and is significantly upregulated during inflammatory 
conditions (Vigetti D, 2014). While the knockouts of Has1 and Has3 survive, loss of Has2 results 
in early embryonic lethality highlighting the importance of HA synthesis by Has2 during 
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embryonic development (Camenisch TD, 2000). At the post-translational level, the activity of the 
Has enzymes can be regulated by phosphorylation, O-GlcNAcylation, or ubiquitination. In 
addition, the concentration of the UDP- GlcNAc, and UDP- GlucA in the cytoplasmic pools is also 
a major determinant of Has activity (Tammi RH, 2011). How these mechanisms are integrated and 
coordinated in a tissue-specific manner to achieve localized accumulation of HA during 
organogenesis is currently unknown and warrants further investigation. 
1.6.3 Catabolism of HA 
 There is rapid turnover of HA levels in vertebrate tissues. Hence tight regulation of HA catabolism 
is crucial for modulating steady state levels of HA that is important for normal homeostasis, 
embryonic development, wound healing, regeneration, and repair (Csoka AB, 2001; Frost GI, 
1996). Hyaluronidase (Hyal) enzymes are a class of enzymes (endo-β-N-acetyl-hexosaminidases) 
which degrade HA by employing non-processive substrate hydrolysis involving the cleavage of 
the β1,4 glycosidic bond between the disaccharides generating mostly tetrasaccharides (Gushulak 
L, 2012). In the human genome, homology-based sequence analysis has identified six genes coding 
for hyaluronidase-like sequences. They include human Hyal1, Hyal2, Hyal3, Hyal4, and PH-
20/Spam1, as well as a pseudogene Phyal1 (Csoka AB, 2001). Of these, Hyal1 and Hyal2 are the 
somatically active HA-degrading enzymes (Frost GI, 1997) while PH-20 or SPAM1 (SPerm 
Adhesion Molecule 1), is a sperm-specific Hyal that is necessary for allowing the sperm to 
penetrate through the cumulus mass to the ovum. Hyal3 although widely expressed in tissues does 
not appear to have Hyal activity while the Hyal4 gene, encodes for a chondroitinase (Hemming R, 
2008).  
A characteristic feature of the vertebrate Hyal enzymes is their ability to produce a wide 
range of HA oligomers with size-specific biological activities (Stern R, 2006). For example, the 
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HMW-HA is anti-angiogenic and immunosuppressive (Deed R, 1997; Slevin M, 2007).  In vitro 
studies show that Hyal-1 degrades the HMW-HA into small oligomers, primarily to 
tetrasaccharides which are anti-apoptotic and inducers of heat shock proteins (Triggs-Raine B, 
1999). Hyal2, on the other hand degrades HMW-HA to an approximately 20 kDa product (~50 
disaccharide units) (Lepperdinger G, 1998) which have been shown to be pro-angiogenic and pro-
inflammatory (Deed R, 1997). A popular model of HA degradation in the HA field suggests that 
HMW-HA is first tethered to cell surfaces by the HA receptor CD44, concentrated in caveolin-
rich lipid rafts. It is then cleaved by Hyal2 into intermediate-size fragments in acidic 
microenvironments created by the Na+-H+ exchanger. The generated intermediate-size fragments 
participate in signaling processes and are finally broken down to oligosaccharides within cells by 
Hyal1 present in the lysosomes in coordination with lysosomal β-glucuronidase and β-N-acetyl-
glucurosaminidase (Erickson M, 2012) (Figure 1.6B). However, this model fails to explain the 
mechanism by which HA is degraded in tissues and cell culture systems that do not express the 
Hyal family of genes (Csóka AB, 1999) suggesting that new HA-degradation pathways 
independent of the Hyal1, Hyal2, and CD44 system may exist. 
Recent studies have shown that apart from the Hyal family of hyaluronidases, the 
hyaldherin CEMIP, also known as KIAA1199, possess HA binding and degrading activities 
(Hiroyuki Yoshida, 2013). Originally discovered as a gene related to deafness but with unknown 
function, CEMIP has a principle role in binding and depolymerization of HA (Hiroyuki Yoshida, 
2013). In addition to the enzymatic processes that cleave HA, HA can be degraded by oxidation 
reactions, particularly, by reactive oxygen species (ROS) and free radicals. Originally discovered 
for its ability to degrade HA in the synovial fluid (Stern R, 2007), ROS has been shown to induce 
HA fragmentation directly and indirectly through a p38 MAPK-dependent signaling pathway in 
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normal human bronchial epithelial cells (Casalino-Matsuda SM, 2009). However, Further studies 
to elucidate the kinetics of the HA degradation by KIAA1199 and ROS are needed to understand 
the mechanisms cells employ in vivo to catabolize HA. 
1.6.4 Role of HA in development  
HA has multiple roles in early development, tissue organization, and cell migration and HA 
localization in the embryo correlates with tissue expansion, motility, and vascular remodeling 
(Hascall V, 2009). Over the years, perturbation studies have revealed essential roles that HA play 
during the development of several organ systems. Particularly, the discovery of embryonic lethal 
phenotype in Has2-null mice at the time of heart formation (Camenisch TD, 2000) provided a 
genetic window for manipulating and understanding the significance of HA-rich matrices in 
developing embryos by selective perturbation of Has2.  
A pioneering example of the requirement for HA-rich matrices in tissue expansion during 
early development is the process of cumulus cell-oocyte expansion in the mammalian pre-
ovulatory follicle critical for fertility (Salustri A, 1992). Prior to  hormonal stimulation, the 
mammalian oocyte, arrested at the prophase of the first meiotic division, is surrounded by about 
1000 cumulus cells that are densely packed. In response to the circulatory gonadotrophin surge, 
the cumulus cells upregulate Has2 and a link module family hyaladherin encoded by tumor 
necrosis factor-stimulated gene 6 (Tsg6) (Fülöp C, 2003; Salustri A, 1992). Simultaneously, the 
follicle becomes permeable to serum, introducing inter-α-trypsin inhibitor (IαI), composed of the 
protease inhibitor bikunin and two heavy chains that are covalently bound to the chondrioitin 
sulfate chain. In a complex process, Tsg6 catalyzes the transfer of heavy chains from chondroitin 
sulfate onto the newly synthesized HA, stabilizing the HA-rich matrices and causing rapid 
expansion of the cumulus cell-oocyte complex (Mukhopadhyay D, 2004). This HA-mediated 
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expansion is critical for the transport of the oocytes into the follicle and for sperm binding during 
fertilization (Fülöp C, 2003; Mukhopadhyay D, 2004; Salustri A, 1992). The cumulus cell-oocyte 
complexes fail to expand in Tsg6-deficient female mice because of the inability of the cumulus 
cells to assemble their HA-rich ECM. As a consequence, Tsg6-/- female mice are sterile 
(Mukhopadhyay D, 2004). 
The essential role of HA in synchronized cell motility during early development is well 
illustrated by studies that have investigated cell movements that accompany gastrulation 
(Fenderson BA, 1993). Knockout of Has2 using antisense morpholinos in zebrafish embryos 
resulted in the failure of the ventrolateral cells to develop lamellipodia and migrate dorsally 
resulting in the blockage of dorsal convergence during gastrulation (Fenderson BA, 1993). Ectopic 
expression of Has2 in axial cells led to the formation of supernumerary lamellipodia and blockage 
of axis extension. Importantly, epistasis analysis showed that HA, rather than acting as an essential 
structural component, functions as an autocrine signal to stimulate activation of Rac1, a small 
GTPase known to regulate cytoskeletal remodeling to trigger cell motility (Bakkers J, 2004). A 
similar role for HA in mediating synchronized cell migration in organ development has been 
studied in cases of myocardial involution during the formation of the heart tube (Smith KA, 2008) 
and in the migration of neural crest cells during craniofacial morphogenesis (Casini P, 2012). The 
most impressive role of HA in cell motility essential for organ development has been demonstrated 
during the formation of cardiac cushions. Studies by Roger Markwald's group as early as 1970s 
showed that that endothelial cells outlining the cardiac cushions migrated into an HA-rich ECM 
in the cardiac jelly during development implicating HA in this process (Markwald RR, 1978). 
Indeed, this was proven when the embryonic knockout of Has2 displayed a complete loss of 
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cardiac jelly and cardiac cushions in addition to the defective vasculature and other heart 
abnormalities (Camenisch TD, 2000).  
Some of the earliest investigations of the role of HA in vascular remodeling and in 
organizing ECM were carried out in the developing limb (Feinberg RN, 1983; Li Y, 2007). 
Particularly, HA was discovered to be a major component of the ECM of the apical ectodermal 
ridge and the distal subapical mesenchymal cells associated with it. In contrast, the ECM of the 
proximal central core of the limb bud was devoid of HA during the condensation of the cartilage 
elements (Kosher RA, 1981). Overexpression of Has2 in the chick limb bud resulted in the 
formation of shortened and severely malformed limbs that lacked one or more skeletal elements 
while the ectopic introduction of HA-soaked beads in the proximal central core resulted in 
inhibition of the pre-cartilage condensation needed for cartilage differentiation and the creation of 
ectopic avascular zones (Feinberg RN, 1983; Li Y, 2007). Similarly, conditional inactivation of 
Has2 in the distal limb bud mesoderm also resulted in the shortening of the skeletal elements of 
Has2 deficient limbs suggesting that the distal localization of HA is essential for normal growth 
of all limb skeletal elements (Matsumoto K, 2009). The distal localization of Has2 was regulated 
at the transcriptional level by the transcription factor Gli3 downstream of Shh signaling (Liu J, 
2013). Furthermore, the condition knockout of Has2 in limbs resulted in mislocalized distributions 
of chondroitin sulfate proteoglycans, aggrecan and the link protein (Matsumoto K, 2009). Taken 
together these investigations show that HA regulates various aspects of limb morphogenesis. 
HA is also essential for Xenopus tadpole tail regeneration (Contreras EG, 2009), zebrafish 
tail fin regeneration (Ouyang X, 2017), and in the formation of perineuronal nets around neurons 
in the cerebral cortex (Carulli D, 2006). These HA-mediated repair mechanisms are areas of active 
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investigations. Collectively, these studies clearly establish the importance of HA-rich matrices in 
embryonic development.  
1.6.5 Pathobiology of HA matrices  
The increased accumulation of HA in the ECM is one of the hallmarks for pathologies related to 
inflammation such as rheumatoid arthritis, respiratory diseases like asthma, chronic obstructive 
pulmonary disease, inflammatory liver and bowel diseases, in diabetic nephropathies and 
transplant rejections (Petrey AC, 2014). In normal tissues, HA mainly exists in the form of HMW-
HA and suppresses inflammation by decreasing the levels of cytokines such as TNF-alpha and 
interleukins through activation of NF-κB and promoting the suppressive effects of regulatory T-
cells in a TLR4-dependent manner (Nakamura K, 2004). However, in cases of inflammation and 
tissue injury, HA is significantly more poly-dispersed and contains fragments of varying length 
and overlapping functions (Petrey AC, 2014). Particularly, there is a considerable enrichment of 
the smaller fragments of HA which triggers pro-inflammatory effects by stimulating transcription 
of inflammation-related genes including TNF-α, IL-12, IL-1β, and matrix metalloproteinases by 
signaling through TLR4 and TLR2 as well as CD44 (Do Y, 2004; Taylor KR, 2007; Termeer C, 
2002). Furthermore, the inflammatory conditions trigger a reorganization of HA matrices, where 
the HA polymers of variable sizes are organized into cable-like structures that are decorated with 
HA-binding proteins like heavy chains of IαI, Tsg6 and versican (de la Motte CA, 2003). These 
cables act as a biological sink for binding monocytes and platelets, and these interactions likely 
modulate the pro-inflammatory stimuli (Lauer ME, 2009). While these studies clearly highlight 
the importance of HA-mediated signaling during inflammation, more investigations would enable 
us to understand the interactions between HA, HA-binding proteins, and HA receptors during 
inflammation. 
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In addition to regulating inflammatory stimuli, HA is a critical regulator of angiogenesis, 
which facilitates chronic inflammation. HMW-HA is anti-angiogenic and suppresses endothelial 
cell proliferation and vessel formation, while fragmented HA is a pro-angiogenic stimulator (Deed 
R, 1997). The endothelial cell interactions with HA matrices are mediated by a variety of HA-
binding proteins and HA interacting proteoglycans which regulate angiogenic responses to 
different degrees (Savani RC, 2001). This generation of a pro-tumorigenic inflammatory 
environment and the ability to modulate angiogenesis has also resulted in HA being investigated 
from the context of tumorigenesis, wound healing, regeneration, and repair (Hascall V, 2009). 
Several investigations have demonstrated that HA regulates tumor cell migration and invasion in 
vitro and tumor growth and progression in vivo particularly in the context of breast and ovarian 
cancers (Ween MP, 2011; Yahya RS, 2014).  Interestingly, extreme HMW-HA has also been 
credited to provide a mechanism responsible for the naked mole rat's cancer resistance (Tian X, 
2013). 
 
1.7 Regulators of HA function 
The preceding sections have outlined the diverse biological roles of HA which include functioning 
as a regulator of tissue homeostasis during normal conditions; as an organizer of ECM to facilitate 
localized tissue volume changes, cell migration and vascular remodeling during embryonic 
development (Hascall V, 2009); as an activator and regulator of immune cells during inflammation 
and related pathologies (Petrey AC, 2014); and as a critical regulator of cancer, wound healing, 
regeneration, and repair (Ween MP, 2011; Yahya RS, 2014). Also, HA often demonstrates 
opposing functions in the above-mentioned contexts. This diversity in function appears to be a 
consequence of the distribution of interactors of HA in a given microenvironment, the size of HA 
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molecules and cell-specific factors (such as the type of receptor being expressed) in a given tissue 
(Cyphert JM, 2015). The following sections explore hyaladherins which define the composition 
and organization of HA-rich matrices and the signaling pathways that HA can participate in a given 
tissue microenvironment.  
1.7.1 Introduction to hyaladherins- structure, classification  
The interaction of HA with various hyaladherins (HA-binding proteins) is thought to stabilize 
different structural conformations of the HA polymer and at the same time, leads to the formation 
of multi-molecular complexes with distinct structural arrangements (or architectures) that underlie 
their different functions (Day AJ, 2002). Most hyaladherins interact with HA via HA-binding 
domains (HABD), composed of structural motifs called link modules (Figure 1.7A). The link 
module is of ∼100 amino acids in length and is composed of two α-helices and two triple-stranded 
antiparallel β sheets.  The binding of the link module to HA has been attributed to the hydrogen 
bonds and the aromatic stacking interactions between HA and the aromatic amino acids of the link 
module, and the stacking and ionic interactions between the carboxylic acid groups of the 
glucuronic acid residues of HA and the positively charged amino acid residues of the link module 
(Higman VA, 2014). The HABD of different hyaladherins differs in the number of link modules 
and in the N and C-terminal extensions of the link modules and can be classified into type A, type 
B, and type C. Type A HABD consists of a single link module domain and can be found in 
hyaladherin Tsg6 (Kohda D, 1996). Type B HABDs extend the β-sheet structure and forms an 
extra lobe that is in intimate contact with the link module. The hyaladherins CD44 and Lyve1 
possess the type B HABD (Teriete P., 2004). Type C HABD contains contiguous pairs of link 
modules and is found in the lectican superfamily (aggrecan, brevican, neurocan, and versican) and 
link proteins (HAPLN1–4) (Seyfried NT, 2005) (Figure 1.7B).  
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Figure 1.7: A) Domain structures of the different Hyaladherins in the vertebrate genome. All of them 
contain the link module which is essential for binding to HA. B) Classification of hyaladherins 
depending on the structure and the number of link modules. 
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In addition to the link module containing hyaladherins, recent studies have revealed 
hyaladherins that can bind HA without the link module such as RHAMM, CD38, plasma 
Hyaluronan Binding Protein, P-32, IHABP4, IMP-50, and SPACRCAN (Day AJ, 2002). While 
the domains that participate in HA binding have been identified in these molecules, the exact HA 
binding sites are unknown and needs to be established. 
1.7.2 Tsg6, a unique member of the hyaladherin family: structural and biochemical properties 
The hyaladherin Tsg6 is a 35-kDa secreted enzyme that is usually expressed in response to pro-
inflammatory stimuli at sites undergoing ECM remodeling. Originally discovered from a cDNA 
library derived from TNF-treated human fibroblasts, both the gene sequence of Tsg6 and its 
encoded protein demonstrate a high degree of sequence conservation (Milner CM, 2003). The 
domain structure of Tsg6 comprises of the link and CUB modules that are flanked by N- and C-
terminal sequences respectively (Day AJ, 2002). The link domain enables Tsg6 to bind ligands 
such as HA, chondroitin 4-sulfate, and heparin. While there is considerable overlap between the 
binding sites for HA and chondroitin 4-sulfate, the binding sites for heparin are distinct (Parkar 
AA, 1997). The binding of Tsg6 to HA can directly crosslink HA chains via the formation of HA 
induced Tsg6 oligomers (Baranova NS, 2011). This crosslinking of HA could serve to remodel 
ECM. Similarly, Tsg6 binding to HA has also been shown to enhance and induce the interaction 
of HA and CD44 on lymphocyte cell lines possibly by the promotion of CD44 clustering or by 
switching CD44 into a high-affinity conformation (Lesley J, 2004). The binding of Tsg6 has also 
been found to be chondroprotective in murine models of inflammatory arthritis where its serum 
concentration correlated with the severity of the disease (Bárdos T, 2001). 
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Figure 1.8: Tsg6 is the only hyaladherins that can also function as an enzyme to covalently 
modify HA. This covalent modification occurs in the presence of Inter-α- inhibitor (IαI) 
complex which consists of the protease bikunin and heavy chain (HC) peptides. Tsg6 
catalyzes the covalent transfer of HC from IαI on to HA. This modified form of HA, known 
as HC- HA has numerous physiological and pathological roles. Of relevance are its ability 
to modulate tissue volume changes and increase anti-angiogenic potential of HA. Figure 
adapted from (Lauer ME, 2013) 
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In addition to its inflammation associated functions, it is well established that Tsg6 is 
essential for female fertility in mice, for the assembly of an HA-rich ECM in the cumulus cells 
surrounding the oocyte prior to ovulation (Fülöp C, 2003). Upon hormonal stimulation, this HA-
rich matrix undergoes a striking, nearly 20-fold, expansion.  Interestingly, Tsg6 binding to HA is 
not sufficient to trigger this expansion. Instead, a covalent complex formed by HMW-HA and the 
heavy chain (HC) from the serum proteoglycan inter-α-inhibitor (IαI) is required. Formation of 
this HC-HA complex is mediated by Tsg6, which catalyzes the transfer of HC from IαI to HA 
(Mukhopadhyay D, 2004). This modification results in the formation of a stable gel-like HA-rich 
matrix, which subsequently maintains the integrity of the cumulus cell-oocyte complex critical for 
female fertility (Salustri A, 1992).  
The mechanism of the Tsg6-mediated HC transfer to HA has been shown to involve the 
formation of covalent HC·Tsg6 complexes as intermediates (Figure 1.8). These HC·Tsg6 
complexes are linked through ester bonds between Ser-28 of Tsg6 and the C-terminal aspartates 
of the HCs (Sanggaard KW, 2008). This transesterification reaction is preceded by the formation 
of non-covalent complexes between Tsg6 and IαI that inhibit the HA-binding activity of Tsg6 and 
promote Tsg6 catalytic function. The calcium chelating site in the CUB domain of Tsg6 has been 
shown to mediate this non-covalent interaction by correctly orienting the Tsg6 molecule relative 
to IαI to facilitate the transfer of HC to Ser-28 of Tsg6 (Briggs DC, 2015).  The HCs are then 
transferred from Tsg6 onto HA presumably when the HC·Tsg6 complex and HA interact, for 
which the mechanisms are not yet fully understood. It is worthy of mention that HC-HA complexes 
are also formed in contexts other than ovulation. Recently, studies have detected HC-HA 
complexes to be present in the chick amniotic membrane and to have anti-angiogenic functions 
(Shay E, 2011). This suggests that the formation of the HC-HA complex is an ancient process in 
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vertebrates predating cumulus expansion in mammals and can have diverse functions depending 
on the exact composition (e.g. number and type of HCs, the size of HA, etc.) and the identity of 
other associated structural/signaling molecules.  
In Chapter 2, investigating into how HA enacts its function, I show that the expression of 
Tsg6 is right sided in the DM and that it plays critical roles in regulating the HA-mediated 
expansion and avascularity in the DM important for asymmetric gut morphogenesis.  Together, 
my work described in detail in Chapter 2 identifies a novel pathway during gut development where 
asymmetric enrichment of HA in right DM results in tissue expansion and vascular exclusion in 
the right DM that is critical for the conserved counterclockwise rotation of the gut and development 
of the gut arterial blood supply.  
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2.1 Abstract 
Counterclockwise intestinal rotation prevents midgut volvulus, a catastrophic strangulation of 
abdominal vasculature. We previously showed that cellular asymmetries within the midgut dorsal 
mesentery (DM) initiate this rotation and pattern the gut vasculature. Whereas the left-right Pitx2 
orchestrates all organ laterality, its expression in the left DM long precedes any morphological 
asymmetries, indicating that rotation does not initiate by Pitx2 alone. Here we show that the 
extracellular matrix (ECM) component hyaluronan (HA) breaks lateral symmetry within the DM 
and initiates gut rotation. Unexpectedly, HA is produced on the right side and induces robust ECM 
expansion as the first evidence of DM morphological asymmetry. This is dependent on 
modification of HA by the asymmetrically expressed enzyme Tsg6, forming stable matrices to 
mechanically expand the right mesenchyme. Tsg6-null mice are predisposed to both malrotation 
and volvulus. Our studies reveal novel ECM-driven laterality signals, and may illuminate the 
origins of gut and vascular anomalies. 
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2.2 Introduction 
An essential aspect of organ morphogenesis is the timely introduction of molecular asymmetries 
to spatially pattern the developing organ’s form and its vascular supply. Mechanistic studies of 
these events are challenging because they are often confounded by tissue multi-dimensionality and 
by the dynamic remodeling of structures to achieve the complex final form. The embryonic midgut 
(intestine) serves as a powerful model to simplify and study organ asymmetry in vivo. In contrast 
to the heart or stomach, which, in addition to looping, exhibit complex patterns of ballooning, 
differentiation, and asymmetric growth, the midgut remains as a simple cylindrical tube throughout 
its morphogenesis. This simplicity is evident when the gut is viewed in cross-section (Figure 2.1A), 
where asymmetries in cell architecture and extracellular matrix (ECM) composition that drive 
midgut looping can be studied in a single visual plane. Thus, using the midgut, the problem of LR 
organ asymmetry can be distilled to the initial events that establish directional gut looping. This is 
a critical paradigm because while vertebrates exhibit a high degree of bilateral symmetry, the 
initially symmetrical gut tube later loops and rotates in a highly conserved, asymmetrically looped 
pattern (Savin et al., 2011). This complex process correctly packs the gut tube into the limiting 
space of the body cavity subject to strict topological and evolutionary constraints, and is also 
intimately linked to gut absorptive function. Even simple errors in the events that loop the gut lead 
to catastrophic birth defects, such as intestinal malrotation and midgut volvulus (Applegate, 2009; 
Savin et al., 2011). 
Formation of intestinal loops is the result of homogeneous and isotropic forces that arise 
from the differential growth of the gut tube and its tissue anchor, the dorsal mesentery (DM) 
(Savin et al., 2011). However, the chirality of gut looping is initiated by a directional bias during 
the first gut tilting event, driven by left-right (LR) asymmetric changes in the cellular and 
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extracellular architecture of the DM (Davis et al., 2008; Kurpios et al., 2008). The embryonic 
chicken DM arises on day 2.5 (Hamburger-Hamilton [HH] stage 17, akin to mouse embryonic [E] 
day 10) (Hamburger and H.L., 1992) from the fusion of the left and right splanchnic mesoderm. 
While morphologically symmetrical in cross-section, the early DM consists of molecularly distinct 
left and right cellular compartments (Figure 2.1A). Shortly thereafter (HH20, E10.5 in mice), 
initial DM symmetry is broken during a dramatic reorganization where the left mesenchyme 
condenses and the right side expands, causing a trapezoidal deformation of the DM that swings 
the gut tube leftward (Figure 2.1A). This critical leftward tilt provides a directional bias for the 
conserved counterclockwise gut rotation, disruption of which randomizes gut looping chirality 
(Davis et al., 2008; Kurpios et al., 2008; Savin et al., 2011; Welsh et al., 2013). 
In addition to directing gut rotation, the DM is the conduit for the extensive network of 
blood and lymphatic vessels that nourish and drain the intestine and provide the necessary channels 
for transport of dietary lipids. We recently showed that vascular development of DM arteries is 
highly stereotypical, commensurate with the onset of gut rotation, and proceeds strictly on the DM 
left side (Mahadevan et al., 2014). Interestingly, whereas arterial endothelial progenitors are 
initially present on both sides of the DM, they become progressively excluded on the right side.  
Thus, intestinal blood vessel development is restricted to the left side (Mahadevan et al., 2014), 
intimately linked to the pathways driving morphologic asymmetry of the parent organ itself. How 
and why this vascular asymmetry is established remains unknown.  
Initial LR symmetry-breaking decisions are made early at the node and lead to left-sided 
secretion of the highly conserved ligand Nodal throughout the left splanchnic mesoderm (Levin et 
al., 1995). While Nodal expression is transient, Nodal induces the homeobox transcription factor 
Pitx2 at E7.5 (HH7-8) (Piedra et al., 1998), which persists to maintain the left side identity of all  
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Figure 2.1: Expansion of the right side of the DM initiates LR asymmetric gut 
rotation. A The symmetrical primitive gut tube (GT, grey), in the chicken at HH17 (mouse 
E9.5) suspended by the DM (blue-right; orange-left) undergoes a critical counterclockwise 
rotation to drive gut looping. Leftward tilt of the GT (HH21, mouse E10.5) mediated by 
changes in cell architecture across the LR axis of the initially symmetric DM (HH17), initiates 
this counterclockwise rotation. B Pitx2 expression in the left DM appears prior to the initiation 
of the leftward tilt (Pitx2 RNA ISH). C H&E staining of Z3 midgut sections from HH17-21 
shows that right-sided expansion breaks the symmetry of the DM at HH18, prior to left-sided 
condensation at HH20. D Quantification of intercellular (cell-free) spaces from C; right 
expansion: p = 0.0001, left condensation: p = 0.0044 (unpaired two-tailed Student’s t-test). 
Error bars represent mean ± SEM for 10 chicken embryos per developmental stage. E Angle 
of midgut tilting from HH17-21, measured as displacement of GT from the midline 
(notochord) reveals significant increase in tilting angle at HH18 coincident with expansion.  
Gut tilting on expansion p = 0.0012 (unpaired two-tailed T-test with Holm-Sidak correction 
for multiple comparisons). Error bars represent mean ± SEM for 10 chicken embryos per 
developmental stage for HH17, 18 and 19, and 7 embryos per developmental stage for HH20 
and HH21. See also Figure S1. Scale bars: B (100 µm); C (50 µm).  
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organ primordia to which the splanchnic mesoderm contributes. This Pitx2-driven asymmetry is 
evolutionarily conserved, and altered Pitx2 activity disrupts visceral laterality, including chiral and 
positional randomization of multiple organs and vessels (Shiratori et al., 2006).  In the chicken and 
mouse DM, Pitx2 induces a left-specific gene signature that drives cell behavior only on the left 
side and Pitx2-null mice are unable to generate the leftward tilt (Davis et al., 2008; Kurpios et al., 
2008; Mahadevan et al., 2014; Welsh et al., 2013). However, despite the importance of Pitx2 
during gut rotation, Pitx2 expression in chickens and mice initiates in the splanchnic mesoderm 
long prior to any morphological asymmetries within the DM, and even in locations of the intestine 
that do not loop. Thus, Pitx2 expression alone is insufficient to break LR symmetry within the DM 
that is required to initiate the leftward tilt; other factors expressed in the region of the looping 
midgut must intersect with Pitx2 target genes to drive intestinal rotation.  
Unexpectedly, here we show that the mesenchymal expansion specifically on the right side 
of the DM precedes all other DM cellular asymmetries taking place on the left, suggesting that 
events on the right side break initial DM symmetry. Moreover, the timing of expansion coincides 
spatiotemporally with the progressive loss of vascular progenitor cells observed on the right, 
suggesting a shared mechanism driving right mesenchymal expansion and left sided formation of 
gut vasculature. Hyaluronan (HA), a non-sulfated glycosaminoglycan, is the predominant ECM 
component on the right side of the DM (Kurpios et al., 2008). We now show that HA drives right-
sided symmetry breaking events by a mechanism that is dependent on its covalent modification by 
the enzyme tumor necrosis factor alpha-inducible protein 6 (Tnfaip6, also known as Tsg6). 
Moreover, the loss of modified HA in Tsg6-null mice caused randomized gut looping and vascular 
patterning defects. Interestingly, we have found that intact HA matrices on the right side are 
required to exclude gut vasculature by repressing right-sided Cxcl12 expression, highlighting the  
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tightly interwoven nature of the pathways driving gut looping morphogenesis. Taken together, our 
studies identify a novel ECM-derived pathway driving LR organogenesis initiated on the right side 
of the embryo, and may shed light on the origin of gut and vascular anomalies. 
 
2.3 Results 
2.3.1 Expansion of the right side of the DM initiates LR asymmetric gut rotation  
The cellular asymmetries observed in the left and right DM are transient and serve to initiate gut 
rotation by deforming the DM and tilting the gut tube leftward (Figure 2.1A) (Davis et al., 2008; 
Kurpios et al., 2008). We previously demonstrated that these asymmetries include condensation 
of the left mesenchymal compartment and expansion restricted to the right side (Figure 2.1A). 
While Pitx2 is necessary for the molecular and cellular properties within the left DM, Pitx2 
expression in the left lateral plate mesoderm initiates at E7.5 in mice and HH7-8 in chickens 
(Piedra et al., 1998), several days prior to the leftward tilt (HH20) (Figure 2.1B). This provides 
evidence that Pitx2 expression alone does not break the cellular symmetry within the DM to initiate 
the tilt (Davis et al., 2008). To identify the symmetry-breaking mechanism, we performed careful 
histological analysis of the LR DM mesenchymal architecture prior to the formation of the leftward 
tilt (HH17-HH21, Figures 2.1C and 2.1D). 
The DM of the embryonic midgut is formed via the fusion of the left and right splanchnic 
mesoderm at HH17 (28-32 somites) (Hamburger and H.L., 1992). To quantify the LR differences 
in the mesenchymal architecture of the midgut DM, tissue sections from caudal (posterior, P) to 
rostral (anterior, A) midgut were stained with Hemotoxylin and Eosin (H&E) and the intercellular 
(cell-free) spaces in the left and right DM were quantified (Figures 2.1C, S1A, and S1B). To 
understand how these changes subsequently affect the tilting of the midgut, the angle of the tilt 
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was quantified as a tilt of the midgut with respect to the embryonic midline (Figure 2.1E).  At 
HH17, the cellular architecture of the entire AP length of the midgut was symmetric with both the 
left and right mesenchymal compartments densely packed (Figures 2.1C, 2.1D and S1B) (Davis et 
al., 2008). Correspondingly, the axis of the midgut was closely aligned with the embryonic midline 
demonstrating that gut tilting had not yet initiated (Figure 2.1E).   
Within 4 hours, by HH18 (34-36 somites), the fusion of the splanchnic mesoderm 
progressed further resulting in the ventral extension of DM (Figure 2.1C). Strikingly, within these 
4 hours, while the cellular architecture of the left mesenchyme remained unchanged, the acellular 
mesenchymal compartment on the right became significantly expanded (Figures 2.1C and 2.1D, 
dotted line, percentage of intercellular spaces in HH18 right side DM is ~37% (36.57 ± 1.248) vs. 
HH17 right side DM, ~23% (23.27 ± 1.557), n = 10, p = 0.0007). Thus, the early symmetry of the 
DM is first broken by changes taking place on the right. Coincidentally, the axis of the midgut 
tilted significantly to the left of the midline (Figure 2.1E). Thus, the tilting of the midgut appears 
to be linked with the changes taking place on the right.  
We also observed a rostral to caudal variation in the expansion of the right DM with the 
rostral end of the midgut showing significantly more expansion compared to the caudal expansion 
(Figure S1; n = 10: caudal vs. midcaudal: p = 0.0219, caudal vs. central: p = 0.0185). 
Concomitantly, the tilting angle of the rostral midgut was more significant in comparison to the 
caudal midgut (Figure S1, n = 10, p = 0.007). Hence, the tilt of the midgut is spatially coordinated 
with the rostral-caudal variation in the expansion of the right DM. 
Surprisingly, it was not until HH20 (6 hours after expansion) that we observed mesenchymal 
condensation on the left (Figures 2.1C and 2.1D, percentage of intercellular spaces HH20 left side 
DM is ~37% (37.09 ± 0.9789), n = 8 vs. HH17 left side DM, ~23% (22.11 ± 1.112), n = 9, 
60 
 
p = 0.0041). A significant increase in the tilting angle of the midgut was again observed (Figure 
2.1E, HH21 (38.99 ± 2.123) degrees, n = 6 vs. HH19 (23.95 ± 1.26) degrees, n = 9, p = 0.001), 
which can be attributed to the changes in the left DM. This observation is consistent with our 
previous work showing that changes in both the left and right DM compartments contribute equally 
to the tilting of the gut tube (Kurpios et al., 2008). Thus, leftward gut tilting is initiated by DM 
expansion on the right side, independent of mesenchymal condensation within the left DM.  
2.3.2 HA accumulation within the right DM coincides with DM expansion 
We previously uncovered dramatic LR asymmetries in the ECM composition of the DM that 
accompany changes in mesenchyme architecture (Kurpios, 2008). Specifically, on the right, we 
identified hyaluronan (HA) as the prominent ECM component. HA is an extremely long 
glycosaminoglycan (GAG) polymer (Hascall and Esko, 2009), in which the disaccharide unit of 
glucuronic acid and N-acetyl-glucosamine can be repeated several thousand times (Fülöp et al., 
1997). HA is the simplest of all the GAGs, and unlike the other GAGs, is not sulfated (Hascall and 
Esko, 2009). HA is required for cardiovascular development, and HA synthase (Has)-2 knockout 
mice die mid gestation at E9.5 (Camenisch et al., 2000). HA functions both as a structural 
component of tissues and as a signaling molecule that can influence many aspects of cell behavior. 
In general, our knowledge of the developmental and mechanistic roles of HA remain incomplete.  
  To test whether HA enrichment in the right DM coincides with the observed expansion in 
the DM, we performed HA immunohistochemistry (de la Motte and Drazba, 2011) between HH17-
21 (Figures 2.2A, 2.2B and S2). To quantify the LR differences in HA distribution, we obtained 
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Figure 2.2: Hyaluronan (HA) drives the right-sided mesenchymal expansion of the DM. A. 
Immunohistochemistry for HA using biotinylated HABP shows that asymmetric enrichment of HA is 
first observed in the dorsal right DM at HH18, at the onset of mesenchymal expansion, and proceeds to 
extend ventrally to cover the entire right DM. B. Quantification of HA accumulation reveals significant 
enrichment of HA in the right DM at HH18, p = 0.0007. Average intensity profile of HA distribution 
across the LR axis of 7 embryos at HH19, confirms extensive HA accumulation in the right DM (blue) 
compared to the left DM (orange). Fold enrichment calculated by measurement of area under intensity 
profile graph generated for each embryo.  C. Targeting of the right chicken DM with MU-Xyl. MU-Xyl 
soaked beads are surgically inserted into the right coelomic cavity (HH14) prior to DM formation to 
target splanchnic mesoderm (DM precursor). Beads remain intact at HH21 when embryos are analyzed. 
D. MU-Xyl treated DM shows significant reduction in HA accumulation when compared to vehicle 
(DMSO) treated controls (quantified in right panel, p = 0.0031). E. Depletion of HA in MU-Xyl treated 
embryos results in the loss of right-sided DM expansion (quantified by measurements of intercellular 
spaces in the right panel: MU-Xyl vs. DMSO, p = 0.0012; WT vs. Hyal2, p = 0.0053). Unpaired two-
tailed Student’s t-test has been used to compare fold-enrichment values and measurements of 
intercellular spaces and obtain statistical significance. Error bars represent mean ± SEM. See also Figure 
S2. Scale bars: A (50 µm); D (30 µm); E (50 µm). 
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the intensity profiles of the HA signal in the left and right DM using ImageJ and calculated the 
area under the curve to estimate the amount of HA present (Figures 2.2A and 2.2B). 
At HH17, the DM had a basal level of HA accumulation with no detectable enrichment of 
HA in the left or right DM consistent with no observable DM expansion at this developmental 
stage (Figures 2.2A and 2.2B). HA accumulation was seen in the region surrounding the notochord 
as previously reported (Solursh and Morriss, 1977) and served as a positive control for HA staining 
(Figure S2). Strikingly at HH18, we observed HA-rich ECM in the dorsal right DM (Figure 2.2A) 
that spatially overlapped with the domain of initiation of DM expansion (Figures 2.1C and 2.1D). 
The ECM of the left DM had lower levels of HA that was uniformly distributed throughout the 
mesenchyme (Figures 2.2A and 2.2B). A comparison of the intensity profiles across the LR axis 
revealed that the right DM overall had more HA accumulation than the left side (Figure 2.2B). 
Remarkably, by HH19, the HA-rich ECM extended ventrally towards the gut tube to cover the 
entire right side of the DM, resulting in ~12-fold (11.76 ± 3.43) enrichment of HA levels in the 
right DM as compared to the left (Figures 2.2A and 2.2B). Thus, HA accumulation within the right 
DM spatiotemporally correlates with its expansion.  
2.3.3 Hyaluronan is required for ECM expansion and the leftward gut tilting  
To test the role of HA in the chicken DM, we surgically inserted resin beads soaked in 4-
Methylumbelliferone-β-D-Xyloside (MU-Xyl), an inhibitor of endogenous HA synthesis (Hamati 
et al., 1989; Kakizaki et al., 2004), in the right coelomic cavity of the splanchnic mesoderm (DM 
precursor) prior to DM formation (HH15) (Figure 2.2C) (Mahadevan et al., 2014). Compared to 
vehicle (DMSO) controls, the MU-Xyl-treated embryos had significantly reduced levels of HA in 
the right DM (Figure 2.2D; DMSO beaded: ~9-fold enrichment (8.83 ± 0.78) vs. MU beaded: ~3- 
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Figure 2.3: Genetic depletion of right-sided HA causes loss of gut tilting.  
A Targeted degradation of HA in the right DM via electroporation of pCAG-Hyal2 shows loss of 
expansion (top panel, H&E, R: pCAG-Hyal2) and gut tilting (quantified in B across the AP axis of the 
midgut). Bottom panel of A shows region of pCAG-Hyal2 electroporation indicated by co-
electroporation of GFP. C Depleting HA in the right DM via Hyal2 degradation or MU-Xyl inhibition 
of HA synthesis ablates gut tilting in the Z3 region of the midgut. MU-Xyl vs. WT, p = 0.00016; 
pCAG-Hyal2 vs. WT, p = 0.0025 (unpaired two-tailed T-test with Holm-Sidak correction for multiple 
comparisons). Error bars represent mean ± SEM for 7 chicken embryos per experimental condition. 
See also Figure S4A. Scale bar: A (100 µm).  
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fold enrichment (3.18 ± 1.36), n = 7, p = 0.0031), with a corresponding significant reduction of 
ECM expansion (Figure 2.2E; R: MU-Xyl vs. R: DMSO: n = 7 for each, p = 0.0053).  
While MU-Xyl inhibits HA synthesis, it may also affect synthesis of other GAGs such as 
chondroitin sulfate, albeit to a much lesser extent (Hamati et al., 1989). To selectively deplete HA, 
we electroporated the right splanchnic mesoderm at HH14 with Hyaluronidase 2 (Hyal2), encoding 
a highly specific enzyme that degrades extracellular HA (Albeiroti et al., 2015; Harada and 
Takahashi, 2007) (Figure 2.3A), marking targeted cells with co-electroporated GFP (Figure 2.3A, 
green). GFP-positive cells were found only on the electroporated right side at HH21, and 
electroporations with GFP alone had no effect on DM expansion (Figures 2.2E and 2.3A).  
However, similar to the MU-Xyl beading experiments, DM expansion was significantly reduced 
in Hyal2 electroporated embryos (Figures 2.2E and 2.3A, n = 7, p = 0.0025). Thus, HA is required 
for ECM expansion of the right DM.  
To determine the impact of HA on gut tilting, we quantified the tilting angles in the MU-
Xyl-beaded and Hyal2 electroporated embryos at HH21, as described above. Compared to control 
embryos, the leftward tilt of the midgut was lost in both the MU-Xyl-beaded and Hyal2 
electroporated embryos (Figures 2.3A-C, n = 7, MU-Xyl vs. WT: p = 0.00016, Hyal2 vs. WT: 
p = 0.0025).  Moreover, the slight tilting that we observed in manipulated embryos was oriented 
randomly (L vs. R, Figure 2.3B). Collectively, these results establish that HA mediates ECM 
expansion of the right DM and plays a pivotal role in the initiation of gut tilting.  
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2.3.4 Loss of HA disrupts the normal process of vascular exclusion in the right DM 
The gut vascular system derives from incompletely identified progenitors (Pardanaud et al., 1989) 
that form a bilaterally symmetric endothelial plexus residing in the left and right splanchnic 
mesoderm (Mahadevan et al., 2014; Thomason et al., 2012). We previously showed that at the 
onset of gut tilting, vascular endothelial cells within the right mesenchyme become progressively 
excluded, and at HH21, only the left-sided vascular endothelial cords remain (Figure 2.4A) 
(Mahadevan et al., 2014). We named these dorso-ventral (DV) cords, because they course 
dorsoventrally between the dorsal aorta and the gut vascular plexus (Figure 2.4A1, red arrow) 
(Mahadevan et al., 2014). Thus, blood vascular development within the DM is restricted to the left 
side via loss of vasculature on the right.  
We also demonstrated that during subsequent gut development (beyond HH21), the left-
sided DV cords remodel to form the highly stereotypical gut arterial branches within the left DM 
(Figure 2.4A2, red arrowhead) (Mahadevan et al., 2014). The first arterial branch to form, the 
primary longitudinal artery (1°LA, HH23, red arrowhead), becomes the ileocolic artery in the 
adult supplying the cecum, ileum, and appendix (human) (Mahadevan et al., 2014). Shortly after, 
a secondary longitudinal artery (2°LA, HH25) forms that extends cranially and is positioned 
halfway between the dorsal aorta and the gut tube (Figure 2.4D, green arrowhead).  The 2°LA 
becomes the middle colic artery in the adult (Mahadevan et al., 2014).   
Because the timing of HA accumulation and ECM expansion coincides spatiotemporally 
with the progressive vascular exclusion observed on the right, we hypothesized that HA-mediated 
mechanisms are responsible for the generation of avascular DM (Feinberg and Beebe, 1983). To 
test the relationship between HA and DM vasculature, we initially performed time series 
experiments to learn when vascular exclusion is first initiated. We used RNA in situ hybridization  
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Figure 2.4: Loss of HA from the right DM perturbs gut arterial vasculature.  
A Model of gut arteriogenesis in WT embryos where endothelial cells of the right-sided DV cords at 
HH17 emigrate to establish the avascular right side. At HH21, only the left-sided arterial DV cords 
remain. Subsequent remodeling of left-sided cords form the 1°longitudinal artery (1°LA, red 
arrowhead) by HH23. 2°LA (green arrowhead) forms by HH26 as shown in D. B VE-cadherin RNA 
ISH shows ectopic maintenance of DV cords at HH21 due to loss of HA. C This aberrant maintenance 
of DV cords in the right DM disrupts remodeling of the DV cords to form the 1°LA. Instead, an 
abnormally large arterial vessel forms (green arrows) seen in the transverse vibratome section of the 
midgut (Cx40 RNA ISH). E This ectopic mutant vessel (green arrows) forms in the anatomical position 
of the 2°LA at HH24, before the initiation of the WT 2°LA at HH25 in F. The 1°LA, in HA-depleted 
embryos (E, F, red arrow) is significantly shorter than in WT embryos, or is missing (RNA ISH for 
Cx40). G Quantification of the length and thickness of 1°LA and thickness of 2°LA in WT and HA-
depleted embryos. Length of 1°LA is significantly shorter in HA-depleted embryos, p = 0.0019; 2°LA 
is thicker in HA-depleted embryos, p = 0.0088 (unpaired two-tailed Student’s t-test). Error bars 
represent mean ± SEM for 7 chicken embryos per experimental condition. H Model summarizes defects 
in gut arteriogenesis due to loss of the right sided HA. CMV, cranial mesenteric artery; DA, dorsal 
aorta; DV cords, dorso-ventral cords. See also Figures S3 and S4A. Scale bars: B, C (100 µm); E, F 
(200 µm). 
68 
 
 
 
69 
 
(ISH) to VE-cadherin, a pan-vascular endothelial marker, on tissue sections isolated from WT 
chicken embryos between HH17-21 (Figure S3A). In addition, we performed 
immunohistochemistry on tissue sections isolated from transgenic Tie1:H2B-eYFP quail embryos 
(HH17-21) (Figure S3B).  
At HH17, when the DM had a basal level of HA accumulation on both sides, we noted 
bilateral vascular plexuses traversing both the left and right sides of the DM and connecting with 
the dorsal aortae. Thus, at HH17, the DM exhibits both cellular and vascular symmetry (Figure 
S3). Remarkably, at HH18, while the vascular endothelial cords of the left DM remained 
continuous and fused with the dorsal aorta, we noted disrupted continuity of cords in the dorsal 
right region with loss of the endothelial cells (Figures S3A and S3B). This region aligns with the 
domain of initial ECM expansion and HA accumulation in the right DM (Figures 2.1C, 2.1D, 2.2A 
and 2.2B). By HH19-20, at peak expansion and HA accumulation (Figures 2.1C, 2.1D, 2.2A and 
2.2B), we observed complete loss of vasculature from the right side (Figure S3). Thus, vascular 
exclusion within the right DM spatiotemporally correlates with DM expansion and HA 
accumulation.  
To determine whether HA is required for vascular exclusion, we used VE-cadherin ISH in 
MU-Xyl-beaded or Hyal2-electroporated chicken embryos. In HH21 control embryos, DV cords 
were only present in the left, but not the right DM (Figure 2.4B, red arrow). However, DV cords 
were observed on both sides of the DM in HA-depleted embryos (HH21, a “double-left” 
phenotype, n = 10/15). While the “double-left” phenotype was previously observed only when 
Pitx2 was misexpressed in the right DM (Mahadevan et al., 2014; Welsh et al., 2013), the 
expression of Pitx2 and a downstream target, Gpc3 remained restricted to the left DM in HA 
depleted embryos (Figure S4A). Thus, loss of HA on the right disrupts the normal process of 
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vascular exclusion without the loss of “Pitx2-negative” right side identity. Collectively, HA-rich 
ECM on the right side is anti-angiogenic and likely restricts vessel development to the left side. 
Furthermore, depletion of this HA-rich matrix causes loss of right-sided avascularity and aberrant 
maintenance of DV cords. 
2.3.5 Reduced HA synthesis perturbs the formation of gut arterial branches 
In wild type embryos, once formed at HH21, DV cords remodel ventrally to form the highly 
stereotypical 1°LA and 2°LA (Figure 2.4D, red and green arrowheads, respectively) (Mahadevan 
et al., 2014). We hypothesized that vascular exclusion on the DM right side must be necessary to 
allow for such stereotypical formation of gut arteries. To address this, we perturbed HA synthesis 
in the right DM as described above and asked whether the aberrant maintenance of DV cords on 
the right interferes with the subsequent formation of 1° and 2°LAs. We used RNA in situ 
hybridization (ISH) to Connexin 40 (Cx40), an arterial-specific vascular endothelial marker, on 
vibrotome-generated tissue slices of the DM and gut tube. At HH23, all WT embryos formed 
proper 1°LA located at the junction of the left DM and the gut tube (Figure 2.4C, red arrowhead). 
In contrast, we observed a single, abnormally large Cx40-positive arterial vessel positioned along 
the DM midline in embryos electroporated with Hyal2 on the right (Figure 2.4C, green arrows, n 
= 5/10). We concluded that the loss of HA-driven avascularity on the DM right side interferes with 
proper patterning of the 1°LA.  
To further characterize how the 1°LA is affected upon HA loss (Hyal2 overexpression), 
we performed ISH to Cx40 on whole embryos, and extended these analyses to two additional time 
points (HH24, 25) to learn whether 2°LA formation is also affected by Hyal2. First, in 3 of 8 
embryos electroporated with Hyal2 the 1°LA was absent, and was reduced in length in the 
remaining five embryos (Figures 2.4E and 2.4F, red arrowhead). Again, we observed an 
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abnormally large Cx40-positive arterial vessel positioned halfway between the dorsal aorta and the 
gut tube, anatomically resembling the 2°LA (Figures 2.4E-2.4G, green arrows, thickness of 1°LA 
WT embryos = 23.4 ± 4.54 μm, thickness of abnormal vessel resembling 2°LA R: pCAG-Hyal2 
embryos = 62.5 ± 26.58 μm, p = 0.0088). It is important to note that in WT embryos, 2°LA 
formation does not initiate until HH24-25 and is complete by HH26 (Mahadevan et al., 2014). In 
contrast, in embryos electroporated with Hyal2, the anomalous vessel resembling 2°LA was fully 
developed at HH23-24 (Figures 2.4C and 2.4E), a difference of ~12 hours. This indicates that HA-
driven vascular exclusion may also control the precise timing of blood vessel development, and 
underscores the complexity of coordinating development of an asymmetric organ with that of its 
nascent vasculature (Figure 2.4H). 
2.3.6 Tsg6 regulates HA-mediated expansion and vascular exclusion in the right DM 
In wild type embryos, once formed at HH21, DV cords remodel ventrally to form the highly 
stereotypical 1°LA and 2°LA (Figure 2.4D, red and green arrowheads, respectively) (Mahadevan 
et al., 2014). We hypothesized that vascular exclusion on the DM right side must be necessary to 
allow for such stereotypical formation of gut arteries. To address this, we perturbed HA synthesis 
in the right DM as described above and asked whether the aberrant maintenance of DV cords on 
the right interferes with the subsequent formation of 1° and 2°LAs. We used RNA in situ 
hybridization (ISH) to Connexin 40 (Cx40), an arterial-specific vascular endothelial marker, on 
vibrotome-generated tissue slices of the DM and gut tube. At HH23, all WT embryos formed 
proper 1°LA located at the junction of the left DM and the gut tube (Figure 2.4C, red arrowhead). 
In contrast, we observed a single, abnormally large Cx40-positive arterial vessel positioned along 
the DM midline in embryos electroporated with Hyal2 on the right (Figure 2.4C, green arrows, n  
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Figure 2.5: Tsg6 expression in the DM is right-sided and necessary for DM expansion 
and gut tilting. 
A Cartoon shows Tsg6 modification of HA via transfer of heavy chain complexes from the 
inter-α-inhibitor. A catalytically inactive form of Tsg6 (S28A) fails to covalently modify 
HA. B Laser capture microarray data and RNA ISH for Tsg6 in the chicken DM reveal 
right-sided expression at HH21. C Onset of Tsg6 expression in the right DM at HH19 
(bottom panel) coincides with vascular exclusion (top panel left: Tie1-H2B-YFP quail 
embryos; right: RNA ISH for VE-cadherin). D Knockdown of Tsg6 via electroporation of 
translation blocking morpholinos causes reduced right-sided DM expansion and 
subsequent loss of gut tilting. E Quantification of intercellular spaces in Tsg6-MO-
knockdown embryos confirms reduced right DM expansion compared to scrambled MO 
control (left panel, p = 0.0001). Loss of gut tilting is also quantified in the graph on the 
right, p = 0.0036 (unpaired two-tailed Student’s t-test). Error bars represent mean ± SEM 
for 5 chicken embryos per experimental condition.  See also Figures S3, S4B, S5 and S6B. 
Scale bars: B, C (100 µm); D (50 µm). . 
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= 5/10). We concluded that the loss of HA-driven avascularity on the DM right side interferes with 
proper patterning of the 1°LA.   
To further characterize how the 1°LA is affected upon HA loss (Hyal2 overexpression), 
we performed ISH to Cx40 on whole embryos, and extended these analyses to two additional time 
points (HH24, 25) to learn whether 2°LA formation is also affected by Hyal2. First, in 3 of 8 
embryos electroporated with Hyal2 the 1°LA was absent, and was reduced in length in the 
remaining five embryos (Figures 2.4E and 2.4F, red arrowhead). Again, we observed an 
abnormally large Cx40-positive arterial vessel positioned halfway between the dorsal aorta and the 
gut tube, anatomically resembling the 2°LA (Figures 2.4E-2.4G, green arrows, thickness of 1°LA 
WT embryos = 23.4 ± 4.54 μm, thickness of abnormal vessel resembling 2°LA R: pCAG-Hyal2 
embryos = 62.5 ± 26.58 μm, p = 0.0088). It is important to note that in WT embryos, 2°LA 
formation does not initiate until HH24-25 and is complete by HH26 (Mahadevan et al., 2014). In 
contrast, in embryos electroporated with Hyal2, the anomalous vessel resembling 2°LA was fully 
developed at HH23-24 (Figures 2.4C and 2.4E), a difference of ~12 hours. This indicates that HA-
driven vascular exclusion may also control the precise timing of blood vessel development, and 
underscores the complexity of coordinating development of an asymmetric organ with that of its 
nascent vasculature (Figure 2.4H). 
2.3.7 Tsg6 catalysis on HA is pivotal to ECM expansion and vascular exclusion 
Tsg6 catalyzes the transfer of HC proteins from the inter-α-trypsin inhibitor (IαI) to HA to form 
the highly stable HC-HA matrices (Figure 2.5A) (Lauer et al., 2013b). To understand whether the 
anti-vascular effects of Tsg6 on the right side depend on its covalent modification of HA, we 
obtained catalytically inactive human Tsg6 (Tsg6-S28A, gift from J. Enghild), mutated at a residue  
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Figure 2.6: Covalent modification of HA by Tsg6 is necessary and sufficient for gut vascular 
development.   
A Knockdown of Tsg6 via electroporation of morpholinos, but not scrambled control morpholinos, 
prevents vascular exclusion in the right DM at HH21 (red arrow, right DM), leading to the formation of 
the thicker ectopic 2°LA-like vessel at HH25 (B, red arrow, right panel). RNA ISH for Cx40; GFP marks 
electroporated cells. C Ectopic left Tsg6 expression is sufficient to inhibit vascular development in the 
DM (RNA ISH for Cx40 and VE-cadherin). D Catalytically dead Tsg6 mutant (S28A) fails to inhibit 
arteriogenesis (red arrow) when introduced into the left DM (RNA ISH for Cx40). E Exogenous right-
sided expression of catalytically dead Tsg6 mutant (S28A) serves as a dominant-negative Tsg6 and 
competes with endogenous WT Tsg6, preventing right-sided vascular exclusion (red arrow) at HH21 
(RNA ISH for Cx40). See also Figure S6A. Scale bars: A, C, D, E (100 µm); B (200 µm).  
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required for transfer of HC from IαI to HA (Figure 2.5A) (Sanggaard et al., 2008). In vitro, this 
one residue change ablates HC transfer activity without affecting HA binding capacity (Sanggaard 
et al., 2008). First, we electroporated a full-length Tsg6 WT construct (pCAG-Tsg6) on the left 
side of the (vascularized) DM to learn whether Tsg6 is sufficient to cause avascularity. We found 
that Tsg6 on the left resulted in the loss of DV cords at HH21 (not shown) and loss of the 1°LA at 
HH23 (ISH to Cx40, Figure 2.6C, n = 11/19 embryos showing complete loss of 1°LA, 8/19 with 
partial loss of 1°LA). Tsg6-mediated loss of vasculature depended on the dosage of electroporated 
Tsg6 in the DM. For example, at low Tsg6 doses in the left DM, vascular development was only 
partially inhibited (Figure S6A). We confirmed this anti-angiogenic effect of Tsg6 on the left with 
ISH to VE-cadherin (Figure 2.6C).  
To understand whether Tsg6 ablation of vessels on the left depends on its enzymatic 
activity, we repeated this experiment with the pCAG-Tsg6-S28A mutant. Strikingly, this had no 
effect on DM vasculature suggesting that the covalent modification of HA by Tsg6 is responsible 
for its anti-angiogenic function in the chicken DM (ISH to Cx40, Figure 2.6D). This result also 
argues that endogenous HA in the left DM, however weak in HA staining, may have a role, 
consistent with bilateral Has2 expression in the DM (Figure 2.5B, graph). Interestingly, 
electroporating either the WT or mutant Tsg6 on the left was insufficient to overcome the left-
sided condensation downstream of Pitx2 (Figure S6B), highlighting the optimal environment in 
the right DM for HA-mediated expansion that is suppressed on the left side by Pitx2. Thus, whereas 
Tsg6 is sufficient to cause vascular exclusion, it is not sufficient to induce ECM expansion on the 
left. These data also imply that the process of vascular exclusion driven by the HA/Tsg6 pathway 
may occur independent of ECM expansion.    
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Next, to prevent the formation of HC-HA on the right side of the DM, we electroporated the 
right side with the inactive pCAG-Tsg6-S28A construct to compete with the WT Tsg6 protein for 
HA binding (to act as a dominant-negative) (Sanggaard et al., 2008). H&E sections revealed a 
significant reduction of expansion in the right DM in embryos electroporated with pCAG-Tsg6-
S28A (Figure S6C, n = 5, p = 0.0015). Moreover, ISH staining for VE-cadherin revealed double-
left cords in pCAG-Tsg6-S28A embryos and normal left-sided DV cords in WT controls (Figure 
2.6E, red arrows). Collectively, these experiments suggest that Tsg6 catalysis on HA is pivotal to 
ECM expansion and vascular exclusion. 
2.3.8 HA negatively regulates Cxcl12 expression at the level of transcription 
Our previous live imaging of Tie1:H2B-eYFP quail embryos revealed that vascular exclusion in 
the right DM is dependent on endothelial cell migration (Mahadevan et al., 2014). Of specific 
interest to this process is the chemokine Cxcl12, a ligand for the G protein-coupled receptor Cxcr4 
(Mahadevan et al., 2014). We previously identified Cxcl12 as a direct target gene of Pitx2 and showed 
that mesenchymal expression of Cxcl12 is restricted to the left where it governs neighboring Cxcr4-
positive arterial endothelial cell migration (Mahadevan et al., 2014). Mice lacking the 
Cxcr4/Cxcl12 axis display defective DM arteriogenesis and fail to form arterial DV cords 
(Mahadevan et al., 2014; Tachibana et al., 1998).  
We previously showed that prior to the rise of DM asymmetries, when the intervening 
vascular endothelial plexus is initially bilateral (HH17), Cxcl12 mRNA expression in the DM is 
also bilateral (Figure 2.7A, HH17) but becomes lost on the right side commensurate with HA 
accumulation and vascular exclusion of DV cords (Figure 2.7A, HH19) (Mahadevan et al., 2014). 
This observation led us to hypothesize that loss of Cxcl12 expression on the right is driven by HA 
production. To test this, we investigated Cxcl12 expression in HA-depleted chicken embryos (via  
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Figure 2.7: HA negatively regulates Cxcl12 mRNA expression. 
A Bilateral Cxcl12 expression at HH17 in WT embryos becomes restricted to the left side concurrent 
with expansion and vascular exclusion at HH19. B Depletion of HA from the right via pCAG-Hyal2 
electroporation causes abnormal maintenance of Cxcl12 mRNA in the right DM at HH19. C Model 
showing dynamics of Cxcl12 expression in WT embryos where the left-restricted Cxcl12 progressively 
acquires a dorso-ventral (DV) gradient at HH23 and becomes concentrated in the ventral DM, adjacent 
to the gut tube. Loss of HA aberrantly maintains Cxcl12 in the right DM and perturbs the DV gradient 
of Cxcl12 in the left DM. D Perturbing the DV gradient of Cxcl12 by overexpressing pCAG-Cxcl12 in 
the left DM leads to loss of positional information for 1°LA, which fails to traverse along the gut tube-
DM border and instead forms along the anatomical position of the 2°LA (red arrowhead: WT, green 
arrows: L-pCAG-Cxcl12). RNA ISH for Cx40; GFP marks electroporated cells. Scale bars: A, B (100 
µm); D (50 µm). 
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pCAG-Hyal2 electroporation). Strikingly, Cxcl12 expression on the right was abnormally 
maintained suggesting that HA negatively regulates Cxcl12 at the transcriptional level (Figure 
2.7B). In WT embryos, accompanying the formation of the 1°LA from DV cords on the left, 
Cxcl12 expression subsequently develops DV gradient asymmetry in the left DM, with its highest 
concentration ventrally where the 1°LA forms (Figure 2.7C, HH23) (Mahadevan et al., 2014). 
Thus, to understand whether perturbed gradient of Cxcl2 expression could be the cause of the 
aberrant formation of the 2°LA and loss of the 1°LA that we observed in HA-depleted embryos, 
in a separate experiment, we overexpressed Cxcl12 in the left DM. Intriguingly, this resulted in 
the loss of the 1°LA and accelerated formation of the 2°LA-like vessel (Figure 2.7D, green arrows, 
n = 3/5), phenotypes similar to those obtained when HA or Tsg6 was depleted (Figures 2.4E, 2.4F 
and 2.6B). Thus, loss of the Cxcl12/Cxcr4 angiogenic signal may be one mechanism by which HA 
accumulation in the right DM mediates vascular exclusion and hence restricts vascular 
development to the left DM.   
2.3.9 Tsg6-null mice display defects in gut looping chirality  
Beyond fertility, the developmental role of Tsg6 is not known. To explore the role of Tsg6 in the 
mouse intestine, we characterized Tsg6 +/+, Tsg6 +/- and Tsg6 -/- mouse embryos (Fülöp et al., 
2003) at E18.5, when the final topology of the digestive tract is achieved (Kurpios et al., 2008; 
Savin et al., 2011). Unexpectedly, our preliminary genetic characterization of Tsg6-null mice 
suggested a significant departure from the expected Mendelian inheritance ratios, pointing to 
potentially lethal or sub-lethal phenotypes associated with loss of Tsg6 (not shown). As expected, 
in Tsg6 +/+ and Tsg6 +/- mouse embryos at E18.5, we observed stereotypical looping topology 
with jejunal and ileal loops tightly packed without entanglement (Figure 2.8A). Strikingly, in Tsg6 
-/- embryos, a spectrum of perturbations to the gut looping topology was observed  
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Figure 2.8: Tsg6-/- mice display altered gut looping morphogenesis. 
A Analysis of gut looping in E18.5 mouse embryos.  In Tsg6 +/- and Tsg6 +/+ embryos, the distal 
jejunal loop is reproducibly aligned perpendicular to the ileal loop (red), located adjacent to the 
proximal jejunum. In Tsg6 -/- embryos, proximal distension of the jejuno-ileal loops is observed 
and the distal jejunal loop crosses over the ileum, indicating gut malrotation. B Analysis of gut 
looping in E13.5 mouse embryos shows defects in orientation of the jejunal and ileal loops in Tsg6 
-/- embryos compared to Tsg6 +/- embryos. In Tsg6 +/- embryos, the jejunal loops exist in different 
planes compared to the ileal loop while in the mutants, the jejunal and ileal loops traverse in 
parallel. C In Tsg6 +/+ embryos, the apex of the midgut consisting of distal ileum and jejunum 
undergoes characteristic tilting pointing towards the cranial axis. This tilt is lost in Tsg6 -/- 
embryos. D Model for HA function in the gut: HA production and stabilization of HA matrix via 
Tsg6 expressed on the right side initiates counterclockwise gut rotation. The HA matrix negatively 
regulates Cxcl12 in the right DM leading to vascular exclusion and left-side restricted arterial 
patterning. See also Figure S7. Scale bars: A (1000 µm); B (500 µm); C (200 µm). 
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(Figure 2.8A, n = 4/5) with the ileum traversing a loop of distal jejunum, causing entanglement of 
the loops (Figure 2.8A, n = 2/4).  
Whereas most intestinal malrotations do not lead to volvulus, some possess characteristics 
that strongly predispose to this deadly strangulation (Langer, 2017) (Pelayo and Lo, 2016). These 
include mispositioning of the duodenojejunal junction (DJJ) and the cecum, resulting in the 
distance between the DJJ and the ileocecal junction (ICJ) being less than half the width of the 
abdomen, leading to a narrow mesenteric stalk (Langer, 2017). Out of five Tsg6 -/- embryos 
obtained from multiple litters, four of the mutant embryos displayed mispositioning of the cecum, 
where the distance between the DJJ and the ICJ was less than half of the abdominal width, strongly 
indicating the occurrence of malrotation due to a narrow mesenteric stalk (Figure S7).  
To understand the origins of the looping defect observed in the Tsg6 -/- embryos, we 
analyzed gut looping at two earlier time points, E12.5 and E13.5, during formation of the primary 
and secondary loops, respectively. At the onset of gut looping, the cranial tilt of the apex of the 
midgut loop was lost in Tsg6 -/- mutant embryos, suggestive of defective primary looping 
morphogenesis (Figure 2.8C, n = 4/4 mutants). At E13.5, three of five Tsg6 -/- embryos showed 
large deviations from the otherwise highly reproducible looping geometry commonly observed in 
age-matched Tsg6 +/- embryos (Figure 2.8B). This included altered positioning and orientation of 
the distal jejunal and ileal loops and mispositioning of the cecum, an important characteristic of 
intestinal malrotation (Langer, 2017; Pelayo and Lo, 2016).  
 
2.4 Discussion 
In the present study, we have shown that the leftward tilt of the vertebrate midgut results from the 
break in the midline symmetry initiated by the rapid expansion of the mesenchymal compartment 
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within the right side of the DM. Concomitantly, vascular development of the DM becomes 
restricted to the left side via exclusion of endothelial DV cords from the right. Our results reveal 
that the timely asymmetric accumulation of HA-rich matrix in the right DM and its covalent 
modification by Tsg6 orchestrates the mesenchymal expansion and vascular exclusion unique to 
the DM right side. Thus, initiation of the leftward tilt of the midgut and asymmetric assembly of 
gut arteries are driven by signals derived from the right, not left, DM (Figure 2.8D). 
Following the right-sided initiation of cellular and vascular asymmetries, the downstream 
targets of Pitx2 mediate the condensation of the left mesenchymal compartment as the gut tube 
tilts further to the left. Simultaneously, the left-sided DV cords remodel to form the permanent gut 
arteries. Thus, while the right side-restricted cellular and vascular transformations of the DM serve 
to initiate asymmetric morphogenesis of the midgut, subsequent transformations on the left side 
likely serve to further the tilt and initiate subsequent remodeling of the vasculature to give rise to 
the stereotypical gut looping and vascular topology. Our studies uncover the first LR symmetry-
breaking event regulated by the ECM that triggers evolutionarily conserved gut rotation and 
vasculogenesis. 
2.4.1 HA-dependent mechanisms in vivo 
 
The association of increased HA accumulation in the ECM with tissue volume changes during 
embryonic development has been known for decades (Toole, 2001). Knockout of the 
embryonically active Has2 results in early embryonic lethality at E9.5 and is accompanied by a 
severe reduction of cell-free matrix defined spaces such as cardiac jelly, resulting in loss of cardiac 
cushions (Camenisch et al., 2000). Similarly, the role of HA in vessel development and disease has 
been long appreciated, but the mechanisms are challenging to study in vivo and are mostly unknown 
(Wang et al., 2011; Wang et al., 2015). This is primarily attributed to the structural variability of 
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HA that enables it to participate in a complex spectrum of interactions (Cowman and Matsuoka, 
2005), existence of multiple HA receptors that bind to HA with different affinities within the same 
microenvironment (Jaime et al., 2015) and the heterogeneous distribution of HA polymers of 
different sizes in vivo, which regulates distinct signaling pathways that can sometimes result in 
opposing biological responses (Jaime et al., 2015; Pardue et al., 2008). 
Currently, our understanding of how HA facilitates tissue expansion and vascular exclusion 
is aided by the use of ex vivo model systems such as the cumulus cell-oocyte complex and in vitro 
cell culture-based assays (Fülöp et al., 2003; Shay et al., 2011).  The cumulus cell-oocyte complex 
is formed by the maturing oocyte surrounded by ~1500 cumulus cells. Upon hormonal stimulation, 
the complex undergoes a rapid, striking, nearly 20-fold HA-mediated expansion, that ejects the 
oocyte into the oviduct for subsequent fertilization (Salustri et al., 1989). HA or Tsg6 alone are 
insufficient in this process; formation of the HC-HA complex by Tsg6 initiates the expansion and 
maintains the integrity of the cumulus cell-oocyte complex (Fülöp et al., 2003; Mukhopadhyay et 
al., 2004).  
Tsg6-modified HC-HA has further been shown to inhibit angiogenesis in culture (Deed et 
al., 1997) and in amniotic membrane (Tseng, 2016) and is 100-fold more potent than HA alone in 
suppressing endothelial cell proliferation in HUVEC cell culture (Shay et al., 2011).  
While the use of these ex vivo and in vitro models have enabled us to gain very valuable 
insights into HA biology, the molecular and cellular mechanisms by which HA mediates biological 
and pathophysiological responses in vivo are complex, context-dependent and mostly unexplored 
due to the lack of a robust system to study HA in living animals. Most in vivo studies are often 
compromised by the three-dimensionality and inaccessibility of tissues and organs, or suffer 
complications of isolating specific regions from global and often lethal effects of transgenic 
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studies. For example, loss of Has2 results in early (E9.5) embryonic lethality, making it 
challenging to study the role of HA in embryogenesis (Camenisch et al., 2000). In contrast, the 
chicken DM is a binary planar structure that has left (HA-negative) and right (HA-positive) sides 
that are juxtaposed yet distinct, with strict boundaries for transcription factors and cellular effectors 
that are highly conserved and readily amenable for separate molecular and functional in vivo 
analyses.  
2.4.2 Significance of vascular asymmetry within the DM 
 
In addition to the essential role of gaseous exchange, the intestinal vasculature has critical 
functional roles in absorption and transport of dietary nutrients. The DM serves as the major 
conduit for the blood vessels that supply the gut. We previously showed that DM vasculogenesis 
proceeds strictly on the left side because endothelial cells are progressively excluded from the 
right, coincident with gut rotation (Mahadevan et al., 2014). This temporally regulated LR vascular 
asymmetry is a key feature employed by the DM to pattern abdominal vasculature, and is driven 
by active migration of endothelial cells from the right DM (Mahadevan et al., 2014). Why the 
embryonic DM excludes angiogenesis on the right side has remained an open question. In the 
present study, we address the significance of vascular exclusion using several methods to 
compromise HA production and Tsg6 expression in the chicken and mouse DM. Both HA 
depletion and loss of Tsg6 function caused vasculature on the right side to be aberrantly maintained 
at the time of the leftward tilt resulting in disrupted patterning of gut vasculature during subsequent 
gut looping morphogenesis.  While this phenotype mirrors the “double-left” vascular lesion 
obtained when Pitx2 is misexpressed on the right (Mahadevan et al., 2014), the loss of avascularity 
in Pitx2-misexpressed embryos is due to the loss of right side identity (double-left isomerism), 
whereas the aberrant maintenance of DV cords on the right in HA or Tsg6-depleted embryos 
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results from the change in the local microenvironment while retaining the Pitx2-negative identity 
of the right side. Indeed, none of the chemical perturbations disrupted the normal left-sided 
expression of Pitx2 (Figure S4). Thus, our studies highlight the importance of the local ECM 
during organ-specific vascular patterning. 
The appropriate patterning of vessels during development is achieved primarily via 
endothelial cell migration (Bentley and Chakravartula, 2017). Whereas this process involves 
spatial distribution of specific molecular cues (chemoattractant/repellant cues) within the local 
tissue microenvironment, time-dependent regulation of these cues is essential for establishing the 
architecture of the organ-specific vascular pattern (Bentley and Chakravartula, 2017; Kim et al., 
2011; Potente et al., 2011; Zambrano et al., 2016). In the DM, the emigration of the vascular 
endothelial cells from the right side and the subsequent remodeling of the left-sided DV cords to 
pattern the DM arterial vasculature proceeds in a highly spatiotemporally regulated manner 
dependent on Cxcl12 expression (Mahadevan et al., 2014). Our current study shows that depletion 
of HA alters Cxcl12 expression resulting in abnormal retention of the right-sided DV cords and 
subsequent defects in arterial patterning. Importantly, these defects resemble vascular lesions 
obtained upon Cxcl12 misexpression known to aberrantly accelerate DM arteriogenesis and 
perturb arterial patterning (Mahadevan et al., 2014) (Figure 2.7D). This suggests that the HA-rich 
ECM is a critical spatiotemporal modulator of arterial patterning within the gut DM. Indeed, 
depletion of HA or reduced expression of Tsg6 results in the loss of 1°LA and accelerated 
formation of the 2°LA-like vessel, highlighting how vascular process within the DM must 
carefully unfold over time and at the right place to generate pattern formation.  
A similar role for Cxcl12 has been described in other development systems. For example, 
in the mouse embryonic heart, perturbation to Cxcl12 expression results in the absence or abnormal 
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positioning of coronary arterial stems (Ivins et al., 2015). In the zebrafish hindbrain, knockdown 
of Cxcl12 results in the formation of misdirected abnormal connections (Fujita et al., 2011). 
Similarly, inhibition of Cxcl12 in ex vivo retinal explants results in altered branching 
morphogenesis of the retinal vasculature (Unoki et al., 2010). Collectively, these data suggest that 
the regulation and timing of Cxcl12 expression may be a global mechanism required for proper 
establishment of organ-specific vascular patterning.  
2.4.3 Mechanisms downstream of HA  
 
We previously identified Cxcl12 as a direct target of Pitx2 and showed that mesenchymal expression 
of Cxcl12 governs neighboring Cxcr4-positive arterial endothelial cell migration (Mahadevan et al., 
2014). We now show that HA negatively regulates Cxcl12 expression at the transcriptional level 
suggesting that loss of the Cxcl12/Cxcr4 angiogenic signal may be one mechanism by which HA 
mediates vascular exclusion.  
How does HA regulate Cxcl12 expression on the right side? There have been several 
factors reported to regulate Cxcl12 expression including both canonical (Tamura et al., 2011) and 
noncanonical Wnt signaling (Tamura et al., 2011; Witze et al., 2008), hypoxia-inducible factor-1 
and -2 (Ceradini et al., 2004; Martin et al., 2010), and VegfA (Hong et al., 2006). We previously 
showed that the tyrosine kinase receptors for VegfA, VegfR1 (Flk1/KDR) and Vegfr2, are 
expressed on the arterial endothelium of DV cords in the left DM (HH21) (Mahadevan et al., 
2014), whereas VegfA is expressed in the left DM mesenchyme where it mimics Cxcl12 expression 
(unpublished). Moreover, studies involving the hindbrain and retinal vasculature have shown that 
VegfA expression exists in a positive feedback loop with expression of Cxcl12 (Hong et al., 2006; 
Ping et al., 2011; van Weel et al., 2007; Zagzag et al., 2006) and targeted ectopic expression of 
Cxcl12 in the right DM induces VegfA expression (unpublished data). Thus, HA on the right may 
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inhibit VEGF signaling either transcriptionally, or act as an extracellular sink to sequester VEGF 
away from its tyrosine kinase receptor. 
In the heart, degradation of HMW HA into small HA oligosaccharides induces VEGF 
mRNA and protein expression in primary mouse endocardial cushions whereas HMW HA inhibits 
these activities (Rodgers et al., 2006). In zebrafish vasculature, small HA fragments are thought to 
induce VEGF signaling by liberating Vegf molecules from the ECM, with no effect on 
transcription (De Angelis et al., 2017). Given the critical role for VEGF in the formation of blood 
vessels (Ferrara, 2009) the relationship between HA, Cxcl12 expression, and the VEGF pathway 
in the chicken and mouse DM warrants future investigation. Moreover, we have previously shown 
that patterning of DM arteries is critical for subsequent initiation of gut lymphatic development 
(Mahadevan et al., 2014). Thus, the HA mediated mechanisms that regulate the arterial patterning 
may also play a role in the proper establishment of the gut lymphatic network. 
Of note, our studies suggest that HA is likely to employ distinct downstream signaling 
mechanisms to drive ECM expansion and vascular exclusion during gut looping because whereas 
Tsg6 misexpression on the left was sufficient to inhibit vasculature, it failed to induce expansion 
on the left (Figure S6B). This may highlight that additional factors at play that are differentially 
expressed across the LR axis, including Pitx2 or other hyaladherins, may affect the biological 
function of HA, or that distinct properties of the HA molecule itself are produced on the right 
versus the left side of the DM. 
2.4.4 Mechanisms upstream of HA 
 
While the current study provides insights into how HA functions in the DM to generate cellular 
and vascular asymmetries, the mechanisms that result in the asymmetric accumulation of HA in 
the right DM remain unclear. Whereas the expression of Has2 is the first determinant of active HA 
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synthesis, our results show that this enzyme is not differentially expressed in the DM, yet only the 
right side expands whereas the left side condenses. Consistent with bilateral Has2 expression in 
the DM, some HA production can be seen on the left side of the DM. These observations suggest 
that Has2 may not be responsible for the enriched levels of HA on the right and that HA synthesis 
alone may not account for the right-sided ECM expansion. Indeed, Has2 expression may be the 
same bilaterally, but to achieve right-sided expansion subsequent synthesis of HA can be 
asymmetrically modulated by many additional factors, including Tsg6 mediation of Has2 activity 
(Lauer et al., 2013a) and HC-HA stabilization of matrix (Fülöp et al., 2003; Mukhopadhyay et al., 
2004). 
What regulates the LR asymmetric right-sided Tsg6 expression in the DM? Leveraging 
data from our published laser capture microdissection of the left versus right halves of the DM 
(Welsh et al., 2015), we have identified Atf3, the anti-inflammatory cyclic AMP-dependent 
transcription factor 3, to be differentially expressed on the right side of the DM commensurate 
with Tsg6 expression (unpublished). Similar to Tsg6, previous studies have implicated the function 
of Atf3 in the ovarian cumulus HC-HA matrix (Inan et al., 2006). Importantly, we found a highly 
evolutionarily conserved region immediately upstream of Tsg6 that is enriched for the binding 
sequence of Atf3, suggesting direct regulation (unpublished). Moreover, Pitx2 directly binds the 
promoter region of Atf3 in mouse neonatal hearts where it suppresses Atf3 transcription (Wang et 
al., 2014) and forced Pitx2 expression in the right chicken DM inhibits Atf3, Tsg6 and HA 
production (unpublished).  
The T-box transcription factor Tbx18 is one of the most highly differentially expressed genes 
on the right side of the chicken DM tilt (Davis et al., 2008). Tbx18 expression pattern is specific to the 
midgut region and coincides spatiotemporally with the initiation of the leftward gut tilt (Davis et al., 
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2008). In chickens and mice, Tbx18 expression is negatively regulated by Pitx2 (Davis et al., 2008; 
Kurpios et al., 2008). These observations suggest that the cellular transformations unique to the DM 
right side may be downstream of Tbx18. Whether Tbx18 or Atf3 are responsible for the right-sided HA 
production and Tsg6 expression stands unexplored and warrants further investigation. One possibility 
by which these transcription factors could contribute to the asymmetric production of HA on the right 
is via regulating signaling pathways that serve to differentially modulate Has2 function via distinct 
posttranslational modifications (Tammi et al., 2011). However, mechanisms independent of Has2 
function in the DM are equally possible where Tsg6 in the DM may regulate HA stability by 
preventing HA catabolism (Lauer et al., 2013a). Future investigations are needed to elucidate these 
important mechanisms. 
2.4.5 Role of Tsg6 during intestinal malrotation and volvulus  
 
Gut malrotation is a complex congenital disorder of abnormal gut rotation that arises from failure to 
follow the stereotypical pattern of gut looping. Intestinal malrotation anomalies are relatively 
frequent in humans, occurring once in 500 live births (Torres and Ziegler, 1993). Serious 
consequences are observed when contorted twisting of the different segments of the gut tube 
around each other lead to a life-threatening lesion known as midgut volvulus characterized by 
gastrointestinal occlusion and strangulation of the associated mesenteric vasculature (Filston and 
Kirks, 1981; Torres and Ziegler, 1993). During embryonic development, the herniating midgut can 
be anatomically segmented into the cranial and caudal limbs by the cranial (superior) mesenteric 
artery (CMA) (Mahadevan et al., 2014; Noden and DeLahunta, 1985). The cranial limb of the 
midgut refers to the region of the midgut between the hepatic vein and the CMA while the caudal 
limb of the midgut extends from the apex of the midgut to the cecum (Soffers et al., 2015). The 
primary counterclockwise rotation (90 degrees), which begins at E10.75 in mouse embryos, serves 
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to bring the cranial and the caudal limbs of the midgut to the same plane (Onouchi et al., 2013; 
Ueda et al., 2016). During subsequent gut development, the formation of the four secondary loops 
initiates. The first secondary loop, also known as the duodenal flexure, extends rightward and 
caudally, and eventually extends leftward to establish the duodenal rotation (Onouchi et al., 2013; 
Soffers et al., 2015). The other secondary loops form in the regions of the midgut that give rise to 
the proximal and distal jejunum and the ileum (Soffers et al., 2015).  
Mouse mutants which have defects in the formation of these secondary loops exhibit a 
disorganized looping topology, suggestive of malrotation which is characterized by severe 
perturbations to the relative positioning of the duodeno-jejunal junction and the cecum (Langer, 
2017; Pelayo and Lo, 2016).  The current mouse models that exhibit defects in gut looping chirality 
include Pitx2HD (Lu et al., 1999), Pitx2ΔASE/ΔASE (Shiratori et al., 2006) and Nodalneo/neo (Saijoh et 
al., 2003). The Pitx2HD mice (Pitx2-null) display loss of the duodenal rotation  but die due to heart 
failure during early embryonic development prior to the formation of the  tertiary loops (Lu et al., 
1999; Soffers et al., 2015). The Pitx2ΔASE/ΔASE mutant embryos (lack the asymmetric Pitx2c isoform 
expression) and Nodalneo/neo (hypomorphic for Nodal) display aberrant duodenal rotation and an 
overall disorganized looping topology. However, a fraction of these embryos suffer from early 
embryonic lethality while others die immediately after birth (Saijoh et al., 2003; Shiratori et al., 
2006). Hence, whether these malrotations predispose to volvulus during later development cannot 
be studied. In contrast, Tsg6 -/- mice are reported to survive to adulthood, albeit at non-Mendelian 
inheritance ratios (unpublished observation). Of note, our preliminary genetic characterization of 
the Tsg6-null mice confirms a significant departure from the expected Mendelian ratios, pointing 
to potentially lethal or sub-lethal phenotypes associated with loss of Tsg6. Whether this is a 
consequence of HA-dependent or -independent Tsg6 function is not known, but it is fascinating to 
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speculate that gut and/or vascular anomalies are the underlying cause of these phenotypes. 
Collectively, Tsg6 -/- mice may provide an important genetic model where the clinical 
consequences of early gut malrotation and volvulus can be followed throughout adult life.  
Taken together, our studies unravel the first LR symmetry-breaking event in chickens and 
mice that triggers evolutionarily conserved gut rotation and vasculogenesis. We identify a novel 
ECM-derived pathway during LR organogenesis initiated by the HA matrix and its enzymatic 
modification dependent on Tsg6. Vasculogenesis - induction of new vessels and destruction of 
existing ones - is among the most important processes in human biology and vascular anomalies 
are the leading cause of gestational failure, but by their nature are very difficult to study. Similarly, the 
role of HA in vessel development and disease has been long appreciated, but the mechanisms are 
complex and mainly unexplored. Our work offers new insights into the mechanisms regulating 
HA function and addresses a critical area of vascular developmental biology and medicine, with 
potential relevance for developmental defects and inflammatory diseases. 
 
2.5 Materials and Methods 
2.5.1 Animals 
Fertile chicken eggs (White Leghorn) or transgenic Tie1-H2b-YFP quail eggs (Ozark) were 
obtained from the Sunrise Farms and Cornell University Poultry Research Farm, incubated at 
380C, and staged accordingly (Hamburger Hamilton 1951). Mouse embryos were obtained from 
Tsg6 mutant colony (Fülöp C, 2003) that were kindly provided by Dr. Hascall (BALB/cJ inbred 
background). WT BALB/cJ mice were purchased from Jackson Labs (Stock number 000651). 
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2.5.2 In ovo electroporation  
Candidate genes were delivered to the developing DM using in ovo DNA electroporation as 
previously described (Welsh IC, 2013). Briefly, full-length genes or mutant constructs were 
delivered using the pCAG vector system (Matsuda T, 2004). A solution of plasmid DNA (encoding 
Hyal2, Tsg6, S28ATsg6, Cxcl12) was microinjected into the left or right coelomic cavity of HH14 
chicken embryos (prior to the formation of the DM) and 3 pulses of 50V, 10mA were applied using 
a BTX electroporator. Eggs were then sealed and incubated until the desired stage. The pCAG 
vector was co-electroporated with pCAG-GFP for identification of target cells. 
2.5.3 Morpholino design and electroporation 
Tsg6 knockdown experiments were carried out by electroporation of targeted morpholinos (Gene 
Tools) targeting the right side of the DM. To target Tsg6, the following 5' UTR targeting FITC-
labeled translation-blocking morpholino was designed: 
AGGGCAATCATCTCTTCCGAACTGT-3′. As an experimental control, FITC-conjugated 
standard scrambled RNA MO (Sc-MO) (Gene Tools) was used. The morpholinos were injected 
into the right coelomic cavity at HH14 and were electroporated at a concentration of 1.0 mM along 
with carrier DNA (pSlax) at a concentration of 1 μg/μl and 10 mM Tris (pH 8). The pulsing 
conditions were three 10 ms pulses 50 V spaced out by a 100 ms time interval.  
2.5.4 In ovo bead implantation: 
For inhibition of HA synthesis, vehicle (DMSO) or 40mM solution of 4 Methyl umbelliferone-B-
D-Xyloside (Sigma, #M7008) was adsorbed onto AG resin beads (Bio-Rad, #143-1255) overnight 
(ON) at 4°C, washed and inserted into the coelom with fine forceps (Dumont 55). 
2.5.5 Histology and Quantifications  
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WT embryos were dissected in cold 1X PBS and fixed ON using Bouin’s fixative. The embryos 
were washed in 70% ethanol and embedded in paraffin. 6 μm tissue sections were collected on 
Superfrost Plus slides and were stained with H&E. Color development was moderated by 
controlling the exposure in 1% HCl /70% EtOH and ammonium hydroxide solution. Images of the 
sections taken using a 40X plan/achromat objective and the Zeiss Observer Z1 microscope. To 
quantify cell-free spaces within the DM (acellular compartment) sections were processed using 
ImageJ program for calculating the fraction of acellular compartment. To do this, random regions 
within the left and the right DM were selected and duplicated for processing (Figure S1A). The 
cell-free spaces were identified by negative thresholding using ImageJ Thresholding Tool with the 
dark background option, segmented into smaller parts using ImageJ Watershed Algorithm and the 
sum total of their areas were estimated using Image J Particle Analyzer (Figure S1A). The percent 
ratio of the cell-free area to the total area was identified as the parameter that quantifies extent of 
DM expansion in the left and right DM. Student t-test was used to test the significance of the 
differences. The ImageJ analysis was verified by counting nuclei of left and right DM in sections 
stained with DAPI (ImageJ Cell Counter Plugin).  
2.5.6 HA staining and Immunohistochemistry 
The distribution of HA was determined by incubating frozen or paraffin sections with biotinylated 
HA-binding protein (bHABP; 5µg/ ml; EMD Millipore, Cat No. 385911) in 3% Heat Inactivated 
Goat Serum in 1X PBS at 4°C O/N, followed by washing and incubation with AlexaFluor 568 
conjugated streptavidin (Life Technologies #S11226) for 1 hour at room temperature (RT).  
For GFP immunohistochemistry, embryos were dissected in cold 1X PBS, fixed ON in 4% 
PFA/PBS and were washed through a graded series of 30% sucrose/PBS solutions prior to freezing 
in a 1:1 mixture of 30% sucrose/OCT. Sections of 8-30 μm were collected, dried ON, and stored 
97 
 
at -800C. Rehydrated cryosections of DM were then subjected to blocking with 3% Heat 
Inactivated Goat Serum for 1 hour at RT. Sections were then incubated with rabbit polyclonal anti-
GFP antibodies (Abcam, AB290, 1:1000) and with Alexa Fluor 488 (Life Technologies, #A11070) 
for 1 hour at RT. Sections were imaged using Zeiss Observer Z1 with Apotome and/or Leica SP5 
confocal microscope.  
Immunohistochemistry of E18.5 mouse mesenteric and gut vasculature was performed 
using whole mount tissue fixed in 4% PFA ON. The samples were subsequently given 3X PBS 
washes followed by incubation with blocking solution (1% BSA and 0.3% PBST) ON at 40C to 
prevent nonspecific antibody binding. Primary antibody to rat PECAM1 (CD31) (BD Biosciences, 
Cat No. 553370, 1:100) was diluted in blocking solution and incubated ON at 40C. Six washes 
with 0.3% PBST were performed prior to, and following an incubation with secondary antibodies 
(and then incubated with corresponding Alexa flour conjugated secondary antibodies (goat anti 
rabbit Alexa Fluor 488 #A11070 and donkey anti rat 594 #A21209, Life Technologies, 1:500) 
diluted in blocking solution ON at 40C. To image, the intestines attached to the mesentery were 
carefully cut into smaller pieces, and mounted on slides within a 0.5mm spacer (Invitrogen, 
S24735) and imaged using Zeiss 710 confocal microscopy. 
2.5.7 RNA in situ hybridization, Cloning, Plasmids, and Oligonucleotides 
For RNA in situ hybridization (ISH), 400 μm embryo slices were collected with a McIlwain tissue 
chopper (Campden Instruments), fixed in 4% PFA/PBS ON, dehydrated, and stored in 100% 
methanol prior to processing. ISH on embryo slices, whole embryos or frozen cryosections was 
performed by following standard protocols as previously described (Welsh IC, 2013). Probes for 
RNA ISH were cloned using TA cloning kit (Qiagen, #231124) or oligo-dT primed cDNA reverse 
transcription (Superscript III, Life Technologies, #4368814) using RNA pooled from HH19 and 
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21 whole chicken embryos. The following ESTs or cDNA clones were used to generate antisense 
riboprobes: chicken Tsg6 (NM_001037837.2 Fw: 5’ to 3’ GACTATGGGGATTCGCCTCA Rv: 
5’ to 3’ CGTATGTCCCTGCCTGATCT); chicken Cx40 (NM_205504.1, Fw: 5’ to 3’ 
TGTCGGTGTGATCTGTCTCC Rv: 5’ to 3’ CGTCTGGGAGGTTACAGTGG); chicken VE-
Cdh (NM_204227.1 Fw: 5’ to 3’ CAGATAGGTATCAAGAGCCTGCC Rv: 5’ to 3’ 
CTCCTGCCACGAAAGTACTGTG).  Human HYAL2 cDNA was amplified from pCMV6-
HYAL2 (sc117754 OriGene) using the following primers: Fw: 5’ to 3’ 
AAAACTCGAGATGCGGGCAGGCCCA and Rv: 5’ to 3’ 
AAAAGCGGCCGCCTACAAGGTCCAGGTAAAGGCCAG (restriction enzyme sites are 
underlined). It was then subcloned into pCAGEN plasmid (Matsuda T, 2004) using XhoI and NotI 
sites. Chicken Tsg6 cDNA was synthesized and cloned into pCAGEN using the following primers: 
Fw: 5’ to 3’ AAAAGAATTCGGGAGTATTTACAGCCTAAC and Rv: 5’ to 3’ 
TTTTGCGGCCGCTATTCTGCTCACATAAT and cloned using EcoRI and NotI sites. 
The catalytically inactive Tsg6-S28A mutant construct (pcDNA5/FRT S28A mutant Tsg6) was a 
gift from Jan J Enghild lab (Department of Molecular Biology and Genetics, Aarhus University, 
Aarhus, Denmark). The insert was a full length human Tsg6 whose serine 28 was mutated to an 
alanine. The original construct was cloned between KpnI (5'-end) and Xho1 (3'-end) in the 
pCDNA5/FRT vector system and was subsequently subcloned into pCAGEN system via EcoRI 
digest followed by sticky end ligation. All DNA clones were verified by sequencing (Cornell 
University Life Sciences Core Laboratories Center).   
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2.8 Supplemental figures 
These supplemental figures with their legends accompany Chapter 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1: Schematic for quantification of intercellular (cell-free) spaces within the LR DM from 
HH17-21 using ImageJ (related to Fig.2 1). 
A (Left panel) Cartoon model of a transverse section of HH21 midgut-DM showing condensed left 
(orange) and expanded right (blue) mesenchyme. (Middle panel) H&E of HH19 midgut section. Orange 
and blue boxes indicate regions selected for analysis of cell-free spaces. (Right panel) The selected 
regions were copied to a new window in ImageJ (step 1) and cell-free spaces were identified using the 
ImageJ Thresholding Tool with a dark background option (step 2). These were then segmented into 
smaller parts using the Watershed Algorithm Tool and the sum total of their areas were estimated with 
the Particle Analyzer Tool. B Cartoon of the right lateral view of an embryo with the midgut region 
defined. The midgut has been segregated into five zones, Z1-Z5, where Z1 has been defined as the 
caudal midgut, Z2-Z3 the mid-caudal midgut, and Z4-Z5 as the central midgut. Examples of H&E 
images of the caudal, mid-caudal, and central midgut regions are shown in the right panel. Graphs 
demonstrate significant variation in expansion of the right DM across the different defined midgut 
regions at HH18-21 where the mid-caudal and central regions show more expansion than the caudal 
region (orange is left DM, blue is right DM. p-values are indicated within the graphs; unpaired two-
tailed Student’s t-test, with Holm-Sidak correction for multiple comparisons. Error bars represent mean 
± SEM for 5 chicken embryos per developmental stage). Scale bars: A, B (50 μm).  
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Fig. S2: Positive and negative controls for biotinylated HABP immunohistochemistry (related to 
Fig. 2). 
A Internal positive control for biotinylated HABP immunohistochemistry showing expected HA 
accumulation surrounding the notochord. B Biotinylated HABP IHC with streptavidin conjugated 
Alexaflour 568 secondary antibody on HH19 WT embryos showing enriched accumulation of HA in the 
right DM. C Streptavidin conjugated Alexaflour 568 secondary antibody-only negative control showing 
no background signal. Scale bars: A, B, C (40 μm).  
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Fig. S3: Vascular exclusion on the right is coincident with initiation of the leftward gut tilt 
(related to Fig. 4).   
Endothelial cells of the right-sided DV cords (HH17) are progressively excluded from the right 
as DM expansion proceeds starting at HH18, resulting in strictly left-sided DV cords at HH20. 
This was observed via RNA ISH for VE-cadherin in the chicken A and Tie1-H2B-YFP quail 
embryos B. C Model of the spatiotemporally coordinated DM expansion, formation of the 
leftward gut tilt, and vascular exclusion of the DV cords.  Scale bars: A, B (100 μm).  
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Fig. S4: Loss of HA or Tsg6 in the right DM does not alter LR asymmetric Pitx2 expression 
(related to Fig. 3).  
A (Top panel) Pitx2 RNA ISH on pCAG-Hyal2 electroporated embryos confirms left-sided Pitx2 
expression in the DM. (Bottom panel) The expression of Gpc3, a downstream Pitx2 target and effector 
of the non-canonical Wnt signaling is also not altered in these embryos as demonstrated by the left-
restricted DM expression of Gpc3 (RNA ISH to Gpc3). B Pitx2 RNA ISH on electroporated chicken 
embryos with Tsg6-targeting morpholinos confirms left-sided Pitx2 expression in the DM.  Scale bars: 
A (left panel, 100 μm; right panel, 50 μm); B (left panel, 200 μm; right panel, 100 μm). 
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Fig. S5: Spatiotemporal expression profile of Tsg6 in the chicken DM (related to Fig. 5) 
RNA ISH for Tsg6 in the chicken DM demonstrates that right-sided expression of Tsg6 
coincides with DM expansion. Scale bars: 50 μm 
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Fig. S6: Differential requirement for Tsg6 in the left versus right side of the DM 
(related to Fig. 6). 
A (Top panel) Anti-angiogenic effect of Tsg6 misexpression on the left is dosage 
dependent. Complete loss of DM vasculature is seen in embryos strongly electroporated 
with pCAG-Tsg6 on the left side. (Bottom panel) Weakly electroporated embryos show 
only partial loss of the 1°LA. B (Top panel) Tsg6 is not sufficient to induce expansion 
of the DM mesenchyme. Condensation of the left mesenchyme is unaffected in embryos 
electroporated with pCAG-Tsg6 on the left (H&E staining). (Bottom panel) DM 
expansion is lost in embryos electroporated with catalytically inactive Tsg6 (S28A) 
mutant on the right side (H&E staining). Scale bars: A (100 μm); B, C (50 μm). 
 
114 
 
 
115 
 
     
Fig. S7: Tgs6-/- mice may be predisposed t midgut volvulus. 
The distance (in microns) between the duodenojejunal junction (DJJ) and ileocecal 
junction (ICJ) (red double-headed arrow) and of the abdominal length (green double-
headed arrow) was measured in Tsg6 +/+ and Tsg6 -/- E18.5 embryos (top panel). The 
ratio of the two values were plotted (bottom panel) and compared against the threshold 
value for defining a narrow mesenteric stalk (black dotted line) reflective of increased 
predisposition to volvulus (n = 4/5). The Tsg6 -/- mutant embryo marked with red asterisk 
(n = 1/5) had normal looping morphology. Scale bars: 1000 μm. 
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CHAPTER 3: TRANSCRIPTIONAL REGULATION OF CELL SHAPE CHANGES 
DURING VISCERAL ORGAN MORPHOGENESIS 
 
This chapter is part of an invited review for the Journal of Cell Biology. It is written with Dr. Natasza A 
Kurpios. It has been submitted and is currently under review.  
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3.1 Abstract  
The blossoming field of transcriptional regulation of cell shape changes during organogenesis aims 
to address the question of how gene regulatory networks and signaling mechanisms are integrated 
with cell intrinsic chromatin dynamics to produce the single most desired output- a change in cell 
shape. This process is fundamental to all cellular behaviors required to sculpt the organ. This 
review integrates concepts that have emerged from multiple studies that have contributed to the 
existing knowledge of transcriptional regulators, signaling pathways, and morphological processes 
that shape the visceral organs including heart, lungs, gastrointestinal tract and its accessory organs, 
and the kidneys. The review also emphasizes on the conservation of these processes across 
different species highlighting the best studied models in terms of cell shape changes during the 
different morphogenetic processes that underlie organ development. Perspectives have been 
provided on the questions that remain to be answered at the end of each section that may provide 
new research avenues and therapeutic opportunities.  
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3.2 Introduction 
The morphogenetic processes that sculpt tissues and organs during embryogenesis univocally 
involve three-dimensional changes of sheets or clusters of individual cells. These complex events 
are regulated by precise spatial coordination of a limited repertoire of cellular behaviors such as 
oriented cell division, polarized growth, directional migration, differentiation, and programmed 
cell death – all which fundamentally involve changes in cell shape. The shape of any given cell in 
a cell-cluster is the result of an interplay between cell-cell, cell-matrix adhesion, and cortical 
tension (Lecuit T, 2007; Vogel V, 2006).  While cortical tension is an isotropic regulator of cell 
shape, the distribution of the protein complexes involved in cell-matrix and cell-cell adhesion can 
be polarized and is primarily governed by two pathways: the apical-basal polarity (ABP) and the 
planar cell polarity (PCP) pathways which determine the cell shape perpendicular and parallel to 
the extracellular matrix (ECM), respectively.    
 The PCP pathway involves several modules of interacting proteins that function to 
establish specific geometric states within a cell to execute directed cellular behaviors along the 
sheet parallel to the matrix. The cellular behaviors include, but are not limited to, convergent 
extension, oriented cell division, directional migration, cellular rearrangements such as directed 
intercalation and polarized ciliary beating. Often, a core set of protein modules comprising of 
Vangl1, Vangl2, Celsr1, 2, 3, Disheveled (Dsh), Prickle, and orthologs of Fzd are generally 
associated with regulation of the PCP behavior.  Additional regulators include an accessory 
module comprising the atypical cadherins, Fat and Dachous, and the Golgi resident protein Four-
jointed that provide directional cues.  Most often, the core and the accessory regulators also interact 
with tissue-specific effectors for regulating the PCP behavior. These have been thoroughly 
reviewed elsewhere (JB Wallingford, 2012; Karner CM, 2006; Seifert JR, 2007).  
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The ABP pathway involves asymmetrically localized multiprotein complexes that 
demarcate the boundary between the apical and basolateral membrane domains of a cell. They also 
serve as a barrier to intramembrane diffusion of proteins and macromolecules between the apical 
and basolateral membrane domains and aid in the formation of apical specializations such as brush 
borders. These proteins complexes include apically localized Par3-Par6 complexes, proteins that 
localize to apical lateral boundary such as PatJ and Stardust, and proteins that localize to the 
basolateral domain, Lgl2, Dlg, and Scribble. A detailed description of these can be found in the 
following reviews (Elsum I, 2012; Macara, 2004; Mellman I, 2008). 
 During embryonic development, tissue morphogenesis is driven by coordination and 
alignment of the local cellular behaviors with the three embryonic axes: dorsal-ventral (Bakkers 
J), anterior-posterior (AP) and left-right (LR) axes (Bakkers J). Since the spatiotemporal patterning 
in the embryo is specified by evolutionarily conserved and tissue-specific genetic and 
transcriptional regulatory networks, the above-mentioned polarity pathways that govern the local 
changes in cell shape in the embryo are ultimately regulated by these transcriptional regulatory 
networks. Importantly, while the morphogenetic pathways involved in regulating cell shape 
changes are thought to be generally permissive in nature and not instructive, recent studies have 
revealed that cell shape changes can be programmed by changes at the genomic level in addition 
to changes in protein localization (Halbleib JM, 2007). However, much remains to be explored to 
elucidate the complex signaling cascades that link the upstream transcriptional regulators to the 
cytoskeletal remodelers that are central to cell shape changes during organogenesis.  
 In this review, we explore how the regulatory networks specific to the structural and 
functional development of different organs, uniquely integrate at the transcriptional level to 
produce the necessary changes in cell shape and cell behavior during visceral organogenesis. For 
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each organ, the physical processes underlying its morphogenesis have been concisely described, 
followed by the cell shape changes that underlie these processes. Current knowledge about the 
transcriptional regulation of these morphogenetic events, gained from studies performed on 
different model organisms, has been integrated to bridge the link between the transcriptional 
machinery and cell shape changes driving the formation of the organ.  
 
3.3 Defining the visceral organs 
Visceral organs refer to the internal organs located within the cavities of the torso and can be 
broadly categorized into the thoracic viscera which includes the heart and lungs, and the abdominal 
viscera that includes the gastrointestinal (GI) tract and its accessory organs such as the liver and 
pancreas. They primarily arise from the splanchnopleure (comprising of the splanchnic mesoderm 
and endoderm) and begin as simple structures comprising of epithelial tubes, lumens and cavities. 
These primitive structures subsequently adopt a well defined conserved morphogenetic themes 
such as budding, looping, branching, and tubulogenesis in unique and specific mechanisms to 
transform into complex three-dimensional structures that are optimally packed within the limited 
space of the body cavity.  These morphogenetic events are accompanied by formation of localized, 
molecularly distinct, spatially segregated microenvironments within the developing organ that 
initiate distinct cell fate specification programs involving changes in cell shape and behavior to 
give rise to the different cell types that are optimally organized for establishing the structure and 
functionality of the organs. 
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3.4 Transcriptional regulation of cell shape during heart development 
The primitive heart is the first organ to form and function during vertebrate embryogenesis and is 
derived from bilateral populations of cardiac precursors that are initially present in the lateral 
mesoderm (Stainier DY, 2001). Its development can be broadly classified into three stages: a) 
formation of the primitive heart tube; b) elongation and looping of the heart tube; and c) 
remodeling to establish the cardiac chambers valves, and aligning the great arteries with the 
chambers. The formation of the primitive heart tube initiates with the synchronized migration of 
the lateral cardiac precursor cells towards the midline where they fuse to form a primitive tubular 
heart tube (Glickman NS, 2002). Subsequently, cardiac progenitors from the secondary heart field 
(SHF) are integrated at the arterial and venous poles resulting in rapid elongation of the heart tube 
(Mjaatvedt CH, 2001; Waldo KL, 2001). As the tube elongates, asymmetric processes initiate to 
displace the heart to the left. This is coordinated with involution and looping that result in the LR 
asymmetries transferred into the DV asymmetries of the cardiac tube (Rohr S, 2008). 
Simultaneously, the formation of the cardiac chambers and its associated valves is initiated 
(Moorman AF, 2003).  Following the formation of the cardiac chambers, the heart undergoes 
significant remodeling that entails separation of the outflow tract into the aorta and pulmonary 
trunk and the alignment of these great arteries with their respective ventricular chambers (Sinha 
T, 2012). This remodeling enables the heart to attain its final form and is also accompanied by 
terminal differentiation of the myocardium (Hirschy A, 2006) and formation of the epicardium 
(Hirose T, 2006).  
The cell shape changes pertinent to heart development can be observed from the earliest 
stages to the later remodeling stages and studies in zebrafish, chick and mice have provided us  
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Figure 3.1: Schematic representing processes, transcriptional factors and signaling pathways 
that regulate cell behavior during different stages of heart development. Figures represent the 
embryological processes while the text in black represents the cellular behavior that requires 
changes in cell shape. Each transcription factor and its downstream signaling pathway and its 
cytoskeletal regulators are listed in same color in adjacent columns. Eg: Tbx1- regulates 
Wnt5a, Wnt 11r pathway which regulates Vangl2 , Dsh to cause addition of SHF progenitors 
at arterial and venous poles by  oriented intercalation.  Genes without any known upstream or 
downstream interactors are listed in gray.  
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with spatial and temporal insights into the critical molecular players and the transcriptional 
regulatory networks that are explored in the following sections (Figure 3.1).   
3.4.1 Cell shape changes during migration of the cardiac progenitors 
Towards the end of gastrulation, as the cardiac precursors migrate towards the midline, the medial 
myocardial progenitor cells adopt a polarized epithelial organization, becoming columnar and 
displaying basolateral distribution of β-catenin, apical localization of atypical protein kinase C iota 
(αPKCί) and junctional localization of zonula occludens (ZO-1), while the lateral myocardial 
progenitors remain cuboidal in shape (Rohr S, 2006).  Defects in this midline migration results in 
cardiac bifida (formation of two hearts). Studies in zebrafish, chick and mouse embryos have 
shown that Wnt, Fgf, and BMP signaling pathways are major signaling pathways that regulate this 
migration (Yang X, 2002; Yue et al., 2008). In the chick and mouse embryos, Wnt3A and the 
BMP2 pathways have been shown to converge to regulate the transcription factor SMAD-1 to 
ensure proper migration of the cardiac progenitors (Song J, 2014). Similarly, GATA4 (Kuo CT, 
1997) has also been shown to regulate the cardiac progenitor migration. However, its exact cell 
intrinsic roles in regulating the cell shape changes are unknown. Interestingly, Mesp1, a homeobox 
transcription factor, has been shown to act cell autonomously to coordinate the specification and 
polarity of the myocardial progenitor cells with the directional migration of the cardiac progenitors 
(Ref). Particularly, Mesp1 directly regulates the expression of Prickle1, a core component of the 
PCP pathway, to determine the directionality of the migrating myocardial progenitors. 
Additionally, Mesp1 also targets RasGRP3, a critical regulator of cell motility, and ERK signaling 
pathway, to regulate the speed of migration of these myocardial progenitors (Chiapparo G, 2016). 
However, how Mesp1 is integrated with the more upstream transcriptional network and signaling 
pathways during myocardial progenitor migration in the embryo is currently unknown. Studies in 
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zebrafish have shown that while the PCP components Diversin and Dsh are the major downstream 
regulators of cell shape changes that accompany the migration of the cardiac precursors (Moeller 
H, 2006), transcriptional mechanisms that directly regulate these PCP components remain to be 
identified. 
3.4.2 Cell shape changes during initiation of heart looping and elongation 
The changes in cell shape during the formation and looping of the heart tube have been more 
extensively studied in zebrafish embryos compared to chick and mouse embryos. In zebrafish, as 
the cardiac progenitors migrate to the midline, they fuse to form the cardiac cone (Figure 3.1) 
(Holtzman NG, 2007; Trinh LA, 2004). As the cardiac cone extends, it undergoes leftward 
displacement which is also called cardiac ‘jogging’, following which the linear heart tube 
gradually bends at the boundary between the ventricle and the atrium to create the S-shaped loop. 
While the molecular mechanisms regulating the formation of the loop are not fully understood, the 
changes in cell shape of the cardiomyocytes during looping is a major force driving this process 
(Taber, 2006). At the onset of looping, the cardiomyocytes change shape from small and rounded 
(isotropic) morphology of the linear heart tube to flattened and elongated in the outer curvature at 
the expanded chamber stage. Tbx1, a member of T-box family of transcription factors, is the cell 
intrinsic master regulator of the cell shape change of the cardiomyocytes during looping. In Tbx1-
/mutants, cells in the outer and inner curvatures retain the small and rounded morphology and do 
not elongate. Interestingly, Tbx1 directly targets Wnt11r, an ortholog of Wnt11 to regulate these 
cellular changes (Choudhry P, 2013).  The downstream mechanisms of the Tbx1-Wnt11r signaling 
pathway remain to be elucidated and are an open topic for investigation. The dynamic cellular 
rearrangements that accompany cardiac looping are poorly understood in chick and mice and much 
remains to be discovered. 
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As the heart tube loops, it also undergoes elongation by oriented intercalation of cohesive 
sheets of cardiac progenitor cells derived from the secondary heart field (SHF) to its arterial and 
venous poles to form the right ventricle, outflow tract (OFT), and atrial myocardium tube (Figure 
3.1) (Mjaatvedt CH, 2001; Waldo KL, 2001). The SHF progenitor cells originate from the dorsal 
wall of the coelomic cavity, and constitute an atypical polarized epithelium with monocilia on the 
apical side and dynamic filopodia on the basal side.  In mice, Tbx1 is a critical regulator of the 
epithelial cell morphology of the SHF cells in addition to regulating its proliferation and 
differentiation. Tbx1 also regulates oriented intercalation by interacting with the BAF chromatin 
remodeling complex to regulate the expression of Wnt5a, which interacts with Wnt11, Dsh, and 
Vangl2 to induce cell intercalation (Chen L, 2012). In addition to the Tbx1 mediated mechanisms, 
the transcription factor Mef2C is known to regulate the lengthening of the OFT. However, the 
cellular basis of the Mef2C-mediated elongation is poorly understood (Barnes RM, 2016). 
3.4.3 Cell shape changes post looping of the primary heart tube 
At the time of looping, the primary heart tube within the pericardial cavity can be divided into the 
atrial and ventricular components along with an outflow tract. Subsequently, remodeling of these 
components to form the cardiac chambers is initiated (Figure 3.1). The formation of ventricles 
begins with the outpocketing of the inlet ventricular component to give rise to the left ventricle 
followed by the outpocketing of the outlet ventricular component to give rise to the right ventricle 
(Moorman A, 2003). The ventricular outpocketing is marked by thickening of the myocardial 
layer, accompanied by a change in shape of the primary spherical cardiomyocytes, where they 
begin to elongate, become rod shaped and polarized, with majority of cell junction proteins 
localized to specialized intercalated discs, joining the cells end to end to give rise to both compact 
and trabeculated myocardium (Passer D, 2016). While Vangl2, Scrib, and Rho kinases such as 
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Rac1 regulate the polarity of the myocardium, implicating a role for PCP signaling pathway in 
determining myocardial polarity (Phillips HM, 2008), the organization of the clustered ventricular 
cardiomyocytes is coordinated by Wnt11 that patterns the expression of the cell adhesion 
components, N-cadherin and β-catenin (Nagy I, 2010). The transcription factor Hand2, which has 
been implicated in the myocardial polarity in mice embryos, also drives apical-basal polarization 
of the myocardium in zebrafish embryos by regulating fibronectin deposition on the baso-lateral 
side (Trinh LA, 2005). However, signaling events downstream of Hand2 that drive this polarity 
have yet to be explored. 
The maturing heart is enveloped by a subtype of coelomic epithelium called the epicardium 
that displays apical-basal polarity. A subset of cells in the epicardium undergoes epithelial to 
mesenchymal transition (EMT) to give rise to a group of mesenchymal cells that are known as 
epicardially derived cells (EPDC), which migrate into the myocardium of the ventricular wall 
contributing to the endothelial and smooth muscle cells and to the forming coronary vessels and 
connective tissue that are critical for heart development (Martinez-Estrada OM, 2010). Par3, a key 
apical-basal polarity component, plays a critical role in the formation of the mouse epicardium. In 
Par3 knockout embryos, the apical domain of proepicardial cells is disrupted, which causes the 
formation of epithelial cysts and prevents the formation of an intact epicardial monolayer (REF). 
In the absence of the resulting epicardially-derived cells, the coronary vessel network fails to form 
and the ventricular myocardium remains thin (Hirose T, 2006). Thus, while the transcriptional 
network involved in the specification of the epicardium has been discovered (Martinez-Estrada 
OM, 2010), the cell autonomous transcriptional regulatory mechanisms that regulate the Par3-
mediated polarity in the epicardium remain unknown. 
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3.4.4 Perspectives on cell shape changes in heart development 
Investigations in several model systems thus far have shown that the cell shape changes during 
cardiac progenitor cell migration towards the midline to form the heart tube are conserved. 
However, accompanying the general similarities are species-specific differences. In zebrafish, the 
cardiac progenitors migrate to form a cardiac cone, which undergoes cardiac jogging, myocardial 
involution, and extension to set the stage for subsequent looping morphogenesis (Holtzman NG, 
2007; Trinh LA, 2004) . But, in chick and mice, the cardiac progenitors form a cardiac crescent 
which undergoes inversion as the cells migrate towards the midline and fuse to form the heart tube 
Trinh LA, 2004. While the general transcriptional mechanisms for the migration have been 
elucidated as described in Section 3.3.1, the exact molecular mechanisms underlying the fusion of 
the progenitors to form the heart tube in the vertebrate and mammalian model systems are poorly 
understood. Furthermore, the genomic/transcriptional regulatory programs that regulate the 
differences between the lateral and medial cell populations and govern the behavioral differences 
between the migrating cells remain unknown. Further investigations in these areas may provide 
mechanistic insights to improve our understanding of conditions such as cardiac bifida. Moreover, 
these fundamental differences in the formation of heart tube are also suggestive of different 
species-specific regulatory mechanisms that control the conserved cell intrinsic mechanisms to 
form the heart tube. For instance, while Mesp1 role as the most downstream cell autonomous 
transcription factor regulating speed and directionality of cardiac migration is best understood in 
mice, its cell-autonomous roles in zebrafish remain to be elucidated.  
Compared to our current understanding of the morphogenetic mechanisms at the early 
stages of heart development, a lot more is unknown regarding the cellular mechanisms that 
contribute to morphogenesis during the later stages.  This is primarily due to the challenges 
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involved in combining our understanding of the three-dimensionality of heart looping 
morphogenesis and the simultaneous occurrence of other morphogenetic processes involved in the 
formation and alignment of cardiac chambers. While histological and morphometric analysis 
provide information regarding the cell shape and organization at different stages of development, 
the exact role of the cell shape changes in cardiomyocytes is difficult to study as the investigations 
are complicated by the beating and the coordinated repetitive contractions of the cardiomyocytes. 
Hence investigations to further refine live-imaging techniques using transgenic models, coupled 
with improvements in our understanding of the basic principles of later stages of heart 
development, are critical to improving our ability to diagnose debilitating cardiac disorders 
pertaining to later stages. 
 
3.5 Transcriptional regulation of cell shape in lung development  
Lung development initiates around embryonic day (E) 9.0 in the mouse with the specification of  
the ventral foregut endoderm into the respiratory endoderm by the expression of the transcription 
factor Nkx2.1. Evagination and protrusion of these epithelial cells ventrally give rise to the 
primitive trachea and the two primary lung buds (Figure 3.2). The primitive trachea undergoes 
further septation to form the eosophagus and trachea, while the primary lung buds generate the left 
and the right lobes of the lung by undergoing a highly regulated branching morphogenesis during 
the pseudoglandular stage to form an arborized network of airways that increases the surface area 
of the lobes (Metzger RJ, 2008). This is immediately followed by the cannanicular and saccular 
stages, where the cells in the terminal branches undergo changes in shape, forming clusters of 
epithelial sacs that later develop into alveoli. Hence, concordant with the stereotypical branching 
morphogenesis, the epithelial progenitors undergo proximal-distal differentiation, involving 
131 
 
extensive interaction between the lung mesoderm and endoderm. This is required to form the 
conducting airways with ciliated, secretory, and basal cells in the proximal regions, and the future 
gas-exchange sites with saccules containing alveolar type 1 and 2 epithelial cells region at distal 
regions (Herriges M, 2014).  
3.5.1 Cell shape changes during lung branching morphogenesis 
Branching morphogenesis is critical for the formation of the structural conducting airways as well 
as the terminal alveolar compartments for gas exchange. Lung branching proceeds in a 
stereotypical manner by concurrent and repeated use of three major branching mechanisms: a) 
domain branching, b) planar bifurcation, and c) orthogonal bifurcation (Metzger RJ, 2008). These 
mechanisms are genetically hard-wired and depend upon integration of autocrine, paracrine, and 
juxtracrine interactions between epithelial and mesenchymal cells that influences processes such 
as apical–basal cell polarity, cell adhesion, and ECM remodeling. Fgf10, secreted by the 
mesenchyme at the distal end of the primary lung buds, regulates both initial outgrowth of the 
primary and secondary lung buds during the later stages of branching morphogenesis via signaling 
to Fgfr2 (Sekine K, 1999). The expression of Fgf10 is regulated by the interplay of retinoic acid 
(RA) signaling pathway, Shh via its transcriptional activators Gli-1-3, and the BMP4/Tgf-β 
signaling pathways. While the following reviews (Herriges M, 2014; Warburton D, 2010) have 
wonderfully detailed these processes and the molecular pathways upstream of Fgf10, woefully 
little is known about the regulatory processes that drive cell shape changes of the airway epithelial 
sheet during branching morphogenesis downstream of Fgf10. Recent studies implicate changes in 
orientation of cell division as a mechanism of “directional-shape change” that mitigate extension 
of branches. This regulation of oriented cell division 
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Figure 3.2: Schematic of processes involved in lung morphogenesis. The main regulatory pathways 
underlying lung branching morphogenesis and proximal-distal differentiation have been outlined along 
with the processes. Transcription factors have been listed in purple, signaling molecules in brown, and 
cytoskeletal effectors in blue.  
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is accomplished by the Ras/Spry activity, which occurs downstream of Fgf10 signaling and 
regulates spindle-pole orientation leading to a specific directionality in epithelial cell proliferation 
while the branches extend (Tang M, 2009). Although the direct transcriptional regulators 
downstream of Fgf signaling is unknown, the Notch-transcription Eya1 was found to regulate cell 
polarity, spindle orientation, aPKCz phosphorylation and Numb segregation in a cell autonomous 
manner in the distal epithelium (Ahmed HK 2011). These observations suggest potential cross-
talk between the Fgf and the Notch signaling pathways.  Additionally, the cell shape changes 
required for the epithelial sheet to bend and generate new bud tips are also regulated by the PCP 
components Scribble, Celsr1, and Vangl2, which regulate the cytoskeletal organization in response 
to Fgf signaling (Laura LY, 2013). Furthermore, Wnt/Frizzled 2 receptor signaling directly 
regulates Rho to control epithelial cell shape and apical constriction during branching (Kadzik RS, 
2014). Disruption of canonical Wnt signaling during lung development by conditional deletion of 
β-catenin or overexpression of the Wnt inhibitor Dickkopf1 severely impairs branching 
morphogenesis (Rajagopal J, 2008). This Wnt/Fzd-mediated signaling is regulated at least in part 
via Fgfr2 and BMP4 in the lung epithelium (Volckaert T, 2015). Whereas the signaling pathways 
that regulate the cell shape changes during branching morphogenesis have been partly identified, 
further studies are much needed to identify the transcriptional regulation of these signaling 
mechanisms.  
3.5.2 Cell shape changes during differentiation along the proximal-distal axis of the lung 
As the lung buds branch, proliferate, and extend distally, the lung endoderm differentiates along 
the proximal-distal axis of the developing airways. A nucleocytoplasmic shift in the localization 
of the Hippo effector, Yap, marks the boundary between the proximal airway and the distal 
alveolar sac lung compartments. The nuclear activity of Yap is critical for the progenitor identity 
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of the lung epithelia, with the removal of nuclear Yap driving airway cell differentiation (Mahoney 
JE, 2014). Crb3 mediated apical-basal polarity in the proximal airway epithelial cells causes Yap 
to bind to Lats1/2 kinases present at the apical junctions to promote cytoplasmic sequestration of 
Yap, and, consequently, initiates proximal airway progenitor cell differentiation (Szymaniak AD, 
2015). This is accompanied by downregulation of miR-17-92, miR20a, and miR106b clusters 
(Ventura A, 2008) while the rate and extent of differentiation of the progenitors is regulated by 
expression of miR302/367 cluster. This cluster coordinates the balance between proliferation and 
differentiation through direct regulation of Rbl2 and Cdkn1a as well as the apical-basal polarity 
via regulation of Tiam1 and Lis1 (Tian Y, 2011). 
 As the progenitors differentiate at the proximal end, they give rise to ciliated, secretory, 
and basal cell lineages. This is initiated by downregulating Sox9 and upregulating the transcription 
factor Sox2. Notch signaling also plays a key role in the differentiation of the proximal airway 
epithelium, including establishing and maintaining a proper balance between the ciliated and 
secretory cell types. The central target of Notch signaling in multiciliated cells appears to be the 
transcriptional cofactor Multicilin (Stubbs JL, 2012). Targets of Multicilin include several other 
transcription factors required for motile ciliogenesis, including multiple Rfx family members, C-
Myb, and FoxJ1 (Stubbs JL, 2012). The Rfx transcription factors are broadly required for 
ciliogenesis in vertebrates, including in multiciliated cells. Direct targets of Rfx2 contribute to 
essentially all ciliary machinery including genes required for cilia assembly, cilia motility and 
planar polarization of directional beating (Swoboda P, 2000).  
In contrast, within the distal progenitor population, Sox9 is upregulated whereas Sox2 is 
downregulated (Hashimoto S, 2012). These Sox9/Id2 expressing endoderm progenitors first 
differentiate into a bipotent progenitor state and this is accompanied by inhibition of Notch 
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signaling. These progenitors subsequently generate the critical alveolar epithelial lineages known 
as type 1 and 2 alveolar epithelial cells (AEC1 and AEC2) by promoting the program of one 
lineage over the other depending on cues from the microenvironment. AEC1 cells are elongated 
epithelial cells that form a thin barrier between the alveolar airspace and closely approximated 
blood-filled capillaries (Weibel ER, 2015). Activation of canonical Wnt signaling by interaction 
of Wnt 7 with Fzd1/10 and Lrp5, has been shown to be critical for AEC1 development (Mutze K, 
2015; Wang Z, 2005). AEC2 cells, in contrast, are cuboidal cells that serve as a major 
manufacturing and recycling lineage of the alveoli, producing surfactant proteins for reducing 
surface tension. The TCF/β – catenin activity modulated by Wnt signaling as well as dosage of 
Nkx2.1 expression is critical for formation of AEC2 cells (Wang Z, 2005).  While the apical basal 
polarity is critical for AEC2 cells for apical secretion of surfactants and ions into the lumens, the 
cellular mechanisms needed to define the polarity at the time of AEC2 maturation and their 
interaction with the known signaling pathways remain to be elucidated.  
3.5.3 Perspectives into regulation of cell shape changes during lung morphogenesis 
The signaling pathways involved in the regulation of epithelial cell shape during early branching 
morphogenesis of the lung are one of the relatively well studied aspects of lung development. 
While the mesenchymal signaling mechanisms involved in the distal extension of lung are also 
well understood, the behavioral aspects such as packing of the mesenchymal compartment and 
polarity of mesenchymal cells in relation to the branching epithelia are less known. Epithelial cell 
shape changes also follow the differentiation of the epithelia along the proximal-distal axis of the 
branching airway to give rise to different lineages. Several studies investigating the mechanisms 
of the epithelial differentiation have uncovered mechanisms involving epigenetic modifications to 
DNA, domain-specific alterations in chromatin architecture, and microRNAs that are critical for 
137 
 
the differentiated state (Swarr DT, 2015). While current investigations are giving rise to an 
integrated picture of the transcriptional networks that regulate the epithelial differentiation, again, 
very little is known about how the adjacent mesenchyme is patterned, or how the transcriptional 
networks regulate the cell shape behavior or the crosstalk between the epithelia and the 
mesenchyme that contributes to overall lung branching morphogenesis. Moreover, since the 
mesenchyme gives rise to the vasculature, the neuronal networks, and the muscular connections 
critical for lung function, further studies utilizing high-throughput screening methods such as 
single-cell RNA-seq and single-cell proteomics could greatly enhance our understanding of the 
mechanisms involved in mesenchymal regulation. This could potentially uncover novel pathways 
and provide additional therapeutic targets for pulmonary disorders. 
 
3.6 Transcriptional regulation of cell shape in development of the GI tract 
The GI tract is derived from the primitive gut tube that arises from the endoderm and the fusion of 
the lateral limbs of the splanchnic mesoderm. The gut tube is divided regionally along the cranial-
caudal axis into the foregut, midgut, and hindgut regions based on their vascular supply (Figure 
3.3) (Roberts DJ, 1999). Following the regional specification, the primitive gut tube undergoes 
differential elongation along the cranial-caudal axis with the midgut elongating disproportionately 
compared to the other regions of the primitive gut (McGrath PS, 2015). As the gut tube elongates, 
asymmetries across the left-right axis initiate to establish the stomach curvature and to trigger the 
critical counterclockwise rotation of the midgut that sets the directionality for subsequent gut 
looping morphogenesis (Raya A, 2006). Concurrently, the gut endoderm undergoes radial 
intercalation to give rise to a single layer of polarized epithelium that undergoes cytodifferentiation 
to form the enterocytes and the different lineages of secretory cells (Barbara PS, 2003). In the 
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following sections we examine the critical molecular players and the transcriptional networks that 
regulate cell shape changes during gut morphogenesis across cranial-caudal, left-right, and along 
the radial axis.   
3.6.1 Regulation of cell shape changes during cranial-caudal morphogenesis of the GI tract 
Prior to gut tube elongation, the endoderm cells of the gut tube undergo a cell shape change from 
cuboidal to columnar morphology along the cranial-caudal axis and become radially oriented as 
they fuse to form the gut lumen (Chalmers AD, 2000). Subsequently, during elongation, the 
endodermal cells undergo oriented division and intercalate between their anterior and posterior 
neighbors within the gut walls to contribute to the lengthening of the endoderm (Matsumoto A, 
2002). Crosstalk between the gut endoderm and its surrounding mesenchyme ultimately results in 
the lengthening of the gut tube (Reed RA, 2009).  
In the foregut region, interaction between the forestomach gut endoderm and its 
surrounding mesenchyme is mediated by Shh and PCP pathways downstream of Wnt5a 
(Matsuyama M, 2009). While Shh secreted by the endoderm regulates surrounding mesenchyme 
via activation of Notch signaling, the Stbm/Vangl2 interactions with a mesenchyme-derived 
Wnt5a regulate the polarity needed for oriented cell division of the endodermal epithelia 
(Matsuyama M, 2009) (Figure 3.3). In the duodenum, elongation is accompanied by the decrease 
in the diameter of the epithelia and occlusion of the epithelial lumen followed by recanalization 
and emergence of the villi. Intriguingly, contrary to the prior notion that increased epithelial 
proliferation drives the occlusion phase during duodenal development, it has been suggested that 
convergent extension of the epithelial cells in the radial-caudal axis could be the mechanism behind  
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duodenal elongation implicating PCP signaling as a driver of the duodenal elongation (Matsumoto 
A, 2002). While ECM molecules, such as fibronectin, are critical for epithelial integrity and 
polarity in the duodenum, the transcription factors and downstream players regulating convergent 
extension of the duodenum remain unknown.  
At the midgut region, elongation of the gut tube results in manifold increase in the length 
of the gut tube within a short time compared to the crown-rump length of the embryo (Yamada M, 
2010). Like the duodenum, the epithelial tube diameter of the midgut narrows as it elongates, 
suggesting similar mechanisms of convergent extension for elongation. In the midgut, non-
canconical Wnt5a signaling is the master regulator of not only convergent extension but also 
polarity and proliferation of both the epithelia and mesenchyme. It also regulates re-intercalation 
of post-mitotic cells into the epithelium after cell division (Cervantes S, 2009). Furthermore, Ror2, 
a co-receptor for Wnt signaling, specifically regulates the rearrangement of the epithelia needed 
for the convergent extension in the midgut endoderm (Yamada M, 2010) (Figure 3.3).   
The elongation of the hindgut endoderm also relies on convergent extension, where the 
non-canonical Wnt5a functions via Dact1 to regulate Vangl2 and Dsh for mediating convergent 
extension of the epithelia (Wen J, 2010). Chato, a KRAB zinc-finger protein, also controls 
convergent extension in the endoderm for the closure of gut tube.  However, the downstream 
targets and the cellular mechanisms by which Chato causes this process remain to be uncovered 
(García-García MJ, 2008). 
3.6.2 Regulation of cell shape changes during left-right morphogenesis of the GI tract 
The first evidence of LR asymmetry in the gut involves a left-sided bulge and turn at the posterior 
end of the foregut that gives rise to the distinct, conserved shape of the stomach. Prior to the bulge, 
the lumen of the primitive stomach is aligned with symmetric walls with respect to the LR axis. 
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The initiation of stomach curvature is accompanied by an outward bend and lengthening of the left 
wall compared to the right wall (Davis A, 2017). Following the lengthening, a thinning of layers 
of the left stomach wall is observed compared to the right.  This preferential bending, lengthening, 
and thinning of the left wall of the stomach is driven by LR asymmetric cell rearrangement (Davis 
A, 2017). Appearing concomitantly with these LR differences in cell rearrangement are 
asymmetries in apical-basal polarity of the endoderm.  
Pitx2, a homeobox transcription factor and a master regulator of LR asymmetric organ 
morphogenesis, regulates these cell rearrangements as well as the endodermal polarities on the left 
wall to give rise to this curvature (Davis A, 2017) (Figure 3.4). However, the mechanisms 
downstream of Pitx2 remain to be elucidated.   
At the midgut region, the gut tube undergoes a critical counterclockwise rotation initiated 
by a conserved leftward tilting of the gut tube. This leftward tilt is driven by changes across the 
LR axis in cell behavior and architecture of the epithelial and mesenchymal compartments of the 
adjoining dorsal mesentery (DM), a mesodermally-derived structure that suspends the gut tube 
from the body wall (Davis NM, 2008b; Hecksher-Sørensen J, 2004). Prior to the initiation of the 
tilt, the DM is symmetrical with a dense mesenchyme sandwiched by cuboidal epithelia. However, 
prior to the tilt, the left epithelial cells become columnar, the left mesenchymal cells become more 
compacted, the right mesenchymal cells become more sparsely distributed, and the right epithelial 
cells assume squamous morphology.  Similar to the stomach, the left-sided expression of Pitx2 
regulates the changes in cellular behavior in both the left epithelia and mesenchyme (Kurpios NA, 
2008b). In the left mesenchyme, Pitx2-specific effector Gpc3 integrates non-canonical Wnt5a 
signaling from the gut to activate the formin Daam2 in the left DM to stabilize cell-cell adhesion 
and cause compaction of the left mesenchymal compartment (Figure 3.4). Simultaneously, the  
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Figure 3.4: Left-right asymmetric pathways downstream of Pitx2 regulating cell shape changes during A) 
stomach and B) intestinal morphogenesis. Figures have been taken from (Davis A, 2017) and (Welsh IC, 
2013). 
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cytoskeleton of the mesenchymal cells is reorganized such that they are polarized and oriented to 
the left across the LR axis (Welsh IC, 2013). Interestingly, this mesenchymal reorganization of the 
mesenchyme in the left DM is spatiotemporally linked with the maintenance and subsequent 
remodeling and patterning of gut specific arteries (Mahadevan A, 2014) suggesting a role for 
mesenchymal cell shape changes in gut arteriogenesis.  In the left epithelia, loss of Pitx2 results in 
the formation of cuboidal instead of columnar epithelia. A similar phenotype is recaptured in 
embryos where Shroom3, a critical determinant of epithelial cell shape, is deleted. Interestingly, 
the expression of Shroom3 in the DM is not dependent on Pitx2.  Rather, Shroom3 functions 
cooperatively with N-cadherin downstream of Pitx2 to directly regulate the epithelial cell shape 
changes in the left DM (Plageman TF Jr, 2011). However, the factors that regulate the shape 
changes and cellular organization within the right DM remain to be elucidated.  
3.6.3 Cell shape changes during morphogenesis of the GI tract across the radial axis 
During the process of radial patterning, the stomach endoderm invaginates into the submucosa to 
form deep invaginations termed crypts and glands. In contrast, the endoderm of the small intestine 
evaginates to form finger-like projections known as villi and crypts. Similar events take place in 
the colon where crypts form, but, instead of villi, a flat surface epithelium remains (Haffen K, 
1987). Along the crypto-villous axis, cytodifferentiation of the gut epithelia forms the absorptive 
enterocytes and the secretory goblet, enteroendocrine, and Paneth cells (Barbara PS, 2003). This 
cytodifferentiation continues postnatal and is accompanied by shape change of the endoderm from 
cuboidal to pseudostratified to columnar epithelium, and is influenced by interactions with the 
underlying mesoderm, basement membrane proteins, and the regulators of apical-basal polarity 
(Sääf AM, 2007). However, the precise transcriptional regulation of this process, while widely 
studied in various disease conditions, remains underexplored during embryonic development.  
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In vitro studies using Caco-2 cells, which resemble the enterocytes lineage in morphology 
and function have provided a detailed genomic portrait of changes in transcript patterns during the 
establishment of enterocyte cell polarity. These studies have revealed that the transition from 
proliferating, non-polarized cells, to post-mitotic polarizing cells involves a switch in gene 
expression programs (Halbleib JM, 2007). While gene expression of Wnt targets is robust in 
mitotic non-polarized Caco-2 cells, it decreases over time as cells become post-mitotic and 
polarized, akin to the decreasing gradient of Wnt activity from the crypt to villi in vivo. After 
polarization, the decrease of Wnt gene expression is accompanied by an increase of β-catenin 
levels in the cell nucleus and is associated with TCF4 (Sääf AM, 2007). Furthermore, the 
transcriptional profiling has revealed a critical interplay between polarization and other signaling 
cascades such as the Tgfβ, Fgf, Shh, and Notch signaling pathways for which cellular details 
remain to be uncovered (Halbleib JM, 2007). In addition, it was also discovered that KLF4, a zinc 
finger transcription factor, regulates polarity-related genes, which include LKB1, EPHB2, and 
EPHB3 (Yu T, 2012). Thus, the Caco-2 cells serve as a useful in vitro model system to characterize 
the pathways and the regulation of cell shape changes during the differentiation of intestinal 
enterocytes along the radial axis.  
3.6.4 Perspectives into the regulation of cell shape changes during morphogenesis of the GI 
tract 
The events shaping gut morphogenesis are relatively understudied compared to the heart and lung, 
and hence comparatively less is known about the mechanisms underlying cell shape changes 
during early GI tract morphogenesis. Thehe current studies have made extensive use of the in vitro 
Caco-2 cell culture model system to characterize the pathways and the regulation of cell shape 
changes during intestinal epithelial differentiation into enterocytes along the radial axis. However, 
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in vivo, the endodermal epithelia differentiate not only into enterocytes but also into secretory cell 
types such as goblet cells, enterendocrine cells and panneth cells which have distinct cellular 
morphologies. Furthermore, the cytodifferentiation varies along the AP axis of the gut. Therefore, 
the mechanisms proposed by invitro studies fail to explain variation in the cell shapes of the other 
cell lineages during cytodifferentiation of the endodermal epithelia in vivo. Nevertheless, they 
have been useful in identifying the regulatory signaling pathways for enterocyte that the future 
studies can use for integrating the existing knowledge with the in vivo regulatory mechanisms.  
Compared to the morphogenesis along the radial axis, the physiological relevance of the 
endodermal epithelial shape changes across the anterior-posterior axis are only beginning to be 
elucidated. Moreover, it is possible that there are significant variations in the regulation of cell 
shape changes across the A-P axis in different species due to differential elongation and 
morphogenesis of different regions of the GI tract. For instance, whereas the hindgut fermenters 
are known for their large colon and cecum, the ruminants and pseudo ruminants that are primarily 
foregut fermenters have multi-chambered stomach, known as the rumen (Cronjé P, 2000). Hence, 
the studies investigating regulatory mechanisms specific to cell shape changes along the AP axis 
should integrate analysis of multiple species to obtain a more complete understanding of the key 
transcriptional networks that are either common to different species or that are species-specific. 
Despite the tremendous variation in intestinal looping topology observed among different 
animal species, within the same species the intestinal looping pattern is remarkably fixed (Davis 
NM, 2008a; Kurpios NA, 2008a; Savin T, 2011; Welsh IC, 2013) . Failure to follow the conserved 
pattern of gut looping leads to intestinal malrotation that predisposes to catastrophic midgut 
volvulus, where the malrotation results in contorted twisting of different segments of the gut tube 
resulting in strangulation of the gut tube and the accompanying blood vessels (Filston HC, 1981; 
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Torres AM, 1993) . Although our understanding of transcriptional regulation of the left-right 
asymmetric gut morphogenesis is still in its infancy, it is becoming clear that both the epithelial 
cell shape changes and the organization of the adjoining mesenchymal cells within the DM are 
essential to gut rotation. While current studies have mainly focused on understanding the 
mechanisms that orchestrate cell shape changes on the left side of the DM, almost nothing is known 
about the mechanisms that regulate the right side. Understanding the contribution from both sides 
of the DM is critical for developing techniques to diagnose and treat disease conditions associated 
with intestinal malrotations such as midgut volvulus.  
 
3.7 Regulation of cell shape changes during development of the GI tract accessory organs 
The accessory organs of the GI tract form as endodermal derivatives (diverticula) of the foregut 
and include the liver, the gall bladder, and the dorsal and ventral pancreas (Yin C, 2017). After 
hepatic specification regulated by members of the Sox family of transcription factors, the liver 
progenitor cells delaminate from the foregut endoderm and invade into the septum transversum 
mesenchyme to form the liver bud (Yin C, 2017). They subsequently differentiate into two 
epithelial cell types (hepatocytes and cholangiocytes), arranged into unique structures with distinct 
functions (Zaret KS, 2016). Further growth, morphogenesis, and differentiation during liver 
development are spatiotemporally regulated by numerous mechanisms (Figure 3.3).  
The pancreas is a unique organ that functions as both an exocrine and an endocrine gland. 
It is composed of two morphologically distinct tissues. The exocrine domain contains digestive 
enzyme secreting cells, while the endocrine domain is arranged as Islets of Langerhans that are 
populated by hormone-producing cells (Fujitani Y, 2017). From specification of the pancreatic 
domain in the foregut endoderm to the formation of the functional exocrine and endocrine cell 
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types, pancreas development is a precisely orchestrated multi-stage process regulated by multiple 
signaling cascades (Larsen HL, 2017) (Figure 3.3).  
3.7.1 Regulation of cell shape changes during liver development 
The development of the liver initiates when signals from the mesothelial cells of the proepicardium 
and septum transversum specify the adjoining ventral domain of the anterior foregut to give rise 
to the hepatic diverticulum (Tremblay KD, 2005; Wilson JW, 1963). In mammals, the liver 
diverticulum formation involves three stages. In the first stage, elongation of the hepatic 
endodermal cells near sinus venosus causes the cuboidal epithelia to become columnar, resulting 
in the thickening of the endoderm (Bort R, 2006). The second stage involves interkinetic nuclear 
migration resulting in the transition of the columnar cells into a multilayer of pseudostratified cells 
called hepatoblasts. In the third stage, the basal laminin degrades and the hepatic endodermal cells 
delaminate, proliferate, and invade into the stroma forming the liver bud (Bort et al., 2006). While 
the cell-autonomous transcription factors that regulate the initial transition of cuboidal epithelia to 
columnar are unknown, hHex, a homeobox-containing transcription factor of the 
Antennapedia/Ftz class, is expressed in the foregut endoderm and specifically regulates the 
interkinetic nuclear migration to cause the cell shape transition from columnar to pseudostratified 
epithelium (Bort et al., 2006). 
 The formation of the liver bud is simultaneously accompanied by the remodeling of the 
adjacent endothelial cells that surround the liver diverticulum (Antoniou A, 2009).   Subsequently, 
the hepatoblasts located further away from the portal vein differentiate into the hepatocyte lineage, 
the hepatoblasts located in close proximity to the portal vein differentiate into the cholangiocyte 
lineage (Carpentier R, 2011). While the Hippo pathway regulates the cellular architecture of 
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hepatocytes (Yimlamai D, 2014), the SRY-related High Mobility Group Box Transcription factors 
Sox 4, and Sox9 cooperatively set up the apical-basal polarity in the cholangiocyte lineages (Poncy 
A, 2015). However, the molecular mechanisms downstream of these transcripton factors that 
underlie the cell shape changes remain unknown. This information may provide novel therapeutic 
targets for chronic liver diseases for which the only current treatment is organ transplant.  
3.7.2 Regulation of cell shape changes during pancreatic development 
Pancreatic development initiates with the evagination of the dorsal gut endoderm in the posterior 
foregut into the surrounding condensed mesenchyme to give rise to the dorsal pancreatic bud. This 
is followed by evagination of the ventral endoderm in the posterior foregut caudal to the 
hepatic/biliary bud, resulting in the formation of the ventral pancreatic bud (Sussel, 2012). The 
epithelial-mesenchymal crosstalk that guides the endodermal evagination is modulated by Fgf 
signaling in the mesenchyme (Elghazi L, 2002).  
At the onset of pancreatic bud formation, the dorsal gut endoderm is stratified and consists 
of an outer layer of semi-polarized cell types and an inner layer of unpolarized cells (Gittes GK, 
2009). Following bud formation, the stalk elongates and initiates branching morphogenesis of the 
buds. This is accompanied by the transformation of the initially multilayered stratified epithelium 
into a single-layered polarized epithelium which invades and branches extensively into the 
underlying mesenchymal compartment (Fujitani Y, 2017). During this transition, small 
microlumens form between the epithelial cells. The rise of apical cell polarity in the epithelia 
results in the expansion of the microlumens to form independent luminal networks (Kesavan G, 
2009). While the Cdc42-Rho signaling axis directly regulates the apical-basal polarity, the 
transcription factor Pdx1 drives E-cadherin to induce apical constriction necessary for lumen 
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formation and maintenance (Marty-Santos L, 2016).  Subsequent displacement of the stomach and 
the duodenal looping results in the dorsal and ventral buds coming in close proximity. This is 
accompanied by coalescing of the dorsal and ventral luminal networks to form continuous tubular 
networks connect the ducts of the dorsal and ventral buds. Simultaneously, the glucagon-positive 
endocrine cells become converted to non-epithelial cells and lose connection with the lumen and 
ultimately coalesce into aggregates that represent the first islets of Langerhans, which consist of 
insulin-producing β-cells, glucagon-producing α-cells, somatostatin-producing δ-cells, pancreatic 
polypeptide-producing PP cells, and ghrelin-producing ɛ-cells. Moreover, the epithelial cells lining 
the duct undergo ductal and acinar differentiation to give rise to the fully functional pancreas.  Very 
little is known regarding understanding of transcriptional regulation of cell shape changes that 
accompany the specification of the different cell lineages during pancreatic development. Such 
investigations may pave the way for understanding of how perturbation of these processes may 
lead to  different forms of diabetes (Larsen HL, 2017).  
 
3.8 Transcriptional regulation of cell shape changes during kidney development 
The metanephric kidney is composed of epithelial tubules that function together with apposing 
endothelial capillaries and microvascular networks to purify the blood and maintain optimal blood 
chemistry (Carroll TJ, 2011). Development of the tubules initiate when epithelia of the 
mesonephric duct bud to form the ureteric bud (UB) surrounded by pre-specified intermediate 
mesoderm called the metanephric mesenchyme (MM) (Michos O, 2009; Saxén L, 1987). 
Interactions between the MM and UB induce the ureteric bud to undergo continued branching to 
give rise to the ureter, collecting ducts, major and minor calyces, and the renal pelvis (Figure 3.5) 
(Schedl A, 2007). At the same time, inductive signals produced by the ureteric bud stimulate a 
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subpopulation of metanephric mesenchyme to undergo mesenchymal to epithelial transition to 
form epithelial structures called the renal vesicles (Bertram JF, 2016) . The renal vesicles undergo 
a series of morphological changes transitioning through the comma and S-shaped body-structures, 
with distinct cellular populations giving rise to the various nephron segments (Figure 3.5). The 
most proximal segment is the renal corpuscle, followed by the proximal tubule, loop of Henle, 
distal tubule, and finally the connecting tubule that connects the distal tubule to the UB-derived 
collecting ducts (Dressler GR, 2006). Simultaneously, precursors of the vascular endothelial cells 
take their position at the tip of the renal tubules and differentiate into the cells of the definitive 
glomerulus. Extensive studies have characterized the regulators of cell behavior in the developing 
kidney (Carroll TJ, 2011; Lienkamp SS, 2012) (Michos O, 2009). An interplay between a variety 
of the signaling pathways regulates the cell shape changes with branching morphogenesis and 
tubulogenesis of the nephrons and the connecting duct. In the following sections, we explore the 
transcriptional regulators of these   processes in the developing kidney (Figure 3.5). 
3.8.1 Ureteric bud formation and early branching 
Development of the metanephric kidney initiates when the UB grows out as a swelling originating 
in the caudal nephric duct (Michos O, 2009). This is a consequence of directed cell movements 
within the duct epithelium and is regulated via localized induction of Ret in the epithelia by GDNF, 
a secretory signaling molecule and BMP4 expression in the metanephric mesenchyme (MM) 
(Pachnis V, 1993). Ret activates several downstream effectors pathways 
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Figure 3.5: Genes regulating cell shape changes during kidney morphogenesis. A growing number of 
transcription factors, the signaling networks and their downstream effectors have been identified in the 
mammalian kidney. These genes have been listed according to the processes that they are involved in. 
the transcription factors are in purple, signaling molecules in brown and cytoskeletal remodelers in blue. 
Figure modified from (Bertram JF, 2016)  
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including the ERK, MAPK, PI3Kinase/Akt, and PLC-γ pathways in the epithelia to regulate the 
directed cell movements needed for ureteric bud formation (Fisher CE, 2001; Jain S, 2006; Tang 
MJ, 2002). While the transcription factor Pax2 regulates the overall process of ND development 
and the early UB outgrowth (Brophy PD, 2001), the expression of GDNF in the MM is regulated 
by transcription factors Eya1 (Xu PX, 1999) and Hox11 and the expression of Ret in the epithelia 
is regulated by transcription factor Gata3 (Gong KQ, 2007; Grote D, 2008). The expression of 
GDNF in MM is also maintained and reinforced by expression of Wnt11 (Majumdar A, 2003), 
which in turn is regulated by the canonical Wnt/β-catenin signaling pathway downstream of Wnt9b 
(Karner CM, 2011). The transcription factors HNFβ1 (Paces-Fessy M, 2012) and Ap-2 B (Moser 
M, 1997) regulate the expression of Wnt9b during the UB formation and outgrowth. Following the 
outgrowth, the UB undergoes a characteristic T-shaped branching regulated by PCP components 
Fzd4 and Fzd8 (Figure 3.5) (Ye X, 2011). In addition, Fgf7-10 /Fgfr2, and the synergistic 
interaction of the HGF/Met and Egf/Egfr pathways also play a critical role during branching 
morphogenesis (Sakurai H, 1997). These pathways may act in parallel or sequentially to 
Ret/GDNF signaling but additional studies are required to identify the relevant cellular interactions 
and the transcriptional mechanisms that integrate the different signaling networks to orchestrate 
ureteric branching morphogenesis. 
3.8.2 Renal vesicle induction and morphogenesis of the segments of the nephron 
As the tip cells bifurcate, Wnt4, Fgf8, and Pax8, expressed by the Six2+ lineage of mesenchymal 
cells in the MM surrounding the UB tip, initiate the formation of pre-tubular cellular aggregates 
that undergo mesenchymal epithelial transition (Metzger RJ) to form renal vesicles (Schmidt-Ott 
KM, 2008). Once the epithelial renal vesicle is formed, it further elongates and transitions into the 
comma and S-shaped bodies. The distal end of the S-shaped body fuses with the UB while the 
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remaining parts become specified to generate the proximal and distal tubules of the nephron 
(Schedl A, 2007).  The transcriptional regulator of the Hippo pathway, Yap, regulates the distal 
fusion of the S-shaped body to the UB while the apical localization of Yap is regulated by Cdc42 
(Reginensi A, 2013).  At the proximal end, Notch/γ-secretase signaling is necessary for 
development of the proximal tubular and glomerular segments (Cheng HT, 2005). As the 
proximal-distal specification occurs, the cuboidal epithelial cells in the tubules elongate 
perpendicular to the proximal-distal axis of the tubule, and undergo rosette-based cell intercalation 
(Lienkamp SS, 2012). The non-canonical PCP pathway downstream of Wnt9b drives the myosin 
dependent rosette-based cell intercalation and regulates polarized cell division to cause elongation 
of tubules by convergent extension (Karner CM, 2009; Lienkamp SS, 2012). Concomitant with 
tubulogenesis, different segments of the nephron undergo a series of complex changes that are 
Rho-kinase activity dependent including segmentation, elongation and morphogenesis (Lindström 
NO, 2013). 
A key feature of the proximal tubule development is the differentiation of the epithelial 
precursors in the proximal cleft of the S-shaped body to form podocytes, which are polarized renal 
glomerular cells that play a central role in regulating the formation of the glomerular ultrafiltrate. 
Accompanying this differentiation is a dynamic change in cell shape of the epithelia (Mundel, 
2012). The specification of the podocyte precursors is thought to occur at the preceding comma 
body stage when the cuboidal epithelial cells acquire a columnar morphology. As the comma body 
evolves into the S-shaped body, the intrusion of endothelium and the formation of capillary loops 
due to VEGF signaling in the surrounding MM causes dramatic expansion of the apical surface of 
the epithelia (Schell C, 2014). This is accompanied by migration of cell-cell junctions from apical 
to basal aspect of the cell followed by restructuring and replacement of tight junctions with sieve-
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like junctional complexes called slit diaphragms (Grahammer F, 2013). The polarity in podocyte 
differentiation is regulated by three main polarity complexes: the apical Crumbs complex (Crumbs, 
PALS1 and PATJ) identified by a genetic screen in zebrafish podocyte formation (Ebarasi L, 2009; 
Pieczynski J, 2011); the apical Cdc42/Par3/Par6/αPKC polarity complex as evidenced by several 
studies (Hartleben B, 2008; Hartleben B, 2013; Rizaldy P. Scott, 2012); and the Nephrin/Nck2/n-
WASP/Ark2/3 pathway (Laura AN, 2013; Schell C, 2013). The differentiation of podocytes is 
regulated by the interplay between Pax2 and Wt1, which are regulators of the transcriptional 
network for podocyte development (Guo JK, 2002; Kobayashi N, 2004). However, the 
downstream factors of these genes that regulate the polarity complexes in a cell-autonomous 
manner remain to be elucidated. 
As the proximal and distal components form, they are spatially organized in the cortico-
medullary axis.  While the renal corpuscles and the proximal and distal tubules are located in the 
cortex, the Loop of Henle and the elongated tubular network of the collecting duct system 
constitute the renal medulla (Little MH, 2007). In the medulla, the tubular elongation and the 
growth of Loop of Henle is regulated by paracrine canonical Wnt signaling via Wnt7b. In Wnt7b 
mutant mice , cell division planes of the collecting duct epithelium are biased along the radial axis 
as opposed to bias along the longitudinal axis normally observed in WT mice  (Jing Yu, 2009). 
Interestingly, a similar loss of the medullary region has been documented in Vangl2 and Fat4 
mutant mice in addition to reduced tubular formation (Yates LL, 2010), indicating that components 
of the core PCP network might function alongside the canonical Wnt7b signaling to drive 
tubulogenesis and tubular organization in the medulla. 
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3.8.3 Insights into regulation of cell shape changes during kidney morphogenesis  
The elegant mechanisms that regulate the cell shape changes during kidney morphogenesis are 
better understood when compared to other organ systems of the abdominal viscera. It has been 
clearly established that the epithelial cell shape changes and cell polarity play a critical role 
throughout the development and functioning of the nephrons, from early stages of morphogenesis 
to the later stages of differentiation across proximal-distal axis. The perturbation of cell polarity, 
cell shape, and tubular dilations have been implicated in polycystic kidney disease (PKD) 
conditions. However, at present, it is unclear to what extent are the observed defective polarities 
causative or secondary consequences of the disease condition. Furthermore, the exact roles of the 
cytogenesis genes (implicated in PKD, kidney injury conditions in humans) in the spatiotemporal 
morphogenesis of the kidney remain unknown. One way of investigating would be to understand 
how abrogation of polarities of different cell lineages affects kidney development using 
conditional knockout mice. The presence of such models coupled with the transgenic reporter mice 
labeling specific cell types could facilitate dynamic analysis of cell shape changes during tubule 
formation, extension and active determination of the relationship between cell shape and kidney 
malformations. The interactions between the mesenchymal stroma and the epithelia is well 
understood during UB outgrowth. However, studies investigating the later aspects of kidney 
development such as formation of renal vesicle, S shaped bodies, and comma bodies have mainly 
focused on the epithelial cell behaviors. Hence the mechanisms that regulate the cellular behaviors 
and differentiation of mesenchymal cells in stroma to give rise to kidney-specific vasculature, 
neuronal and muscles are understudied and warrants further investigations.  
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3.9 Conclusion 
Now is an exciting time for studying the transcriptional regulation underlying cell shape changes 
during organogenesis. Substantial questions and unknowns that need to be answered exists in the 
field and have been raised at the end of each section as perspectives. In this review, anatomic 
details and details pertaining to extracellular space such as cell matrix interactions have been 
omitted whenever possible to give emphasis to essentialities. The combination of forward and 
reverse genetics with a multi species approach and  the advent of  sensitive transcriptomic and 
proteomic analysis methods, including single-cell RNA-seq and tissue mass imaging spectrometry 
are likely to provide detailed integrated insights into molecular and cellular mechanisms during 
organogenesis which will hopefully result in better diagnostics and eventually new therapies to 
treat the wide spectrum of malformations that can result in life threatening debilitating disorders. 
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 CHAPTER 4: FUTURE DIRECTIONS 
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4.1 Summary 
My work, described in Chapter 2, has demonstrated that the cellular and vascular transformations 
in the right DM precede all other cell asymmetries that collectively deform this structure, 
suggesting that the key initiator for leftward gut tilting derives from the right side. I have further 
shown that HA produced primarily on the DM right side is a key regulator of the mesenchymal 
expansion and vascular exclusion necessary for asymmetric gut looping and vascular 
morphogenesis (Figure 4.1). Investigating into how HA enacts its functions, I discovered that 
Tsg6, an enzyme that can covalently modify HA to form a stable heavy chain (HC) HA complex, 
is restricted to the right DM. Knockdown and misexpression studies of Tsg6 revealed that while 
Tsg6 is necessary for the right sided expansion and gut tilting, Tsg6 is both necessary and sufficient 
to inhibit vascular development on the right side. These data were further reinforced by my 
findings in the mouse model system where the Tsg6-null embryos demonstrated randomized gut 
looping chirality and gut vascular defects. Thus, these discoveries strongly support the critical role 
of HA-Tsg6 interaction in the initiation of mammalian gut rotation and vascular development 
(Figure 4.1). Furthermore, these findings pave the way for future investigations of the downstream 
mechanisms regulating HA in the DM, the relationship between Tsg6 and HA production, and the 
changes in tissue architecture that establish gut and vascular chirality. The following sections 
provide an outline of the possible investigations that can be carried out to understand the upstream 
and the downstream mechanisms of Tsg6 and HA in the DM.  
 
 
 
172 
 
 
 
 
 
 
 
 
 
 
4.2 Enzymatic evidence for HC-HA modification in the mouse DM  
My results suggest but do not prove that the ability of Tsg6 to mediate avascularity in the right 
DM is dependent on its enzymatic ability to covalent modify HA. Hence, the first step would be 
to determine directly whether Tsg6 is transferring HC to HA. In vitro studies have shown that the 
covalent modification of HA occurs in the presence of inter-α-trypsin inhibitor (IαI), which 
triggers Tsg6 to function as an enzyme that mediates the covalent transfer of HC to HA forming 
the HC-HA complex (Briggs DC, 2015). IαI is a serum proteoglycan composed of 3 polypeptides: 
the trypsin inhibitor called bikunin (35 kDa) and two of the three genetically different heavy 
chains (HC1, HC2, and HC3), 83 kDa each (Salier et al., 1996). Tsg6 and bikunin are essential 
for the biosynthesis of this complex and loss of Tsg6 or bikunin in mice result in abolished 
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Figure 4.1: Summary of our current understanding of the cellular mechanisms that contribute to 
asymmetric arteriogenesis and leftward tilting of the gut. 
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formation of HC-HA. The bikunin-null mice which lack the HC donor IαI fail to form HC-HA 
with nearly identical phenotypes to the Tsg6 null mice (Lauer ME, 2013; Zhuo et al., 2001). 
Importantly, although HC-transfer is disrupted in these mice, Tsg6 is unaffected. Thus, bikunin 
lesion will reveal whether Tsg6 functions independently of HC transfer to HA on the right side, 
affording further mechanistic insights into the role of Tsg6 in the mouse intestine. Thus 
comparative analysis of gut looping and vascular patterns between the bikunin nulls and Tsg6 nulls 
will help define whether Tsg6 functions as a HA modifying enzyme or independent of its catalytic 
activity. For example, if the role of Tsg6 in the gut is dependent on HA catalysis, we expect 
reduced HA staining, perturbed ECM expansion and altered gut looping in both Tsg6- and bikunin-
null embryos because they lack the IαI substrate. If Tsg6 plays a role in the gut independent of HA 
catalysis, we expect no gut phenotypes in bikunin-null mice. Of note, beyond its role in HA 
catalysis, Tsg6 regulates chemokine signaling by modulating chemokine-GAG interactions (Dyer 
et al., 2016). Thus, the HA-independent function of Tsg6 warrants consideration.  
As a corollary to addressing the central question regarding the nature of Tsg6 role in the 
DM, investigations to determine the DM’s ability to support the enzymatic function of Tsg6 needs 
to be carried out. This involves characterizing the source of IαI complex in the DM. The current 
body of literature on IαI shows that majority of the IαI complexes in the body is synthesized by 
the liver hepatocytes and is secreted into the blood at high concentrations (Mizon C, 1996). 
Particularly the serum is enriched with the IαI complex. Furthermore, experiments in vitro have 
shown that simple mixing of serum and HA followed by incubation with Tsg6 at 37°C is sufficient 
to form the HC-HA complex (Yoneda M, 1990). During ovulation or inflammation, IαI has been 
shown to ingress into extracellular tissue spaces following increased vascular permeability, where 
it serves as an HC donor (Lauer ME, 2013). Therefore, the convergence of serum and HA with 
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Tsg6 can be an important regulator during gut rotation. Most recently, synthesis of Tsg6 and a 
member of the IαI family with HC3 have been noted in the mouse lung airway epithelial cells 
suggesting that serum is not the only source of an active IαI production (Abbadi A, 2016). 
Therefore, there are currently two possible sources of the IαI complex. 1)  DM cells can synthesize 
their own IαI substrate in the absence of serum in a manner similar to the lung epithelium; or 2) 
that the blood vasculature has a role in ECM expansion by supplying IαI in the DM, as shown 
during ovulation. My preliminary investigations into the distribution of IαI using 
immunohistochemistry reveal the absence of IαI in the cells of the DM (data not shown) suggesting 
that the serum IαI is the likely substrate. However, further investigations need to be carried out to 
directly address whether DV cords play a role in ECM expansion by supplying IαI in the DM. The 
mechanistic insights obtained from the above investigations can be followed with direct validation 
of the HC-HA modification by extracting the HCs in the DM using Streptomyces hyaluronidase 
mediated digestion (specific for HA) and detecting the released products by mass spectrometry 
(Figure 4.2). 
 
4.3 Investigating HC-HA mediated mechanisms that regulate vascular exclusion 
When HA on the right DM is depleted, Cxcl12 expression in the right is abnormally maintained 
suggesting that HA negatively regulates Cxcl12 expression at the transcriptional level (Figure 2.7).  
However, it remains to be determined whether Tsg6 is necessary to inhibit Cxcl12 expression in 
right DM. Analysis of Cxcl12 expression in Tsg6 knockdown embryos (using MO 
electroporations) and embryos electroporated with catalytically inactive pCAG-Tsg6-S28A on the 
right can provide potential insights into the role of Tsg6 in regulating Cxcl12  
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expression. Another potential candidate pathway that can lie downstream of Tsg6-mediated anti-
angiogenesis is the VEGF signaling pathway- a critical regulator of blood vessel formation and 
patterning (Ferrara N, 2009). Studies in recent times have elucidated interactions between VEGF 
signaling pathway and HA matrices. For example, degradation of the HMW-HA into small HA 
oligosaccharides induces VEGF mRNA and protein in primary mouse endocardial cushions in the 
heart whereas HMW-HA is inhibitory to these activities (Rodgers LS, 2006). Thus, the HA 
matrices can regulate the transcription of VEGF. Interestingly, studies in zebrafish support the 
hypothesis that the small HA fragments induce VEGF signaling by liberating VEGF molecules 
from the ECM, without affecting the transcription suggesting that HA can also act as an 
Modified HA 
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Figure 4.2: Work flow to detect HC-HA complexes in the DM using mass spectrometric 
approaches 
 
176 
 
extracellular sink to sequester VEGF away from its receptor (De Angelis JE, 2017). Thus, assays 
that perturb VEGF expression in chicken embryos where Tsg6 manipulations have been carried 
out can provide insights into the potential link between Tsg6 and VEGF in the DM. 
 
4.4 Elucidating the upstream mechanisms involved in HA and Tsg6 induction in the DM 
While the current study provides insights into how HA functions in the DM to generate cellular 
and vascular asymmetries, the mechanisms that result in asymmetric accumulation of HA in the 
right DM remain unclear. Since Has2 is not differentially expressed across the LR axis of the DM, 
it is unlikely that asymmetric regulation of its expression could be responsible for the enriched 
levels of HA on the right. However, since Has2 is also regulated via post-translational 
modifications (Tammi RH, 2011), it is possible that the differential modulation of Has2 function 
via distinct post-translational modifications in the left and the right DM could underlie the 
asymmetric accumulation of HA. Mechanisms independent of Has2 function in the DM are equally 
possible. One such hypothesis being asymmetric degradation of HA by HA-degrading enzymes 
produced either by the left mesenchymal cells or by the vascular endothelial cells present only in 
the left DM compartment. This would result in the asymmetric accumulation of HA in the right 
side. Further investigations are needed to determine the cellular expression profile of HA-
degrading enzymes, such as Hyal2, in the DM. 
To investigate mechanisms responsible for the timely induction of Tsg6 in the right DM, I 
have previously identified potential candidate transcription factors that could regulate Tsg6 
expression. Using transcriptional profiling data from our previously published laser capture 
microdissection of the LR halves of the chicken DM, I have identified the anti-inflammatory cyclic 
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AMP-dependent transcription factor Atf3 as one such gene. Previous studies have shown that both 
Atf3 and Tsg6 are activated downstream of TNF-α (Inoue K, 2004) and are specifically produced 
in ovarian cumulus cell-oocyte complex (Inan MS, 2006). They are both known to act as negative 
regulators of inflammation (Wisniewski HG, 1997). Furthermore, spatiotemporal analysis of Atf3 
expression revealed that Atf3 is restricted to the right DM commensurate with the leftward tilt and 
with Tsg6 expression (Figure 4.3). Importantly, I have identified a highly evolutionarily conserved 
region immediately upstream of Tsg6 that is enriched for the binding sequence of Atf3, suggestive 
of direct regulation (Figure 4.3). 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4.3:  Tsg6 and Atf3 are both right-sided in the DM. In silico analysis of the 
promoter region of Tsg6 reveal a highly conserved and an enriched Atf3 binding site 
suggesting that Atf3 could potential regulate Tsg6 expression. ChipSeq data showing 
binding sites of Pitx2 upstream of Atf3 showing that Pitx2 is a possible regulator of 
Atf3 that serves to restrict its expression to the right DM. 
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Importantly, I showed previously that Pitx2 misexpression in the right chicken DM inhibits 
Atf3, Tsg6 and HA production (data not shown).  Hence, using the chicken model system, targeted 
knockout of Atf3 using morpholinos or misexpression of Atf3 on the left side can be carried out 
and assayed for Tsg6 expression. This can be followed up with chromatin immunoprecipitation 
assays to detect in vivo binding of Atf3 to the regulatory region of Tsg6.  In addition to Atf3, I 
have identified other transcription factors that are right-sided in the DM (for example Tbx18, 
Tcf21, Smad6), which should be tested for their role in the induction of Tsg6. 
 
4.5 The Mystery of HA in the left DM 
My data argues that endogenous HA in the left DM, however weak in HA staining, may have a 
role, consistent with bilateral Has2 expression in the DM. However, only the HA in the right DM 
is anti-angiogenic whereas the HA in the left coexists with vasculature suggesting that the HA in 
the right DM and left DM are functionally different. Since the function of HA in a given system is 
regulated by its size and its interactors (Cyphert JM, 2015), there are currently two possible 
hypotheses that could explain the functional differences between the left and right DM. Studies 
that have looked into the effect of size on the function of HA have shown that in normal tissues, 
native HMW-HA is anti-angiogenic whereas LMW-HA fragments stimulate angiogenesis (Deed 
R, 1997). Thus, the opposing pro-angiogenic role of HA on the left could suggest the presence of 
LMW HA in the left compartment. The second possibility arises from our preliminary observation 
that while Tsg6 is right-sided in the DM, another HA binding protein, versican, is expressed on 
the left (Figure 4.4). 
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Versican-null (Vcan hdf/hdf) and mutant embryos with reduced HA binding (Vcan delta3) share 
similar cardiac phenotypes as Has2-null mutants, suggesting that the HA-versican interaction is 
crucial to cardiac development (Hatano et al., 2012; Matsumoto et al., 2003). In pathological 
conditions, interaction of versican and HMW-HA, but not HMW-HA alone, acts as an angiogenic 
modulator by promoting endothelial proliferation and migration, transmitting signals in concert 
with HA (Koyama et al., 2007). Thus, the second possibility that may explain the differential 
functions for HA in left and right DM is that HMW HA is produced on both sides of the DM but 
is differentially modified with Tsg6 on the right and bound by versican on the left. Further 
investigations involving inhibition and manipulation of versican in the chicken DM may provide 
us with further insights regarding the in vivo regulation of HA that promotes angiogenesis versus 
anti-angiogenesis, which have immense therapeutic applications for numerous disease conditions. 
 
 
Figure 4.4:  Versican is left-sided in the DM at HH21 (RNA ISH, Vcan).  
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A1 Introduction 
Over the course of the past six years, various protocols and methods have been developed or 
adopted for understanding the role of right-sided mechanisms in orchestrating gut looping and 
vascular morphogenesis in mice and avian (chicken and quail) embryos. These include methods 
from accurately determining the developmental stage of the embryo based on the gut, to 
elucidating gene expression profiles and manipulating gene expression. A summary of the methods 
used for different experiments which seek to provide answers to different hypothesis have been 
outlined in the flowchart shown in the following page (Fig A1). These methods have been 
described in detail in this section with the intention of allowing any person to learn and obtain a 
high level of expertise in these techniques with sufficient practice, which would enable them to 
reproduce the results described in the earlier chapters. As shown in Fig A1, the techniques can be 
categorized into the following: 
A. Embryology:  
While there are a number of references that allow determination of the developmental stage of an 
embryo such as growth of forelimb, size of the allantois, pigmentation of the eyes, and somite 
numbers, these methods are not completely reliable in the context of gut development. Frequently, 
following genetic or surgical manipulation the embryo fails to develop uniformly and 
determination of the developmental stage with respect to how much the gut has developed becomes 
very difficult. To this end, I have developed methods to identify the developmental stage of the 
chicken and mice embryos based on the topology of the gut. These are detailed in sections AA1 
and AA2. 
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Section AA3 describes methods of processing dissected embryos for paraffin and cryo--
sectioning to generate thin sections for looking at tissue morphology or gene/protein expressions 
with cellular resolution. 
B. Histology: 
This technique is utilized extensively in biology, and especially in developmental biology to study 
the microscopic structure and morphology of cells and tissues under light or electron microscopes. 
Generally, a variety of histological stains are employed to visualize or differentially identify 
various cellular structures. Sections AB1, AB2 and AB3 describe in detail three different 
histological staining procedures for different purposes. All three staining procedures are performed 
on paraffin-sectioned tissue samples, described in section AA3.  
C. Gene expression and manipulation: 
Understanding embryonic development requires knowledge of the spatio-temporal expression of 
genes regulating the many different and diverse processes during development.  RNA in situ 
hybridization allows us to look at the spatial expression of genes across different stages during 
embryonic development. The methods for performing RNA in situ hybridization in tissue sections 
of mice and chicken embryo and in whole mice and chicken embryo samples have been described 
in detail in the thesis of Aparna Mahadevan (Aparna Mahadevan, 2016 – Sections A1 and A2). 
However, recently, we have adopted another protocol for investigating gene expression profiles 
using commercially designed probes and reagents. This allows the week-long protocol to be 
shortened to just a single day, and is particularly useful for some genes which are difficult to detect 
using the conventional methods described by Aparna Mahadevan. This technique, termed 
RNAScope, from ACDBio is outlined in section AC1. It should be noted that RNAScope is almost 
exclusively for genes that have been proven to be extremely difficult to detect reproducibly using 
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the in house conventional methods, and that those methods should be tried first. Additionally, 
RNAScope is currently only used in tissue-sections of embryos and not whole mount samples.  
After obtaining information about the spatial distribution of genes, it is important to either 
misexpress or knockdown the gene function to determine the functionality of the gene by 
addressing if it is sufficient or necessary for a particular developmental process. The chicken 
embryo offers itself as an excellent model to transiently misexpress/overexpress or knockdown 
genes in vivo, while the embryo is still developing. Following the genetic manipulation, the 
embryo can continue to develop and the effect of the manipulation can be observed at a later 
developmental stage. In the Kurpios lab, we use a method known as electroporation to specifically 
target the precursor cells of the dorsal mesentery. Briefly, a plasmid DNA containing the gene of 
interest and a ubiquitous promoter is injected into the coelomic cavity, where the precursor cells 
of the dorsal mesentery reside. An electric pulse is then administered to allow the cell to uptake 
the plasmid DNA. This technique of plasmid DNA electroporation in both chicken and quail 
embryos is described extensively in the thesis of Aparna Mahadevan (Aparna Mahadevan, 2016 – 
Section A6). However, I have developed a technique of electroporating Morpholinoes to knock 
down the function of genes (See Chapter 2). While the method of delivery of the Morpholino is 
identical to that of plasmid DNA, and will not be described here, I have outlined the procedures 
for designing the Morpholinoes and the how the Morpholinoes should be prepared for 
electroporations in section AC2.  
Another method to perturb function of gene products is to utilize small molecule chemical 
inhibitors. These chemical inhibitors are soaked in resin beads (or other beads compatible with the 
inhibitor) and surgically implanted into the coelomic cavity of the developing embryo. Again, this 
procedure has been described in detail in the thesis of Aparna Mahadevan (Aparna Mahdevan, 
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2016 – Section A7). In Chapter 2 of this thesis, I have used this technique to inhibit hyaluronan 
synthesis by introducing the small molecule inhibitor, Mu-Xyloside. The conditions and 
procedures for preparing the Mu-Xyloside soaked beads along with the proper vehicle controls are 
described in Section AC3. 
D. Immunostaining: 
Immunostaining allows us to visualize the spatial distribution a protein within a tissue section of 
an embryo (immunohistochemistry) or within the whole embryo (wholemount immune staining). 
The general procedures for immunostaining in tissue sections of mice and chicken embryos and 
mice gut tube sections, and for whole mount immunostaining in mice and chicken 
embryos/intestines have been described in Aparna Mahadevan’s thesis (Aparna Mahadevan, 2016 
– Sections A3-5). I have developed another protocol to be used exclusively with hyaluronic acid 
binding protein (HABP) to determine distribution of hyaluronan in chicken embryo tissue sections 
(see Chapter 2 of this thesis). This protocol is described in detail in section AD1.  
E. Live imaging: 
Embryonic development is very dynamic with numerous processes occurring in tandem to form 
functional organs and organ-systems, ultimately resulting in the formation of a fully functional 
organism. Taking the intestines as an example, there are many cellular processes such as cell 
migration, cell shape changes, proliferation, cell division, differentiation, etc., which allow the 
simple cylindrical primitive gut tube to transform into a complex structure with complex yet 
reproducible looping topology and an extensive vascular network. While detailed histological or 
embryological characterization at different developmental stages allow us to get an overview and 
draw a timeline of the process, the best way to understand these cellular processes is via live 
imaging of the cells, which in this case are fluorescently labelled using confocal or two-
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photon/multiphoton microscopy techniques. As the name implies, this technique involves tracking 
the different cellular processes real time, as they occur. I have developed this technique of ex vivo 
live imaging to track the migration of blood endothelial cells (transgenic quails), lymphatic 
endothelial cells (transgenic mice) and cell shape changes in the dorsal mesentery of reporter-
electroporated chicken embryos. The procedures for preparing the three types of samples for live 
imaging has been described in detail in sections AE1. The microscope set-up varies with the 
microscope being used and the samples, and it is imperative that proper training on the microscope 
and an intuitive understanding of how the microscope functions is obtained. Due to the variability 
in settings in different microscopes and also taking into account the microscope softwares are 
updated regularly, it is almost impossible to describe them in detail and only the essential details 
have been provided. It is best to get properly trained with the professionals who know the 
microscope, when you are ready to do some live imaging with samples prepared according to the 
descriptions in sections AE1. 
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AA1 Embryology: Gut specific staging of chicken embryos 
The chick embryo has been the center piece for many embryological studies and its embryonic 
development have been described in a variety of ways. While its development has been described 
generally in terms of length of the incubation time, a wide variation in external form of the embryos 
could still be observed. Other specific methods of characterization based on distinguishing the 
embryos based on detailed morphological characteristics over the entire incubation period as 
worked out by Hamburger and Hamilton (1951) have greatly enabled scientists for rapid, accurate 
identification and synchronized staging across the world. Intriguingly, the authors of the seminal 
paper had acknowledged that the embryo displays independent variations of different 
characteristics during its development. They had indeed noted that “for instance, the progress of 
differentiation in the visceral arches may lag behind that in limb buds, when compared with an 
average sequence”.   
From empirical observations of others and myself in the Kurpios lab, we find that the 
variations in development of the different features is more extensive during the early embryonic 
development.  These variations could arise from the fact that early embryonic development is 
modular and there is lesser synchronization during the early embryonic development. As 
development proceeds, we find that the variations become significantly lesser showing that there 
is greater synchronization at the later stages. 
As a result of these variations, there is a strong need to develop organ specific staging 
methods for accurate identification of the dynamics of gut development. In my work, I have 
characterized the developing chick gut tube from stages HH17 - HH25 with great amount of help 
from Ian Welsh and Aparna Mahadevan- two senior graduate students in the lab who have guided 
me. I describe specific distinguishing features that will enable one to tell between the stages and 
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to anatomically identify the different zones of the developing gut tube. This has been based on 
several embryos that I had examined over the course of my PhD, illustrated in Figures A2-A7.  All 
the illustrations and descriptions are based on material fixed in Bouin’s fixative or formalin.   
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AA2 Embryology: Characterization of looping topology in chicken and mice embryos 
Since 2009, the Kurpios lab and others have heavily focused on understanding mechanisms 
responsible for the early leftward tilt which initiates the counterclockwise rotation. However, the 
mechanisms that are responsible for the formation of the subsequent loops have been largely 
uninvestigated. While work by (Savin et al ,2011) on growth and form of gut reveal that the 
differences in growth rate between the gut tube and the dorsal mesentery gives rise to isotropic 
tensile forces that results in bending of the gut tube to establish the loops, the authors have for the 
most part ignored the differences in the loops formed across the different regions of the gut tube. 
Moreover, empirical observations that I have carried out in the Kurpios lab reveal that the curvature 
and the timing of formation of these loops are significantly different for the different regions, but 
yet for the most part stereotypical and largely conserved, suggesting that a lot remain unknown 
about the mechanisms of formation and positioning of these loops during gut development. 
Furthermore, a seminal paper by (Soffers et al, 2015) performed an in-depth quantitative 
morphometric study on the growth and development of the human mesentery and intestine and by 
characterizing the looping topology across stages, they had come to similar conclusions. However, 
since the looping topology widely varies between species, a similar detailed characterization has 
not been carried out for other species such as the mouse and the chick. While some efforts have 
been made to study the formation of duodenum outside the initial counterclockwise rotation in 
mice by Sawa et al, 2013, 2015, A lot more is needed to understand the mechanisms that regulate 
the formation of the loops that form subsequent to the primary rotation. In the following section, I 
outline the key features of looping in chick and mice and the methodology I have adopted for 
characterizing the loops.  
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Establishment of loops in mice embryos:  
The establishment of loops of the gut tube in mice occurs across three generations similar to the 
human. The first generation involves establishment of the primary loop, where the cranial limb of 
the of the midgut acquires a position to the right of and at the same transverse level as the caudal 
limb. As this rotation occurs, the gut tube extends into the umbilical cord. In mice, the gut tube, 
comprising the foregut, midgut, and hindgut, is formed between E9.0 and E9.5. Simultaneously, 
the midgut elongates, rotate and extends into the umbilical cord as a primary gut loop starting at 
around E10.5. the cranial limb and the caudal limb reach the same transverse level at E12.5 
indicating the complete establishment of the primary loops. The second generation of loops 
involves establishment of four secondary loops similar to as observed in humans. The first 
secondary loop, also referred to as the duodenal flexure, forms between the duct of the ventral 
pancreas and the passage of the midgut through the umbilical orifice. It expands caudally and 
rightward on the right side of superior mesenteric artery and eventually extends leftward to 
establish the duodenal rotation. In mice, the establishment of the duodenal flexure occurs between 
E10.75- E13.5 as described in (Onouchi et al ,2013; Onouchi et al ,2015). While the first secondary 
loop develops intra-abdominally, the other loops develop extra abdominally. The 2nd and 3rd loop 
(coded yellow and green, respectively) develops from the remaining part of the cranial limb of the 
midgut and expands caudally and then leftward on the right side of the axis formed by the SMA, 
right vitelline vein, and the mesenteric rod. The 2nd loop is formed in the proximal part of the 
cranial limb of the midgut that extends into the umbilicus, while the 3rd loop is formed in the distal 
part of the cranial limb. The 4th loop develops from the caudal limb of the midgut between the 
apex and the cecum and expands cranially on the left side of the axis. While the formation of the 
2nd loop initiates in mice by E12.5, the 3rd and the 4th loop develop from apex of the midgut which 
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undergoes a leftward cranial tilt. This positions the cecum pointing ventrally, perpendicular to the 
caudal cranial axis. Analysis of multiple WT embryos at E12.5, when the cranial tilt is most 
pronounced show that this orientation of cecum is highly conserved. and by E13.5, all of the 
secondary loops are fully established. Thus the establishment of the secondary loops in mice 
mirrors the establishment of secondary loops in human. Subsequent to the establishment of 
secondary loops, with drastic lengthening of the GI tract, tertiary loops form within the secondary 
loops. At E14, the tertiary loops in the 3rd and the 4th secondary loops initiate first. The positioning 
of the tertiary loops indeed demonstrates some variability. Subsequently, the resolution of the 
umbilical hernia occurs, which results in the formation of quaternary loops and in mice, this is 
complete by E16.5. 
Establishment of loops in chicken embryos 
In the chick, similar to mice, the establishment of loops occurs across three generations. The first 
generation involves the establishment of the primary loop resulting in the cranial and the caudal 
limbs of the gut tube occurring in the same transverse plane. This primary loop initiates via the 
leftward tilt of the caudal midgut observed at HH21 and is fully defined by HH25.  Subsequently, 
four secondary loops are established similar to humans and mice however with minor differences 
with orientation with respect to mice and humans. The first secondary loop, the duodenal flexure, 
forms between the duct of the ventral pancreas and the cranial limb of the midgut. However, unlike 
in mice and humans where It expands caudally, in chick, it expands cranially and rightward on the 
right side of SMA. The formation of flexure initiates at HH24 (E4) and is complete by HH32 
(E7.5). Similar to mice and humans, the 2nd loop is formed in the proximal part of the cranial limb 
of the midgut, while the 3rd loop is formed in the distal part of the cranial limb and the 4th loop is 
formed in the distal part of the caudal limb between the SMA and cecum. the 3rd and the 4th loop 
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develop from apex of the midgut which undergoes a leftward cranial tilt.  Compared to the mouse, 
where the formation of the 3rd and the 4th loop is almost simultaneous, the curvature and the timing 
of complete establishment of the 3rd and 4th loop drastically differs in chickens possibly because 
the positioning of the cecum is different in chickens, and a larger region of the gut tube in the 
ileocecal part of the gut tube have to be established. The formation of the 3rd loop initiates by 
HH30 (E6.5) with the cranial limb flexing more cranially and the cranial limb flexing more 
caudally at the apex of the midgut and is fully established by HH35 (E9) (E9). The formation of 
the 2nd loop is intimately tied with the formation of the 3rd loop, where the proximal part of the 
cranial limb moves caudally as the distal part moves cranially.  The formation of the 4th loop which 
appear to initiate by HH32 is formed by the cranial movement of the ileocecal part of the gut tube 
and is only complete by HH36 (E10). Thus by HH36 E10.5, all the secondary loops are fully 
established (as shown in Figure A8).  The formation of the tertiary and the quaternary loops is 
completely different in chickens due to the lack of the umbilical orifice and have been 
characterized in some detail in (Southwell, 2006).  
 
Figure A8: Example of 
looping in HH36 WT 
chicken embryo. At this 
stage the 4 secondary 
loops across the different 
regions of the intestine 
are fully established. 
Illustrations adapted 
from Southwell, 2006.  
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Methodology of characterizing the looping topology at the later stages:  
To characterize the 3-D looping topology at the later stages,  
1. After isolation of the embryo, the intestines along with the stomach need to be completely 
separated from the body cavity. 
2. The intestines are fixed in 4% PFA overnight in large 20 ml vials to preserve the looping 
topology. 
3. The intestines are subsequently imaged in at least 4 different orientations, and the loops 
are traced out. 
Examples for tracing the loops for mouse E12.5, E13.5 and E18.5 are provided in Figure A9.: 
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Figure A9: Tracing of loops in mice embryos of different stages. Duodenal flexure (blue line), 
duodenum/proximal jejunum (grey line), distal jejunum (orange line), ileum (green line) and 
colon (black line) have been traced. 
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AA3 Embryology: Processing of embryos for paraffin and cryo-sectioning 
To generate tissue sections of embryos, two methods are currently being followed: A. Embedding 
them in paraffin B. Embedding them in OCT compound (TissueTek). The following protocol 
outlines the procedures for paraffin and OCT embedding of embryos. 
While cryosections generally give better results for most insitu and immunostaining 
protocols, histology and RNAScope protocols require paraffin embedding as thinner sections can 
be generated while retaining the best tissie morphology. These procedures are adapted from the 
standard Kurpios lab protocol. 
 
Procedure for paraffin embedding of embryos: 
 
1. Sample preparation: 
a. For insitus and immunos : Dissect mice or chicken embryos of the required stage 
in PBS and immediately fix in 4% PFA (mice embryos) or 2% PFA (chicken 
embryos)  overnight at 4°C .Subsequently, wash embryos 3 X 10 minutes in 1 X 
PBS at room temperature.  
b. For histology: Dissect mice or chicken embryos of the required stage in cold PBS. 
Remove PBS as much as possible and immediately fix the embryos in Bouin’s 
fixative for 2 hours at room temperature and give it 10 hourly washes of 70% 
ethanol at room temperature till the yellow color from the Bouin’s fixative is 
almost washed away. Subsequently, give two 100% Ethanol washes. The embryos 
can then can be stored for months at -20C. After that follow steps 4-8 
2. If embedding in paraffin, bring the PFA fixed embryos though series of ethanol gradients 
(25% in PBS, 50% in PBS, 75% in water and 100%). Ensure embryos are immersed and 
allowed to equilibrate for at least 10 minutes in each gradient. Proper dehydration is 
critical. Follow steps 4 – 8. 
3. Wash embryos in 1:1 ratio of 100% ethanol: xylene for 10 mins. 
4. Wash embryos 2 X 15 mins in 100% xylene. 
5. Wash embryos in 1:1 ratio of xylene:paraffin for 15 mins at 65°C. 
6. Wash embryos in paraffin 3 X 45 mins at 65°C. 
7. In an embedding mold, align embryos as required in paraffin and let it solidify. These 
blocks of embryos can be stored at room temperature till they are ready to be sectioned. 
 
Procedure for cryo embedding of embryos: 
 
1. Sample preparation: Dissect mice or chicken embryos of the required stage in PBS and 
immediately fix in 4% PFA (mice embryos) or 2% PFA (chicken embryos) overnight at 
4°C. Subsequently wash embryos 3 X 10 minutes in 1 X PBS at room temperature.  
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2. After the 1X PBS wash, bring them through series of sucrose gradients (25% of 30% 
sucrose, 50% of 30% sucrose, 75% of 30% sucrose and 30% sucrose). The sucrose 
gradients should be prepared in PBS. Embryos should be washed in each gradient till 
they sink to the bottom of the vial, implying they have been equilibrated. Leave embryos 
shaking in 30% sucrose overnight. The 30% sucrose has the same density as OCT.  
3. Wash embryos in 1:1 ratio of 30% sucrose:OCT for 30 mins. 
4. Embed embryos after aligning them as required in the 30% sucrose/OCT mix, and place 
the molds containing the embryos in 2-methylbutane, cooled with liquid nitrogen. Ensure 
that methylbutane does not enter the cavity containing the embryos which might cause 
creation of bubbles. Once the 30% sucrose/OCT mix has solidified, immediately wrap the 
mold with the embryos in aluminum foil and store at –80°C till they are ready to be 
sectioned. Store slides in -80C after sectioning. 
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AB1 Histology: Hematoxylin and Eosin staining 
The following protocol outlines the procedure for the Hemotoxylin and Eosin staining. 
Hemotoxylin is a basic dye which reacts with anionic components of the cells like nucleic acids 
and gives a purplish blue stain. Eosin is an acidic dye that reacts with the cationic components of 
the cells such as proteins and other components of the cytoplasm and gives it a red or pink stain 
depending on the acidity. Thus, the nucleus, and parts of the cytoplasm that contain RNA will stain 
in purple, and the rest of the cytoplasm stains up in pink. This protocol includes differentiation of 
colors using acid ethanol and ammonium hydroxide for color differentiation. Two protocols are 
included for staining paraffin embedded embryos and cryosections. Best results are obtained when 
embryos are fixed with Bouin’s fixative. 
Solutions: 
1. Harris hematoxylin 
2. Eosin Y (1% stock):  
Preparation notes: Add 2.0 g of water-soluble eosin Y to 40 mL of double-distilled H2O, 
and mix until dissolved. Then add 160 mL of 95% ethanol, and mix. Store at room 
temperature. 
3. Eosin Y (0.25% working stock) 
Preparation notes: Take 47 ml of water. Add 251 ml of 95% Ethanol. Add 100 ml of 
Eosin Y and 2 ml of Glacial acetic acid to make 400 ml of working solution. 
4. Acid Ethanol:  
Preparation notes: Add 2 ml of conc. HCl in 70% Ethanol 
5. Ammonium Hydroxide water 
Preparation notes: Add 6 drops of Ammonium hydroxide in 350 ml of water 
6. 400 ml Xylenes – distributed in 2 containers 
7. 200 ml of the following dilutions of ethanol in water : 50%, 60%, 70% , 80% ,95% 
poured into separate containers kept in Kurpios right  
8. 2 containers containing RO H2O 
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Procedure for staining paraffin sections:  
(For cryo sections: Bring sections to room temperature, rehydrate sections by giving 3 washes 
using 1X PBS and directly go to step 4) 
1. Bake slides at 60 C for at least 20 minutes. Cool slides down to room temperature for 
15 minutes. 
2. Place slides in slides holder and give two washes in Xylenes for 10 minutes each. 
3. Remove slide holder from Xylene container, dab the slide holder in paper towels to 
remove excess xylenes and place the container in the following solutions:  
a. 100% Ethanol for two minutes, 
b.  95% Ethanol for two minutes 
4. Remove slide holder from the 95% ethanol , dab the slide holder to remove excess 
Ethanol and follow it up with a 2 minute wash with RO H20 for 2 minutes. 
5. Remove slide holder, dab the slide holder in paper towels to remove excess water, 
and place it in the hematoxylin solution for 3 minutes. 
6. Remove slide holder and dab the slide holder in paper towels to remove excess 
hematoxylin and wash it in RO H2O for two minutes. 
7. To differentiate the color, follow this water wash with a dip in acid ethanol solution 
for 3 seconds. (Note: Extremely time sensitive step !!)  
8. wash it in RO H2O for two minutes. 
9. Transfer the slide holder to ammonium hydroxide water solution for 15-30 seconds. 
For younger embryos, stick to 15 seconds (< HH25) For older embryos (>HH25) 
having a 30 second expose differentiates color beautifully. 
10. Quickly remove slide holder, dab the slide holder in paper towel to remove excess 
ammonium hydroxide and follow it up with the following time sensitive alcohol 
washes 
a. 50 % Ethanol for 1 minute 
b. 60% Ethanol for 1 minute 
c. 70% Ethanol for 1 minute 
11. Remove slide holder and dab the slide holder in paper towels to remove excess 
Ethanol and dip slide holder in 0.25% Eosin for 1.5 minutes. 
12. Quickly remove slide holder, dab the slide holder in paper towel to remove excess 
Eosin and follow it up with the following time sensitive alcohol washes. 
a. 80% Ethanol for 30 seconds 
b. 95% Ethanol for 30 seconds 
c. 100% Ethanol for 45 seconds. 
13. Remove slide holder and dab the slide holder in paper towels to remove excess 
Ethanol and give two washes in Xylenes for 10 minutes each. 
14. Mount slides using permount. 
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AB2 Histology: Alcian blue staining 
Alcian blue stains acid mucosubstances and acetic mucins. Excessive amounts of non-sulfated 
acidic mucosubstances are seen in mesotheliomas, certain amounts occur normally in blood vessel 
walls but increase in early lesions of atherosclerosis. Alcian blue is a large planar pthalocyanine 
molecule with a copper atom in the center. The molecule also contains four basic isothiouronium 
groups which carry a positive charge. The positive charge imparted by these groups results in the 
attraction of the alcian blue dye molecules to the anionic sites in mucin molecules. Like 
mucicarmine, alcian blue does not stain neutral mucins. 
Varying the pH of the alcian blue solution is a useful means for further characterization of 
the subtypes of acid mucins present in a tissue specimen. All acidic mucins whether carboxylalid 
or sulfated will ionize at --a pH of 2.5 to produce anionic groups (COO, SO3). Thus the standard 
alcian blue – pH 2.5 stains all acidic mucins (Figure 3). In contrast, mucins that contain 
predominately carboxylated carbohydrates will stain strongly with alcian blue – pH 2.5 but not 
with alcian blue at a pH of 1.0. The carboxyl groups do not ionize at this lower pH and as a result 
the mucins will display neutral characteristics. The more acidic sulphonic groups are capable of 
ionization at a pH of 1 and therefore stain at this pH. 
Fixation: PFA fixed, Bouin’s solution fixed, paraffin embedded sections. (Works best in 
Bouin’s fixed embryos) Positive Controls: Small intestine, appendix, or colon. 
Solutions and Reagents:   
1. 3% Acetic Acid Solution 
Preparation notes: 3mL of glacial acetic acid in 97mL of distilled water 
2. Alcian Blue Solution (pH 2.5) 
Preparation notes: 1g of alcian blue, 8GX in 100mL of 3% acetic acid solution. Mix well 
and adjust pH to 2.5 with acetic acid. 
3. Alcian Blue Solution (pH 1.0) 
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Preparation notes: 1g of alcian blue, 8GX in 100mL of 0.1N hydrochloric acid solution. 
To prepare HCl 0.1 N, 8.2mL hydrochloric acid concentrate should be added to 991.8mL 
distilled water. 
4. 0.1% Nuclear fast red solution 
Preparation notes: 0.1g Nuclear fast red, 5g of ammonium sulfate in 100mL distilled 
water. Dissolve ammonium sulfate in water. Add nuclear fast red and slowly heat to boil 
and cool. Filter and add a grain of thymol as a preservative. 
     
Procedure for Alcian blue staining at pH 2.5 (Originally from Natasza):  
1.       Deparaffinize slides and hydrate to distilled water.  
2.       Stain in alcian blue solution pH 2.5 for 30 minutes.  
3.       Wash in running tap water for 2 minutes.  
4.       Rinse in distilled water.  
5.       Counterstain in nuclear fast red solution for 5 minutes.  
6.       Wash in running tap water for 1 minute.  
7.       Dehydrate and through 95% alcohol, 2 changes of absolute alcohol, 3 minutes each.  
8.       Clear in xylene or xylene substitute.  
9.       Mount with resinous mounting medium.  
  
NOTE: There is a short version of this protocol developed by Jose from the Tabin Lab, where 
the samples are washed in 3% acetic acid for 3 mins in distilled water, and then stained in 
0.15mg/mL (in 5% acetic acid solution) for 30 mins-several hours. It is advisable to try both to 
see which works better for your specific tissue sample. 
Procedure for Alcian blue staining at pH 1.0:  
1. Deparaffinize slides and hydrate to distilled water.  
2. Briefly rinse in 0.1 N HCl to protect the subsequent Alcian Blue Solution from pH 
changes due to the introduction of water. 
3. Stain in alcian blue solution for pH 1.0 for 2 hours. 
4. Briefly rinse in 0.1 N HCl. 
5. Blot sections dry with fine filter paper after this step. Do not wash with water as this 
will cause a change in pH and potentially cause nonspecific staining in the tissue 
section. 
6.    Counterstain in nuclear fast red solution for 5 minutes.  
7.    Rinse well in distilled water, dehydrate and through 95% alcohol, 2 changes of absolute 
alcohol, 3 minutes each.  
8.    Clear in xylene or xylene substitute.  
9.    Mount with resinous mounting medium.  
 
Anticipated results:  
1. Strongly acidic sulfated mucosubstances stain blue  
2. Nuclei stain pink to red and cytoplasm stains pale pink 
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AB3 Histology: Trichrome staining 
This stain that can be used to differentiate between collagen and smooth muscle in addition to 
staining the different components of the tissues listed below. 
 
The procedure uses Bouin’s solution as a mordant to intensify the stain. Hemotoxylin stains nuclei 
while cytoplasm and muscle are stained red with Biebrich scarlet-acid fuchsin. Following this, the 
samples are treated with polyacids phosphotungstic acid (PTA) and phosphomolybdic acid (PMA), 
which causes the Biebrich saelet -acid Fuschin to diffuse out of collagen fibers decolorizing them. 
This is followed by stained with trichrome blue, containing aniline blue which stain collagens blue. 
Finally, an acetic acid solution is used to rinse the sections after staining which produces a more 
delicate shade of tissue coloration. 
Samples: Works best with Boiun;s fixed paraffinized embryos. PFA fixed tissues that are paraffin 
embedded can also be used. 
Procedure (Adapted from Sigma protocol and Rosen Lab protocols): 
1. Bake slides at 60 for 20 minutes and let the slides cool for 15 minutes. 
2. Transfer slides to a slide holder. 
3. Deparaffinize by using the following washes 
a. Two washes Xylenes 10 minutes each. 
b. 100% Ethanol 5 minutes 
c. 75% Ethanol / water 5 minutes 
d. 50% Ethanol/water 5 minutes 
e. 25% Ethanol/water water 5 minutes 
f. Rinse in deionized H2O 
4. Place slides horizontally in a flat slidebox and cover the slides with Boiun’s for overnight 
at room temperature. (Mordant step) 
5. Transfer slides to slide holder and wash sections with running water for 5 minutes to 
remove the Bouin’s solution. 
Tissue Type Color with trichrome stain 
Collagen, Bone Green-blue 
Muscle, Fibrin, Cytoplasm, Red 
Red blood cells Yellow or red 
Nuclei Dark red-black 
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6. Make Weigert Hematoxylin Solution fresh by adding equal volumes of Solution A (1% 
Hematoxylin in 95% EtOH) and Solution B (1.2% Ferric Chloride and 1% Acetic Acid 
in distilled water). Dip the slide holder in the fresh made up solution of Weigert solution 
for 5 minutes at room temperature. 
7. Wash in running tap water for 5 minutes. 
8. Wash in dH2O for 5 minutes 
9. Transfer the slide holder to the container containing the Biebrich Scarlet-Acid Fuchsin. 
This wash has to be given for 5 minutes. 
10. Wash in dH2O for 5 minutes. 
11. Freshly prepare Phosphotungstic/Phosphomolybdic Acid Solution by mixing 1 volume 
of Phosphotungstic Acid Solution and 1 volume of Phosphomolybdic Acid Solution with 
2 volumes of distilled water. To be discarded after one use. Precipitates should be filtered 
out using whatman filter paper. Transfer the slides holder to this solution and keep it 
immersed for 10 minutes. 
12. Stain section in aniline blue for 5 minutes 
13. Wash slides using dH2O for 2 minutes 
14. Place slides in freshly prepred 1% acetic acid solution for 5 minutes. 
15. Wash slides using dH20 for 2 minutes. 
16. Give the following ethanol washes 
a. 25% Ethanol/water 5 minutes 
b. 50% Ethanol/water 5 minutes 
c. 75% Ethanol / water 5 minutes 
d. 100% Ethanol 5 minutes 
e. Two washes Xylenes 10 minutes each. 
17. Mount using Permount.  
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AC1 Gene expression and manipulation: RNAScope 
RNA SCOPE is a proprietary insitu hybridization method by ACD Cell Bio, which substantially 
improves the signal to noise ratio of RNA insitu hybridization. The technique uses two independent 
Z branched probes that are designed to bind to the target in tandem (next to each other). Each of 
the Z probes contain an 18-25 base pair long lower region of the Z probe that is complementary to 
the target RNA, a spacer sequence that connect the lower and upper regions, and an upper region 
that consists of 14 base pair that is complementary to the pre- amplifier probe. The two tails from 
the double Z probe forms a 28 base binding pair.  Since the probability that two independent probes 
will hybridize to a non-specific target right next to each other is very low, this design concept 
ensures selective amplification of target-specific signals. For each target RNA species, ~20 double 
Z target probe pairs are designed to specifically hybridize to the target molecule, but not to non-
targeted molecules. The procedure initiates with hybridization of the Z probes to the RNA target, 
followed by hybridization of the preamplifiers to the upper tails of the double Z probe. Amplifiers 
are then added which bind to the multiple sites in the pre amplifier and finally, labeled probes, 
containing a fluorescent molecule or chromogenic enzyme, bind to the numerous binding sites on 
each amplifier to give rise to the signal.  
While a variety of procedures are available for RNAScope technique, the procedure below 
is for RNAScope manual 2.5 HD red assay. this was developed when myself and Adam O Neal, 
another graduate student visited Dr.Suneel Apte lab at Cleveland Clinic to learn the technique from 
Dr. Sumeda Nandadasa. 
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Procedure: 
Sectioning and preparation: For RNA Scope analysis to work you will need to section within 
24hrs of running the protocol although the fresh sections can come from blocks which are years 
old. When sectioning first lay out the slides onto the warming plate and then place a drop of DI 
water onto the slide allowing it to warm for about 5 minutes before placing the section on top of 
the water droplet. Cut one section at a time and do not over crowd the slide. 2-3 sections per slide 
is sufficient. Will outline samples with hydrophobic pen so need sufficient distance between 
sample sections on the slide. Best not to exceed 12 slides due to carrying capacity of slide rack 
used for wash steps. 
Use sterile DI water in the bottle throughout every step in this protocol. Also always use fresh 
histoclear (same as Xylenes) and ethanol in clean containers. 
 (I advise starting as early as possible) 
1. Bake slides for 30-40min @ 60°C 
 while slides are baking conduct the following: 
1a. Set oven to 40°C. Wet humidifying paper with sterile DI water and warm for 30min. 
1b. Prepare Pretreat #2 (50ml of 10X + 450ml sterile DI water) store @ RT 
 *bring to boil in microwave right before use, no longer than 30min out. Do not 
boil  longer than 30min as is sensitive to heat and time 
1c. Set incubator to 40°C 
 
2. Histoclear 2x 5min. (must be fresh, use afterwards to replace old histoclear in the H&E 
station) 
3. 100% ethanol 2x 1min. 
4. Air dry slides 5min.  
5. Circle sections on slide with PAP pen (vector lab. Cat No. H-4000, Immedge pen) 
6. Add Pretreat #1 – Cover section for 10min. *move quick, add pretreat #1 after outlining 
w/PAP* 
7. Wash with sterile DI water 2x (this is done in slide holder) 
8. Submerge in Pretreat #2 for 15min boiling 
9. Submerge in sterile DI water 2x (do not slides cool between boiling and submerging in 
water) 
10. 100% ethanol 1min 3-5x up and down 
11. Air dry slides for 5min. @ RT 
12. Re-circle sections with PAP-pen – 2min. dry time before next step 
13. Add Pretreat #3 (5 drops per section) 
14. Place slides in 40°C oven for 30min. 
 while slides are incubating conduct the following: 
14a. Warm probe @ 40°C for 10min in incubator then cool to RT 
15. Add Probe for 2hrs. @ 40°C. 
 while probe is hybridizing conduct the following: 
15a. 15-20min before incubation is complete warm wash buffer for 20min. @ 40°C 
15b. Bring AMPs 1-6 to RT 
16. 1X wash buffer 2min. 
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17. AMP#1 for 30min. @ 40°C 
18. 1X wash buffer 2x 2min. (4min.) 
19. AMP#2 for 15min @ 40°C 
20. 1X wash buffer 1x 2min (2min.) 
21. AMP#3 for 30min @ 40°C 
22. 1X wash buffer 1x 2min (2min.) 
23. AMP#4 for 15min @ 40°C 
24. 1X wash buffer 1x 2min (2min.) 
25. AMP#5 for 30min @ RT 
26. 1X wash buffer 1x 2min (2min.) 
27. AMP#6 for 15min @ RT 
28. 1X wash buffer 2x 2min (4min.) *start making Red Working Solution while waiting* 
29. Add Red Working Solution (~120ul/slide) for 10min @ RT (1:60 ratio RedB:RedA) 
(17ul:980ul ≈ 1ml) *RedA is alcohol sensitive and the entire rxn is light sensitive* 
30. Wash with sterile DI water 2X 
31. 50% Hematoxylin staining (~2min. @ RT: Optional) 
32. Wash with sterile DI water until cleared 
33. Add 0.025% ammonia water for ~10sec. (until blue) 
34. Wash with sterile DI water 3-5X 
35. Dry slides 15min. @ 60°C (shake well before) 
36. Dry additional 5min. @ RT 
37. Dip in xylene for -2min (make sure pen marks removed to avoid air bubbles) 
38. Mount in Cytoseal 60 
39. Image the following day once dried 
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AC2 Gene expression and manipulation: Design and preparation of Morpholinos for 
electroporations 
Morpholino oligos are short chains of about Morpholino subunits about 25 subunits in length with 
each subunit comprising of a nucleic acid base, a morpholine ring and a non-ionic 
phosphorodiamidate intersubunit linkage. Morpholinos do not degrade their RNA targets, but 
instead act via a steric blocking mechanism independent of RNase H. They have higher binding 
affinity than DNA-based antisense oligos and are also designed to have a higher degree of 
complementarity with their target RNA’s to minimize off targeting effects. These factors enable 
them to reproducibly target RNA and yield predictable results. The Morpholino oligos can be used 
to perform two kinds of RNA targeting. A. blocking of translation initiation B. modify pre- mRNA 
splicing. For designing what strategy would be the most effective way against the target of interest, 
the following questions need to be considered. 
a. What is the extent to which the target sequences are known (are they predicted mRNA 
sequences/ confirmed and verified mRNA sequences etc., is enough known about the 
sequences upstream of the start codon to design translation blocking oligos etc.)  
b. What is known about the structure of target mRNA?  
c. Does the target sequence share homology with undesirable gene targets? 
d. How to assay for successful gene knockdown. 
e. What is the method of delivery?  
The key features of an ideal Morpholino sequence is as follows 
a. The base sequence of the oligo should have very little self-complementarity. 
b. The oligo will be about 25 bases long and has a GC content of 40-60%. ( 25 bases is 
considered from the view point of efficacy of blocking) 
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c. Oligos should not have four or more contiguous G’s for sake of solubility. 
Ideally, my recommendation is to design both translation blocking and splice blocking 
morpholinos to target a gene of interest.  
Things to keep in mind for designing translation blocking Morpholinos: 
While the GeneTools representative in general designs the best possible Morpholino for 
you, it is imperative that we should be familiar with the criteria of the ideal translational 
Morpholino. Gene tools defines an ideal translational blocking oligo as “An optimal translation 
blocking Morpholino is an oligo that lies within the region from the 5’ cap through the first 25 
bases of coding sequence, has 40-60% GC content and has little or no secondary structure.” 
Usually it should be possible to find at least two non-overlapping oligo targets within the 
5 ‘cap to start region that can meet the criterion.  In such cases, it would be better to order the 
different oligos and do preliminary testing to determine which oligo produces the best results. It is 
also common practice to use two non-overlapping oligos targeting the same RNA as a specificity 
control set. If the oligos (used in separate experiments) phenocopy one another, that indicates that 
the phenotype is most likely due to interaction with the target RNA and not an unexpected 
interaction with a different RNA.  If co-administration of the two oligos shows dose synergy when 
compared to the individual-administration experiments, that also supports the hypothesis that they 
are interacting with the same target RNA. 
It is always important to BLAST Morpholino designs that the gene tools representative 
gives to see if they bind unexpected sequences. 
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Things to keep in mind for designing splice blocking Morpholinos: 
Designing oligos to interfere with pre- mRNA splicing can create specific desired effects such 
as exon deletion or intron insertion which can be quantitated by RT-PCR which is ideal for genes 
for which antibodies do not exist. To design oligos that can interefere with pre-mRNA splicing, 
the following guidance have been given by GeneTools in their website. 
1. “Targeting exon-intron boundaries or intron-exon boundaries of internal exons generally 
results in complete or partial deletion of the abutting exon along with its flanking introns.” – 
when this happens, it should be taken care that the deletion of the exon causes a frame shift  
and either brings premature termination codon in-frame or trigger nonsense-mediated decay of 
the transcript. 
2. However, in cases where there is a great deal of divergence in splice sites from consensus, it 
is also possible to generate intron insertions.” – Not my favorite. But in some situations this 
might be needed. 
3.  “Targeting a splice junction of the first or last exon in a pre-mRNA generally triggers a 
complete or partial intron inclusion”.  
When designing splice Morpholinos, irrespective of the strategy, it is important to have a high 
RNA binding affinity. 
Nature of oligos to be ordered: 
GeneTools offers different types of Morpholinos. The kind of Morpholinos that are 
generally recommended for chick electroporations are standard oligo controls with a 3’ fluorescein 
cap. While GeneTools offer red, blue and green fluorescent tags (the GeneTools blue, 
carboxyfluorescein and lissamine (rhodamine b) respectively), the red would be my last choice 
because it tends to decrease the solubility of Morpholinos when conjugated to the 
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oligo.  GeneTools blue is fairly close to DAPI in its fluorescence and a DAPI filter set works, but 
to optimize the fluorescence signal you need a custom filter set.  That leaves carboxyfluorescein, 
which is a bright fluor but like all fluoresceins it will photobleach in intense light.  I prefer 
carboxyfluorescein, minimizing bright light exposure until it is time for a measurement. Regarding 
the amount of Morpholinos to order, In general, I recommend starting with 300nmol vial of the 
custom oligo of your interest as that will last at least 10 rounds of electroporations. 
Making stock solution of morpholino oligos and storage: 
The Morpholinos arrive in brown vials that contain lyophilized powder. It is best to 
reconstitute in the same vial. Morpholinos should be stored at room temperature as they are much 
more stable than DNA, and at the same time freezing will affect its solubility. While Gene Tools 
recommends to make the stock solutions of Morpholinos at 1 mM concentration. For chick 
electroporation, Dr. Marcos Simoes Costa advised me to make the stock solutions at 2 mM 
concentration. So care should be taken while reconstituting so that the stock solution is at 2 mM 
concentration. 
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Electroporation mix using Morpholinos: 
 
Dr. Marcos Simoes Costra recommends to electroporate Morpholinos with a carrier DNA 
(a promoterless vector- In my case, I have used pSlax) and he says that this helps with better 
delivery of DNA. 
In addition, he recommends, adding Tris pH 8 for extra stability of morpholinos. 
For a 20 ul electroporation mix: 
 
Morpholinos of interest ( 2mM) = 10 ul  
Carrier DNA: dilute to 1ug/ul 
Tris ph8 (100uM): diluted to a final 
concentration of 10uM 
Luna mix: 6.6 ul. 
H20: to make it up to 20ul. 
This should last for electroporating 100 
embryos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This would dilute the concentration to 1mM 
which is then ultimately diluted to a 100 
uM concentration that we are injecting into 
the HH14 embryo, that takes about about 10 
ul in wet volume. Thus the Theoretical 
concentration that is being delivered to cells 
is between 1-10 uM 
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AC3 Gene expression and manipulation: Preparation of MU-Xyloside soaked beads 
4-Methylumbelliferyl-β-D-Xyalopyranoside (MU- Xyl) is a flurogenic substitute of B-D- 
Xyloside and is a substrate for B- xylosidase. When incubated wit hcells such as chondrocytes, 
Mu-Xyl acts as the primers for the exo-polymerases that add glucuronic acid to the xyloside primer 
to make up the glycosaminoglycan (GAG) chains. In fact, adding Mu-Xyl in excess, results in 
secretion of fluorgenic GAG into the medium that have 4- methylumbelliferone in the reducing 
termini. This results in depletion of endogenous levels of sugars and that drastically affect the 
synthesis of GAGs that require glucuronic acid such as Hyaluronan and Chondroitin Sulfate. Since 
it functions as B-Xyloside primer, it is less toxic than 4 MU itself which has other side effects that 
causes the toxicity. 
Reagents: 
1. Pen-Strep (SV20010-Fisher) 
2. Resin beads (143-1255-BioRad) 
3. 4-Methylumbelliferyl-β-D-Xyalopyranoside- 
Sigma #M7008 . 
4. Luna Mix. 
 
Storage: 0C or -20C. 
Procedure: 
1. Weigh 0.2-0.3g of the beads into a 1.5mL centrifuge tube. 
2. Wash beads 3X with 1mL of 1XPBS by centrifuging at 5000G for 1 min each time. 
3. In a separate tube, weigh out 12 mg of Mu- Xyl and dissolve it in 1 ml of DMSO by 
repeated pippeting.[for 40mM] 
4. Add MU-Xyl to the tube containing beads and allow the beads to soak in MU-Xyl 
overnight at RT, with gentle rotation of the tube. 
5. Add 5ul of Luna mix to 200ul of the inhibitor/beads mix and let the tube rotate for 
another 2 hours at RT, till the beads are no longer colorless. 
6. Use beading technique as described in Aparna Mahadevan’s thesis  (Aparna Mahdevan, 
2016 – Section A7) 
 
 
 
Several references exist that have used 
Mu-Xyl in invtro culture at 1 mM. For in 
vivo beading, I have performed 
empherical trials with the following 
concentrations: 1,5, 10 , 20, 40, 80, 
120nM. Typically, I see the strongest 
phenotype between 5 mM and 120 mM.  
To get the maximal survival rate, I have 
standardized the concentration to 40mM 
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AD1 Immunostaining: HABP staining on tissue sections 
Hyaluronan (HA) is non-immunogenic (i.e. antibodies cannot be raised against it). However, it can 
be detected in tissues and cells by use of a “hyaluronan – binding – protein” (HABP). Typically, 
HABP is isolated from bovine nasal cartilage and is comprised of a combination of G1 and the 
cartilage “Link” protein (both of which have conserved linkmodule HA binding domains. 
Biotinylated HABP permits the addition of a variety of fluorophore or enzymatic (i.e. horseradish 
peroxidase or alkaline phosphatase) streptavidin constructs for fluorescent or light microscopy. 
The following protocol has been Adapted and modified from Programs of excellence in 
Glycosciences, Cleveland Clinic’s HABP protocol (NHLBI P01HL1071247) and amsbio protocol 
for HABP http://www.amsbio.com/protocols/HABP-Protocols-for-IHC-and-ELISA.pdf 
Reagents: 
1. Blocker (3% HIGS in PBST): Add 1. 5 ml of Heat inactivated goat serum (Invitrogen, cat 
number: 16210072) to 50 ml PBS.  
2. Biotinylated Hyaluronan Binding Protein (EMD/Millipore/Calbiochem #385911, 50 ug)  
Reconstitution: Add 100 microliters of water to 50 mg HABP. Vortex, and let sit at room 
temperature for 20 minutes. Vortex again, centrifuge and make 10 aliquots of 10 μl each. Store at 
–80 C indefinitely. Use at 1:40. 
3. Fluorescent streptavidin secondary antibody: Streptavidin, Alexa Fluor 488 conjugate (green) 
(S32356 Invitrogen).  
4.Fluorescent Mounting medium: Prolong Anti fade (Vector Laboratories, H-1200) 
 
Protocol: 
Note: the following protocol is for cryosections (15-20 microns thick). For paraffin sections 
(recommended thickness 6-10 microns), after overnight drying at 37 C, bake slides for 20 
minutes @ 60 C followed by a 10 min cool down. Transfer slides to a slide holder and do the 
following washes: 2 X wash with Xylenes 10 min each, ethanol gradients washes (100%, 75%, 
50%, 25% dilutions of ethanol made in dH20) 10 min each, 2X washes in dH20, followed by 
antigen retrieval [1ml of antigen unmasking solutions (H3300 vector labs) in 100 ml of water, 
microwaved up to boiling point, cool down at 4C for 20 min] before following the protocol below. 
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1.  Rehydrate slides by washing slides with PBS - 10 min, 3X at RT. 
2. Rinse slides in PBST (PBS + 0.03% Tween) [Note, addition of tween helps in proper spreading 
of blocker solution] 
3. Place slides in humidified chamber; apply sufficient amount (500 ul- 1 ml) of blocker per slide 
to cover the sections. Let the slides sit in RT for 45 mins. 
4. Dilute HABP 1:40 (mixed with another primary antibody in the same tube if you have one) in 
blocker. Decant blocker from slide onto a paper towel, by tapping the slide to the paper towel, and 
add the HABP (with second primary if you have one) to the section in a sufficient quantity to cover 
it. Let it sit at room temperature for 45 min. 
5. Decant the antibody solution onto a paper towel and wash the slides with PBST 3X, 5 min, RT 
6.  Dilute the streptavidin 1:500 and DAPI (1: 2000) in blocker. Apply sufficient amount of 
streptavidin –DAPI mix to cover sections. Incubate at room temperature for 45 min in dark.  
7. Give 3 washes in PBST, 2 washes in PBS, 1X H20 and apply few drops of Prolong antifade. 
Place cover slip, wipe excess antifade, and apply nail polish on edges of cover slip. 
Recommended controls: 
1. Positive control: Any sections that contain neural tube and notochord of embryos (preferably at 
stages HH17 and above.) You should see signal surrounding the neural tube, and the signal 
surrounding the notochord {note: notochord by itself does not have any HA signal)  
2. Negative controls:  
a) Hyaluronidase treatment: Use adjacent sections of the tissue that you are investigating for this 
treatment. This treatment has to be done after rehydration with PBS and before rinsing with PBST. 
(between steps 1 and 2)  
Reagent: Streptomyces hyalurolyticus; EMD/Millipore Product #389561) 
Reconstituting hyaluronidase  to conc of 0.2 TRU/ ul  or 200 TRU/ml.: Add 500 µl 100 mM 
ammonium acetate to one ampule of Streptomyces hyaluronidase containing 100 TRU of enzyme. 
Incubate at RT 20 min. Rotate the ampule to make sure that the liquid comes into contact with the 
entire surface of the bottom quarter of the ampule. Make 25 µl aliquots in PCR tubes. Store at –80 
C indefinitely. Final concentration: 0.2 TRU/µl 
Hyaluronidase treatment prescribed by amsbio protocol:  
After rehydration with PBS, Treat slides with reaction buffer of Hyaluronidase (100mM Sodium 
acetate buffer, pH6.0) for 15min at 37°C. No wash . 
Treat with Hyaluronidase (200TRU/mL; 100mM Sodium acetate buffer, pH6.0) for 2hrs at 60°C.  
Wash with PBS 3X 5 min, RT.  
Resume with Blocking. (Steps 2,3 ) 
 
b) No primary control – (To detect background staining by secondary and to look at 
autoflourescence of tissues) – Sometimes, basement lamina, red blood cells are likely to 
autofluresce. 
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AE1 Live imaging: Ex vivo live imaging of embryonic explants 
This is a technique that I had developed to study the cellular and vascular dynamics of embryonic 
gut explants to understand the asymmetric processes that are happening in the DM. I have used 
electroporated chick explants to investigate the cellular processes in left and right DM. I have used 
transgenic quails (Tie1-H2b-YFP) to characterize the vascular dynamics and I have used Prox-1 
GFP mice to characterize lymphatic development in the gut. This technique is best used for 
studying left right asymmetries and is not optimal for analyzing processes that happen in three 
dimensions such as vascular remodeling. 
Before start of experiment:  
Have clean chilled PBS (1 L) along with 4 falcon tubes ready. 
Have petri dishes for doing the dissections ready. 
Have cleaned forceps, spatula ready. 
Have a falcon tube containing 50 ml of F12 media+10mM HEPES+ 1X P/S ready in an ice bucket. 
(Another tube as backup) 
Have another falcon tube containing 10 ml F12 media + 1% agarose ready at room temperature. 
(Another tube as backup) 
Have imaging slots booked at least 3 days before the experiment. 
Keep a falcon tube containing 50 ml of 1X PBS, in a plastic beaker in the 37 C incubator at the 
core facility at least 3 hours before starting the experiment. 
Sample preparation: 
1. Electroporated Chick embryo explants:  
a. Plan in such a way that the eggs will be HH14 for elextroporations and have reached 
HH17 in time for the live imaging slot. 
b. Embryo dissection. Carefully and quickly dissect out the embryos at HH17. Have 
clean chilled PBS ready.  Transfer into chilled PBS once dissected. Remove head 
and limb buds.  
2. Transgenic Quail explants: 
a. Plan in such a way that the eggs will be HH17 four hours before the imaging starts. 
The timing of the quail embryos is slightly different from the chick and the 
experiments should be planned accordingly.  
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b. Embryo dissection: Carefully and quickly dissect out the embryos at HH17. Have 
clean chilled PBS ready. Transfer into chilled PBS once dissected. Remove head 
and limb buds. 
3. Mice explants: 
a. Mice dissection. Carefully and quickly dissect out the embryos at E 11.0. Have 
clean chilled PBS ready.  Transfer into chilled PBS once dissected. Remove head 
and limb buds. 
 
Procedure: 
 
1. Preparation of embryonic slices: 
Take the dissected embryo, one at a time, place it in tissue chopper with clean 
mica plate, remove excess water with Kim wipes, but hold the embryo using the forceps 
while doing this to prevent loss of embryo. (Excess water can result in tissue sliding 
in-between chopping- can result in loss of slices) 
a. Set chopper to chop at 200 um thickness. Once the embryo is chopped, remove 
the mica plate, and squirt down clean PBS using a Pasteur pipette to transfer 
the slices into a glass dish. 
b. Once the slices are in the dish, sort out the best slices that contain intact 
mesentery using fine forceps, and carefully chop of the body wall remains. The 
slices tend to be sticky. Take the selected slices carefully and transfer them to a 
vial that has F12 media + 10mM HEPES+ P/S and keep the vial in ice. If there 
are more than 10 slices, prepare back up vial(s) each containing 10 slices. 
(Transfer can be done using Pasteur pipettes) 
c. Do this for other embryos.  
d. Carefully pack the vial containing the slices with para-film along with forceps+ 
media falcon tubes+ the live imaging dishes + 1 glass dish+ a plastic beaker (to 
hold the agarose – media falcon tube while microwaving in a tray and head to 
imaging core facility at Weill Hall. 
 
2. Embedding of the slice explants:  
a. Transfer slices from the vial to a glass dish under the stereoscope in Zipfel lab 
(the glass dish contain PBS/Media (@ 37C).  
b. Open the live imaging dish, open its cover and keep it ready under the 
stereoscope. 
c. Take the falcon tube containing F12 + agarose to Becky’s (Warren Zipfel) lab 
microwave. Do 5 second bursts (4 times- 20 seconds total heating) and remove the 
falcon tube from the microwave when the media is bubbling. Heating in 5 seconds 
intervals gives greater control and prevents spillage of media in the microwave 
oven. Immediately proceed to embed the slices in the agarose/F12 mix before the 
agarose solidifies. NOTE: If there is a mistake in embedding, the agarose/F12 
cannot be re-melted. This damages the tissue irreversibly. 
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d. Take a Pasteur pipette and place a decent size agarose media bubble in the center.   
Quickly add slices+ very little media. Using good forceps, manipulate the slices 
such that a) the slices are as flat as possible with no damage b) the slices are in the 
center of the dish.  (Best embedding is achieved with not more than 5 slices per 
plate since proper embedding needs to be completed before agar solidifies. 
e. Wait for agar to solidify. Add surrounding layer to root the agar bubble firmly 
on the dish. Make the subsequent layer thin but strong enough to cover the whole 
agar.  Wait for this layer to solidify before adding the F12 media+ HEPES+ P/S . 
Add enough to submerge the whole bubble layer. Keep it in 37C incubator and 
proceed to turn on the microscope. 
 
3.  Basic microscope settings (This only describes the minimal settings to keep in mind. 
Proper training on the microscope is strongly advised, with either Dr. Rebecca Williams or 
Dr. Warren Zipfel. Also mention the intention of your experiment when getting trained to 
receive the most optimal training) 
a. Have incubator along with the CO2 chambers set up. 
b. Use the following parameters for image acquisition: 
Image acquisition: 1024*1024 pixels 
Bit size: 16 bits 
Acquisition speed: 7 or 8.  
Zoom: 0.6- 0.7 to capture both dorsal/ ventral and to allow for XY drift.) 
 Laser settings: not more than 6-7 % 
   Pinhole: 1 AU (essential for Z acquisition) 
                        c. Set appropriate Z intervals to minimize time of acquisition.  
d. Trial images have to be conducted to set the frequency of imaging in time lapse.  
    e. After finalizing parameters, set acquisition for overnight and acquire. 
 
 
 
 
 
 
 
 
